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Introduction 
 
 
 
 
 
 
Allostery is a regulation mechanism common to a number of proteins whereby a 
binding event of an effector molecule at one site affects another distinct functional 
(or active) site of the same protein. The effector can influence either the substrate 
affinity at the active site or the overall protein catalytic activity. For these reasons, 
the effector molecule can be either an allosteric activator or allosteric inhibitor, 
depending on whether it diminishes/blocks or increases protein function.1 
In the recent years, the development of allosteric modulators (both allosteric 
activators and allosteric inhibitors) has been on the rise because allosteric drugs offer 
a number of advantages that make them desired as drug candidates.2, 3 
Allosteric drugs, in fact, can exhibit a higher selectivity profile among proteins 
that belong to the same family than classical orthosteric drugs (i.e. drugs the bind the 
active site), because allosteric binding sites are often less evolutionary conserved. 
Often, allosteric drugs are pursued to treat resistant forms of the diseases, because 
point mutations are often found in the orthosteric binding site, making the classical 
orthosteric drugs poorly effective, or even inactive. Allosteric drugs are also 
interesting from a physiological point of view. They provide a way to modulate the 
natural regulation (amplify or reduce naturally regulated response), rather than 
completely inhibit or activate a protein. In other words, the maximal effect of an 
allosteric binder does not necessarily lead to a complete protein inhibition or 
activation. This saturability allows safer doses. Overdoses of allosteric drugs, in fact, 
do not fully eliminate an essential signal. Also, allosteric ligands can have a 
spatiotemporal specificity. In practice, they can exhibit their function only in 
presence of the endogenous ligand, restring their effect to certain tissue at certain 
time.4, 5  
Notwithstanding their multiple advantages, the development of allosteric drugs is 
challenging. In fact, the number of allosteric drugs present in the market is 
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significantly lower respect to the orthosteric drugs.4 In this regard, one of the main 
issues encountered in the drug discovery process is the identification of the allosteric 
binding site on the protein surface. Very often, in fact, the allosteric binding pocket 
has a highly dynamical behavior, displaying a transient nature that makes it difficult 
to detect by means of conventional X-ray experiments.6 In addition, also an 
exhaustive knowledge of the molecular mechanisms that underlie the propagation of 
the allosteric signaling across the protein might help the process of the drug 
discovery.7 In this respect, allosteric drugs can be rationally designed in order to 
impede the functioning of the protein, working as a ‘stick wedged between the gears’ 
of the protein machinery. In this scenario, computational methods in conjunction 
with experimental techniques, as X-ray crystallography and NMR spectroscopy, 
might help both the detection of allosteric pockets and the comprehension of 
protein’s allosteric behavior.4 
In this thesis, we applied computational techniques, based on molecular modeling 
and simulations, to face both the aforementioned aspects. First, we studied the 
molecular basis that allosterically regulates the function of Abelson (Abl) kinase, a 
relevant pharmaceutical target for the treatment of several malignancies, as chronic 
myelogenous leukemia (CML).8 This study proposes a novel mechanism according 
to which conserved structural motifs dynamically cooperate to regulate allosterically 
the function of the kinase. The information retrieved from this study can be 
employed for the rational design of new kinase allosteric inhibitors. In collaboration 
with Hantschel and Dal Peraro labs at École polytechnique fédérale de Lausanne 
(EPFL), where I spent a period of nine months during my PhD studies, we also 
investigated this mechanism in other kinases, as Btk, using an integrative modeling 
approach. In addition, we also developed a new algorithm for the detection of protein 
pockets in MD simulations. This algorithm has been conceived to identify and 
analyze all the pockets of a given protein without any user a priori information of 
their localization. It also enables the detection of pockets’ network, characterizing 
possible allosteric signaling pathways that connect the functional with the allosteric 
sites. Overall, this tool allows the study of the dynamic properties of pockets and 
might be employed in the early stages of the drug discovery process to design both 
orthosteric and allosteric binders. This study has been performed in collaboration 
with Concept Lab at IIT. Currently, this algorithm has been implemented in 
Pocketron, a module of BiKi software. To conclude, I gave my contribution in 
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several drug discovery projects. In this context, I employed computational methods 
to identify hit compounds able to inhibit validated targets for the treatment of cancer.  
 
This thesis is divided in 7 chapters as follows: 
•   Chapter 1: General introduction on allostery in protein kinases, focusing 
on Abl, and on experimental and computational methods employed to 
elucidate allosteric mechanisms.  
•   Chapter 2: Description of the theoretical methods employed in this thesis 
(i.e., classical MD, enhanced sampling MD and molecular docking).  
•   Chapter 3: Study on the allosteric molecular mechanisms that control the 
A-loop plasticity in Abl kinase investigated via classical MD and free 
energy simulations.  
•   Chapter 4: Presentation of a new algorithm for the detection and analysis 
of protein pockets along extended MD simulation. 
•   Chapter 5: Ongoing work on structural characterization of activated Btk 
kinase structure investigated via integrative modelling. 
•   Chapter 6: Drug discovery projects this PhD course: application of virtual 
screening and molecular modeling techniques to identify inhibitors against 
pharmaceutical relevant protein target.     
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Chapter 1  	  
	  
	  
	  
 
 
Allostery in protein kinases 
 
 
 
 
	  
1. Allostery in proteins  
	  
Allostery is a regulation mechanism present in a number of biomolecular systems. 
In allostery, the binding of a small molecule (or a peptide or another protein) to a site 
far from the functional (or catalytic site) influences the overall protein activity. 
Allostery plays a fundamental role in a number of biological processes as signal 
transduction9, transcriptional regulation,10 molecular machines,11 and metabolism,12 
with great relevance to disease.13 Given the paramount importance of allosteric 
processes in the regulation of cell life, it has been suggested that all proteins can be 
allosteric.14 In this context, the comprehension of protein allosteric mechanisms is 
essential in order to shed light on the functioning of biological processes and to 
explain the dysfunction of a disease to design drugs.15 
Over the last decades, allostery has been largely studied and several models have 
been conceived in order to explain and rationalize the allosteric behavior in proteins. 
The first models proposed to describe the allosteric effects are the concerted MWC 
model by Monod, Wyman, and Changeux16 and the sequential KNF model by 
Koshland, Nemethy, and Filmer.17 Both models were originally developed to provide 
a description of allostery in hemoglobin. They consider two major conformational 
states for the different protein domains, the tensed (T) and the relaxed (R), where the 
relaxed binds the substrate more readily than the tensed. The MWC model assumes 
that enzyme subunits are in the same conformational state and are connected in such 
a way that a conformational change in one subunit is necessarily conferred to all 
other subunits. In absence of ligand, the equilibrium favors one of the conformational 
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state, which can be R or T. The binding of a ligand (allosteric effector) in a site 
different from the active site (allosteric site) shifts the chemical equilibrium in favor 
of the high-affinity state, leading to a cooperative ligand binding (Figure 1.1 A). On 
the contrary, the KNF model states that the enzyme subunits do not have necessarily 
the same conformation. The ligand induced fit binding leads to a conformational 
change in the domain, which is not propagated to the other subunits, as in the 
previous case. In fact, according to this model, the switch of one subunit makes the 
other subunits more likely to change, by reducing the energy needed for subsequent 
subunits to undergo the same conformational change (Figure 1.1 B).1 However, the 
aforementioned models have in common the following features: i) only two protein 
states exist (i.e. the tensed or the relaxed); (ii) there is a conformational change in the 
substrate binding site; (iii) the allosteric signal form the allosteric site to the 
functional site is transmitted via a single pathway.18 
Given the last advances in field of structural biology, proteins and other 
biomolecular systems acquire a new perception, in which they exist in a dynamical 
ensemble, rather than two discrete states. In this new scenario, a protein is seen from 
a statistic point of view, where different conformational states interconvert in one 
another, in an energy-driven manner. Therefore, the protein conformational ensemble 
has a certain distribution, which can be defined by the free energy landscape (Figure 
1.1 C).19, 15 Notably, environmental changes as temperature, post-translational 
modification (PTM), point mutations, covalent or noncovalent ligand binding alter 
the protein population distribution. Such a state redistribution is the key of the 
allosteric effect. In this new view, allostery is a thermodynamic phenomenon, which 
is governed by enthalpy, enthalpy and entropy or entropy.15, 20 Moreover, the 
existence of multiple conformational and dynamic states implies the presence of 
multiple pathways in which the signal is transduced through the protein. The effect 
of an allosteric modulator can vary from major conformational rearrangements to 
subtle shift in conformational population. In this context, the allosteric signal can be 
transmitted through structural motifs, as rigid protein portions or flexible linkers and 
loops.4 
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Figure 1.1. Models of allostery. (Top) The two-state concerted model of Monod–
Wyman–Changeux (MWC) (Middle) The sequential model of Koshland–Nemethy–
Filmer (KNF). (Bottom) The population shift model of allostery. Figure adapted 
from Lu S. et al.21  
	  
	  
Albeit significant progress has been done to comprehend the principles that 
regulate allostery, it has to be investigated case-by-case. In fact, the molecular 
mechanisms that underlie the allosteric signal propagation can be different according 
to the molecular system that we are studying. Recently, it has been proposed that the 
allosteric signal can be propagated according two different models: the domino and 
the violin. In the domino model, the binding of an effector molecule to the allosteric 
site triggers local structural changes that are propagated linearly via a single pathway 
to the functional site.22 PDZ domain family23 GPCRs, hemoglobin24 are examples of 
proteins that possess this type mechanism. In the violin model, instead, the allosteric 
signal is propagated without a specific pathway, but it is transferred throughout the 
whole protein.22 Hereafter, we review the most employed experimental and 
computational methods to study allostery in protein, focusing on those that are also 
used to identify or predict allosteric binding sites.  
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1.1. Experimental methods to study allostery 
	  
During the last decades, protein allostery has been largely investigated by using 
experimental techniques. The X-ray crystallography is one of the most frequently 
used experimental approaches, providing a detailed characterization of static 
conformational states of a protein, for example before and after the allosteric signal. 
In fact, only after the structural characterization of both the tensed and the relaxed 
state of hemoglobin, Monod, Wyman, and Changeux were able to postulate the 
concerted MWC model.25 However, since allostery is a dynamical process, the lack 
of dynamical information on the static crystal structures makes X-ray crystallography 
unsuitable to study alone the allosteric behavior of a protein, but requires the 
integration with other techniques. In this regard, nuclear magnetic resonance (NMR) 
spectroscopy delivers a more detailed information, capturing several transient 
conformations that can fill the gap among the protein states retrieved with X-ray 
crystallography. For example, through 19F NMR experiments, Ye and colleagues 
identified four new states of GPCR protein A2A that helped the interpretation of the 
conformational landscape of the receptor. In this study the authors also found that 
these states, namely S1, S2, S3 and S3’are in equilibrium among them. This 
equilibrium can be perturbed in a ligand depend manner, according to a mechanism 
in line with the conformational selection theory. Importantly, the identification of 
new A2A states enable to design potent and selective A2A binders and the choice of the 
interacting state would then dictate pharmacology.26 
Also, the conformational changes of a protein can be captured with techniques as 
fluorescence resonance energy transfer (FRET) and hydrogen–deuterium exchange 
mass spectrometry (HDXMS). The former method measures the movements of two 
fluorophores properly attached to the protein, while the latter detects the replacement 
of hydrogens with the deuterium on the protein resulting from a conformation 
change. FRET was applied, for example, to study the mechanism of activation of 
APMA receptor. In particular, the authors of this study found the cleft closure in the 
ligand-binding domain of AMPA controls the activation of the receptor, in 
agreement with existing X-ray experiments.27 Instead, HDXMS is an extensively 
used technique aimed at identifying conformational change in the protein upon 
ligand binding. Recently, Chandramohan et al successfully applied HDXMS 
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technique to map the dynamics of Hsp90, distinguishing the effects provoked by an 
orthosteric or an allosteric ligand.28  
 
 
1.2. Computational methods to study allostery  
	  
Computational methods play also a pivotal role in the study of protein allosteric 
mechanisms and in the identification of new targetable allosteric pockets. In this 
regard, molecular dynamics (MD) simulations (see Chapter 2) have emerged as a 
valuable complement to the experimental methods in the study of allostery.29 MD 
simulations are particularly suitable for the study of allostery for three main reasons: 
i) they provide an all-atom description of protein behavior with very high resolution; 
ii) they allow to determine the effect of a perturbation, for example the introduction 
of a point mutation or the ligand binding, on protein’s structure and motion; iii) they 
can be employed to find new allosteric pockets that are not visible in a ligand-free 
crystal structure.14 Hereafter, we report the main computational approaches that are 
used to probe the mechanistic aspects of allostery and to detect allosteric pockets in 
proteins.  
 
 
1.2.1. Protein-sequence analysis methods 
	  
The protein-sequence analysis is a powerful bioinformatics-based method that 
enables the identification of allosteric pathways as well as protein pockets. This 
method is based on the premise that a residue conserved during the evolution is 
likely to have a functional role.23 To perform this analysis, one needs a query 
sequence (i.e. the protein that one want to study) and a set of sequences of 
homologues proteins. After the alignment of the sequences to the query, a specific 
algorithm is applied in order to return evolutionary important residues. Depending on 
the type of algorithm used, this analysis returns two types of outcome. The first one 
is a list of single sequence positions without predicting a specific connection between 
them. In other words, the analysis predicts evolutionary important residues across the 
protein, but does not indicate whether far residues are linked to form the same 
allosteric pathway or not. Conversely, the second outcome returns pairs of 
evolutionary important residues that are linked between them.30 To do so, the 
algorithm detects the residue pairs that mutate in concert more frequently than one 
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would expect given random genetic events. In this sense, coevolved residues are 
assumed to be part of the same allosteric pathway. Despite these analyses are 
appealing because of their simplicity, they suffer of some limitations. Firstly, the 
specific biological role of the predicted evolutionary important residues is not 
indicated. This means that one cannot determine without an additional knowledge if 
a given residue might have catalytic role, might be part of a pocket, might have a 
structural role or might have an allosteric role. Another drawback of this method is 
that the results are strongly dependent on the goodness of alignment and on the type 
and number of structure aligned.31 Protein-sequence analysis was employed in 
different biomolecular systems, identifying new allosteric pockets as well as 
functional residues important for the allosteric signal transmission. For example, co-
evolutionary analysis was successfully used to study the allostery in PDZ domain 
family.23  
 
 
1.2.2. Energy landscape 
	  
In statistical mechanics, the free energy landscape of a biomolecular system is a 
function of the probability of observing a particular event. The deeper is the basin of 
a particular configuration, the more likely the protein visits that particular state. Also, 
the transition among different states is more probable if the energy barriers that 
divide the states are low. In this context, a positive allosteric modulator modifies the 
energy landscape of the unbound protein, increasing the depth of the binding site 
well or decreasing the depth of the competitive wells.15 Here, we report several 
methods that take advantage of the principles based on energy landscape to 
understand allostery in proteins and to identify ligand binding sites. 
The first method is based on protein frustration. This method starts from the 
assumption that proteins are endowed of a precise set of residues that can be key in 
the transmission of the allosteric signal or can be functional for ligand binding. These 
residues are referred to as “frustrated” and can be identified through heuristic 
algorithms.32 Ferreiro et al. for example, systematically perturbed the protein by 
mutating the residues and comparing the total energy of the mutated protein with the 
wild type. If the mutated protein is more energetically favored than the wild type, 
then the residues that have been mutated are considered frustrated.33 Weinkam and 
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colleagues successfully employed protein frustration in CLS transcription factor, 
obtaining useful insights into allosteric mechanism of the protein.34  
The Normal-Mode Analysis (NMA) is another widely-used method to study 
protein allostery. NMA examines the vibrational motion of a harmonic oscillating 
system in the immediate vicinity of its equilibrium. In proteins, NMA is based on the 
assumption that vibrational normal modes with the lowest frequencies describe the 
largest movements in a protein and are the ones that are functionally relevant.35 The 
binding of an allosteric effector perturbs the system, yielding new fundamental 
modes that might provide insights into allosteric mechanisms. NMA was 
successfully employed in several studies. By means of NMA, in fact, Gaillard et al. 
were able to have useful insights on the conformational transition between the high 
affinity ligand and low affinity ligand in LFA-1 protein.36 Also, NMA can be used to 
identify residues in the protein surface that can form a ligand orthosteric or allosteric 
binding site. In this regard, AlloPred is a tool developed recently by Greener et al 
that coupled NMA and machine learning techniques to predict protein binding sites.37   
An alternate option to NMA is the Elastic Network Model (ENM). In ENMs 
models a uniform harmonic potential is used to model the interactions between 
residue pairs. In this scenario, protein is seen as a 3D network, where the edges are 
virtual springs with a given potential energy. ENM was used to study global 
dynamics and allostery in a number of biomolecular structures, such as enzymes,38 39 
ribosome40 and viral capsids.41 42 
 
 
1.2.3. Methods based on molecular dynamics simulations 
	  
Allostery is regulation mechanism that involves protein dynamics. In particular, an 
allosteric effector perturbs the protein function either through large-scale structural 
changes (i.e. domains conformational changes, lid domain motions, loop 
rearrangements) or through subtle residues motions.7 In this respect, molecular 
dynamics (MD) simulations represent an effective tool to extensively study allosteric 
behavior of proteins, because of their ability to capture protein fluctuations and 
motions. So far, a wealth of computational studies adopted MD simulations to 
investigate allostery in proteins. These studies achieved useful insights on molecular 
mechanisms that underlie the allosteric behavior of a protein and were also able to 
identify binding sites of allosteric effectors. To study allostery several methods,
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based on MD simulations, exist. Among them, the most used are methods based on 
the network representation (or graph-based representation) of the protein and 
community analysis. 
The graph-based analysis is one of the most employed computational approach to 
probe the mechanistic aspects of allostery, employing information from MD 
simulation. According to this analysis, the 3D structure of a protein is represented as 
a graph were the nodes correspond to individual residues.14 Each pair of nodes is 
connected by an edge whose length is inversely proportional to the degree of 
interdependence between their motions. The “interdependence” between nodes can 
be computed with different methods that are based on correlated motions (e.g., 
mutual information, 43 fluctuation in atomic positions44 or on the number of specific 
noncovalent interactions (Figure 1.2). At this point, the resulting network 
representation of the protein dynamics can be analyzed with several techniques, in 
order to retrieve important pathways of communication between distant residues that 
contribute to allostery.4 Recently, Rehn et al. focused on the correlated motions, 
based on atomic fluctuation, to study the allosteric activation and deactivation of 
Hsp90. Supported by experimental evidences, the authors identified key residues, 
called ‘hot spots’, that are responsible of activating and inhibiting the allosteric 
signal in Hsp90.45  
Communities of residues (i.e. group of nodes in the network) that have a high 
interdependence among them can be considered an isolated module of the protein. In 
this regard, protein allostery can be seen as a dynamical connection among different 
communities that cooperate for the transmission of the allosteric signal (Figure 1.2). 
Using this approach, Rivalta et al. obtained useful insights on the allosteric 
mechanism of PRFAR binding to IGPS heterodimer, which were also supported by 
NMR experiments.46  
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Figure 1.2. Illustration of the main approach for building community structure, 
using GPCR as an example. (Upper left) GPCR cartoon representation. (Upper 
right) Degree of per residue backbone dynamics derived from molecular dynamics 
simulations. (Bottom right) Example of matrix of residue-residue cross-correlated 
motion derived from molecular dynamics simulations. (Bottom left) Communities 
derived from the cross-correlation matrix represented as nodes. Inter-community 
edge widths (proportional to the cumulative betweenness of intercommunity edges), 
represent the strength of the potential allosteric communication between 
communities. Figure adapted from Schueler-Furman, O. and Wodak, SJ.14  
	  
	  
1.2.4. Identification of protein allosteric pockets 
	  
Binding pockets are cavities on the protein surface where a drug interacts to 
perform its function. Nowadays, a number of algorithms and methods are present, 
which aimed at detecting protein pockets and determine their physicochemical 
characteristics.47 The major part of these tools relies on static structures that belong 
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to X-ray, NMR experiments or selected frames from MD trajectories. These pocket 
detection methods can be classified as geometry, knowledge and energy based.  
-   Geometry-based methods. These methods identify pockets by considering only 
the 3D spatial position of atoms within a protein. These methods return 
important information as volume and pocket’s shape, neglecting however other 
insights as the pocket physicochemical properties. In turn, geometric-based 
methods can be also classified in other three categories: sphere-based, the  a 
shape-based and the grid-based methods. In sphere-based methods, a number 
of spheres are placed around the protein. All the spheres are subsequently 
removed except those that occupy a surface cavity, which form therefore a 
binding pocket. The a shape can be considered a generalization of a convex 
hull, although it is more precise respect to a convex hull. A number of methods 
employ this theory to define a pocket. Lastly, in grid-based methods the 
protein immersed in a grid and the grid points that lie a pocket surface cavity 
are clustered to form a pocket.48    
-   Knowledge-based methods. These methods combine information that belongs 
to structural and genomic databases, taking into account of sequence and 
structural conservation to predict the position of a protein binding pocket.48     
-   Energy-based methods. These methods compute the energy between the 
protein surface residues and a probe, which in most cases is an organic 
molecule as methane or a water molecule, and identify binding site according 
to the resulting binding affinity.48  
Despite the growing number of accurate and robust algorithms for the detection of 
pockets, the identification of allosteric pockets is still challenging. In fact, quite often 
they are not detectable by looking only static structures. Frequently, allosteric 
pockets are transient and can be formed only after a conformational change that 
classical X-ray or NMR experiments are not able to capture. In this regard, coupling 
pocket detection algorithms with MD simulations might represent a viable strategy to 
overcome this issue. In the last years, many efforts have been conducting to develop 
new methods for the study of pocket behavior in a dynamic context. In 2011 
Schmidtke et al. developed the first tool able to pocket dynamics from an MD-
generated ensemble.49 Since then, other groups conceived different algorithms aimed 
at efficiently retrieving important information as pocket appearance, pocket volume 
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trend, pocket persistency along time. In this regard, in collaboration with the Concept 
lab in IIT, we also developed a novel algorithm for the identification and the analysis 
of protein pockets along extended MD simulations. Unlike the already existing 
algorithm, our tool also allows to determine whether near and far pockets 
communicate among each other. This return a network-based representation of 
protein pockets from which one can retrieve pathways that mediate the allosteric 
communication between functional and allosteric site (see Chapter 4).     
 
 
2. Allostery in protein kinases 
	  
2.1. Protein kinases: importance and biological function 
	  
Protein kinases (PKs) constitute nearly the 2% of human genome50 and are one of 
the most important protein families, because they regulate a number of biological 
process, ensuring the correct cell functionality. PKs catalyze the transfer of g-
phosphate from ATP to specific substrates as serines, threonines, tyrosines or 
histidines belonging to peptides or proteins. PKs phosphorylate about a third of all 
proteins in human cells.51 The phosphorylation causes significant changes on the 
structures of substrate proteins and affects also their function, activating or inhibiting 
their activity.52, 53 Therefore, PKs are considered one of the main regulators of cell 
biology, tightly controlling a number of signaling pathways important for cell growth 
and survival. Given their paramount importance in many biological processes, the 
activity of PKs is tightly regulated through several mechanisms. The lack or the 
impairment of such regulation mechanisms cause the dysfunction of PKs, which in 
turn leads to the incoming of multiple diseases as cancer, vascular disorders, 
diabetes, as well as neurological and inflammatory diseases. This makes protein 
kinases attractive pharmaceutical targets. In fact, the inhibition or the modulation of 
PKs activity became a validated strategy for the treatment of several diseases. So far, 
nearly 30 small-molecule protein kinase inhibitors are approved by the US FDA, and 
thousands of clinical studies targeting kinases are ongoing.54, 22  
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2.2. Structure of protein kinases and allosteric regulation 
	  
Eukaryotic protein kinases (EPKs) are endowed of a kinase domain (KD) of 
approximately 250 amino acids that has a catalytic role. Depending on the kinase 
family, KD can be coupled with other domains both at the N- and an C-terminal 
region. These domains can have a regulatory function, modulating the kinase activity 
or can mediate the interactions with other proteins, DNA or with the cellular 
membrane. For example, Src, Csk, Brk and Abl kinase families are endowed of SH3 
and SH2 domains, which play a key role in the allosteric modulation of kinase 
function and in the protein- protein interaction. Instead, Tec and Fes family kinases 
have the PH and the F-BAR domain, respectively, that allow the anchoring with the 
membrane interacting with the phospholipid. However, the KD is the most conserved 
region across all the kinases families. It has a bilobed shape formed by a small N-
lobe a larger C-lobe. The N-lobe is formed by five antiparallel b-sheets and a single 
a-helix named aC, while the C-lobe is chiefly formed by a-helices. The N- and the 
C-lobe are connected through a short sequence of residues called ‘hinge region’. This 
portion forms the ATP binding site, which is the orthosteric pocket that interacts the 
ATP and kinase ATP-competitive inhibitors. The ATP binding site is also formed by 
the G-loop, a glycine-rich sequence between b1 and b2 strands of the N-lobe that 
interacts with the phosphates of ATP, coordinating the ATP-Mg2+ co-substrate 
complex. The C-lobe also contributes to the ATP binding site through the activation 
loop (A-loop). This is a structural feature common in kinases, which is formed by a 
sequence of ~30 amino acids delimitated by the DFG and the APE motifs in the N-
terminal and in the C-terminal part, respectively. The DFG motif has a catalytic role 
because it directly coordinates the Mg2+ ions, while the C-terminal part of the A-loop 
interacts and positions the substrate (see Figure 1.3).55 
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Figure 1.3. A) Kinase domain of Abl kinase in the active conformation. PDB code 
2F4J. Important catalytic elements discussed in the text are reported. B) 
Representation of the C-spine (red) and R-spine (orange) in Abl kinase. Both spines 
are anchored to the aF-helix (green). PDB code 2F4J. C) ATP binding site of 
Insulin receptor kinase in complex with ATP-like molecule (grey sticks) and a 
peptide (orange). PDB code 1IR3.   
	  
	  
So far, X-ray and NMR experiments captured protein kinases in several active, 
inactive and intermediate conformations. Importantly, it turned out that when active, 
protein kinases share common structural organization, albeit they belong to different 
families.22 Conversely, when inactive, protein kinases adopt a particular structural 
assembly that is family-dependent.56 In particular, in the active state catalytic 
important structural elements of KD, as the aC and the A-loop, are proper oriented 
and constrained to foster the phosphotransfer reaction. Here, the DFG motif is found 
in the so called in conformation, where the phenylalanine lies in the ATP binding site 
and the aspartate is in an optimal orientation to coordinate the Mg2+ ions. The aC 
helix is rotated toward the ATP binding site enabling the formation of the conserved 
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salt bridge between the lysine of b3-sheet and the glutammate of the aC helix. The 
A-loop assumes an open conformation, enabling both the ATP and the substrate 
entrance. In the major part of protein kinases, the phosphorylation of A-loop at 
tyrosine, serine or threonine residues, further stabilizes the open conformation of this 
segment. This is made possible through the formation of a salt bridge between the 
phosphate and the arginine located in the conserved HRD motif. Recently, it has 
been found that kinases share two hydrophobic motifs, whose proper alignment is 
related to the active kinase state. The two motifs are the regulatory spine (R-spine) 
and the catalytic spine (C-spine) which are both spines are anchored to the 
hydrophobic αF-helix. 57, 58  
 
From a functional point of view, protein kinases are molecular regulators in many 
biological processes, activating or inactivating specific cellular pathways. To 
efficiently perform their function, kinases have evolved fine allosteric regulation 
mechanisms that enable them to promptly switch on or off in response to external 
agents. This ‘switch-like’ feature has been made possible thanks to their structural 
plasticity and their dynamical architecture. In particular, kinases can be turn on or 
turn off through four main mechanisms:  
1)   Interaction with regulatory subunits. Together with KD, a number of kinases 
are endowed of regulatory subunits that allosterically modulate the catalytic 
function in KD. A paradigmatic example of this class of mechanism is 
represented by PKA kinase. PKA is a tetrameric enzyme, which is formed by 
two KDs and two regulatory subunits named CNB domains, which in turn are 
divided in two subunits, CNB-A and CNB-B. In absence of the second 
messenger cAMP, the CNB domains bind the KDs, suppressing their activity. 
The binding of four molecules of cAMP to the two CNB domains enable a 
conformational change in CBNs that allow the exposure of KDs;59  
2)   Autoinhibition. This is a mechanism of autoregulation found for example in 
Ca2+-regulated kinases, twitchin60 and titin.61 The KD of these protein kinases 
are endowed of a C-terminal regulatory motif that acts as pseudosubstrate 
competing directly with the substrate entrance to the active site. When the C-
terminal tail enters in the ATP binding site, it causes a rotation of the aC 
helix that leads to the disruption of the catalytic important Lys-Glu salt bridge 
(Lys82-Glu98 in twitchin and Lys55-Glu68 in titin);  
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3)   Dimerization. This is mechanism by which the kinase is activated via the 
binding of another kinase. A paradigmatic example of this mechanism is 
represented by EGF kinase. In normal conditions, the kinase in inactivated 
displaying the aC helix rotated outward the ATP binding site and the A- loop 
folded. The binding of another EGF kinase (called activator kinase) forms the 
so-called head-to-tail dimer. This leads to the activation of the receiving 
kinase though the stabilization of the open A-loop conformation and the 
rotation of the aC helix.62  
4)   Phosphorylation by another kinase (trans-phosporylation) or by itself (cis-
phosphorylation). Phosphorylation is one of the most common mechanism 
employed by protein kinases to enhance or inhibit their function. 
Phosphorylation on particular residues, in fact, drastically change the overall 
charge of the protein leading to conformational changes stabilizing the active 
or the inactive form of the protein. An example of this is provided by Src 
kinase. The phosphorylation of the Y527 at the C-term stabilizes the closed 
autoinhibited conformation, where the phosphate docks a pocket in the SH2 
domain. Conversely, the phosphorylation of the A-loop at Y416, stabilizes 
the active conformation of the kinase.55      
 
 
2.3. The case of Abelson (Abl) kinase 
	  
2.3.1. Biological function and clinical significance 
	  
In this thesis, we mainly focused on Abelson (Abl) tyrosine kinases, a cytoplasmic 
and nuclear protein encoded by ABL1 gene located in chromosome 9. Abl plays an 
important role in several signaling pathways that control cell differentiation, cell 
division, cell adhesion and stress response. Mutations in the ABL1 gene often lead to 
the deregulation of Abl activity, which in turn results in the development of diverse 
pathologies, including several solid tumors, inflammatory disorders and 
neurodegenerative diseases.63 
The most common Abl-related disorder is the chronic myelogenous leukemia 
(CML), a cancer of white blood cells characterized by the unregulated growth of 
myeloid cells in the bone marrow and by the accumulation of these cells in the blood. 
The incoming of CML is driven by the chromosomal translocation of ABL1 gene in 
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chromosome 22 within the BCR (breakpoint cluster region) gene, generating the so-
called Philadelphia chromosome (Ph). The resulting fusion gene BCR-ABL encodes 
the unregulated Abl protein, the Bcr-Abl form, enabling the uncontrolled 
proliferation of cancerous cells in blood64 (Figure 1.4). 
 
 
	  
Figure 1.4. The ABL and BCR genes reside on chromosomes 9 and 22, 
respectively. As a result of the (9;22) translocation, a BCR-ABL fusion gene is 
formed on the derivative chromosome 22 (Philadelphia chromosome).  
 
The inhibition of Abl activity, through ATP-competitive small molecules, is a 
viable strategy for the treatment of CML.65 In 2001 the Food and Drug 
Administration (FDA) approved the first Abl inhibitor, Imatinib (or known also as 
Gleevec), a blockbuster drug that induce durable remissions and progression free 
survival in the majority of chronic-phase Ph-positive CML patients63 (see paragraph 
2.3.3.). However, over the last years, the first line therapeutics became ineffective 
against CML because of the incoming of mutated forms of Abl, which make current 
drugs poorly or completely inactive. As a consequence, nowadays many efforts are 
doing in order to design potent and selective Abl inhibitors that are also able to 
overcome the Imatinib-resistant forms of Abl.66 In this respect, one of the main 
strategy consists of targeting Abl allosteric pockets, which are binding site far from 
the functional ATP binding site. Structural and biochemical studies, in fact, have 
demonstrated that allosteric binders are key in the modulation of Abl activity 
stabilizing the active or the inactive form of the enzyme. In this context, the fully 
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comprehension of molecular mechanisms at atomistic level that underlie allosteric 
regulation in Abl is required to help the rational design of Abl allosteric inhibitors.   
 
 
2.3.2. Structure and allosteric regulation 
	  
Abl kinase is a 123 kDa protein that consists of ~1150 residues. Abl has a modular 
structure formed by the N-terminal cap, the SH3 and the SH2 domains and the kinase 
domain (KD) and, finally, by a series of binding elements for SH3 domain, a DNA 
binding functionality and an actin binding domain. In human, Abl is expressed in 
two isoforms: the Abl 1a and the Abl 1b, which differ only for the N-terminal part. In 
particular, the 1b isoform is myristoylated, while the 1a is not (Figure 1.5).67 
 
	  
Figure 1.5. Domain structures of Abl kinase on the top (both isoforms 1b and 1a 
are represented) and of the oncogenic Bcr-Abl kinase on the bottom.  
 
 
The activity of Abl kinase is regulated by a trans-phosphorylation mechanism. 
According to this mechanism, another kinase (as another Abl kinase itself) 
phosphorylates several residues spanned across the kinase structure, provoking a 
conformational rearrangement that ends up with the stabilization of the catalytic 
active form of Abl. In fact, when not phosphorylated, Abl assumes an inactive 
(autoinhibited or closed) conformation where the SH3 and the SH2 domains pack 
against the lateral part of KD (Figure 1.6).68, 69 In contrast, when phosphorylated, 
Abl is in an activated state where the SH2 binds the N-lobe of KD, assuming an 
elongated conformation (Figure 1.6). In this state, important catalytic elements of 
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KD as the aC and the A-loop, are proper oriented and constrained to foster the 
phosphotransfer reaction (see paragraph 2.2.).69, 70  
 
	  
Figure 1.6. Representation of the two main conformations of Abl kinase. On the left 
the autoinhibited (closed) conformation is depicted (PDB code: 1OPK). The SH2 
and the SH3 domains bind the lateral part of KD, while the myristate (Myr) interacts 
with the C-lobe of KD. Because of the low resolution of the crystal the N-cap is not 
shown. On the right, instead, the activated (elongated) conformation is shown (PDB 
code: 1OPL chain B). The SH2 domain binds the N-lobe of KD. The original X-ray 
structure comprehends only the SH2-KD complex. For sake of clarity the SH3 
domain was modeled.      
	  
	  
The N-cap is a region of ~80 amino acids which is important for kinase 
autoinhibition. The myristic group, present only in the 1b isoform,71 binds a deep 
hydrophobic pocket in the C-lobe of KD (Figure 1.6), which is a critical step for the 
maintenance of the autoinhibited form of Abl.72 In this way, the myristate acts as 
allosteric modulator of Abl function, tighly regulating its activity. In fact, the 
deletion of this region as well as the presence of point mutations result in a highly 
active kinase.72  This is the case of the Bcr-Abl oncogenic protein, where the N-cap 
region is replaced with the Bcr protein (Fig. 3). The SH3 domain is formed by two 
antiparallel b-sheets packed forming a barrel-shaped structure. The SH3 domain 
binds the proline-rich peptide that adopt a polyproline type II (PPII) conformation.73 
When in the autoinhibited Abl form, the SH3 interacts with the SH2-KD linker 
further stabilizing the closed conformation of Abl. Deletion of SH3 domain leads to 
an up-regulation of Abl activity, further confirming the importance of SH3 in the 
negative regulation of Abl.74 The SH2 domain is formed by a central antiparallel b-
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sheet flanked by a-helices on each side. The SH2 binds specific phosphotyrosine 
sequences, contributing to recognition and to phosphorylation of Abl substrates. This 
binding site is formed by a conserved FLVRES motif which interacts with the 
phosphotyrosine residue and by a nearby pocket that interact with the third amino 
acid of the C-terminal conferring substrate sequence specificity.75 When in the 
autoinhibited form, the SH2 docks the C-lobe of KD via a network of H-bonds and a 
unique pi-stacking involving Tyr 158 of SH2 and Tyr 361 of KD. Notably, this 
interaction is favored by a conformational rearrangement of the aI helix of KD 
which fold of ~45° after the binding of myristate (or another allosteric inhibitor, see 
later) to the C-lobe pocket in KD. Mutations in the SH2/C-lobe interface increases 
the Abl activity, evidencing the importance of SH2 in the down-regulation of Abl.72 
When in the activated form, the SH2 domain binds the N-lobe of KD. Interestingly, 
this interaction has been found to be important for stabilizing the active conformation 
of Abl (see Chapter 4 for further details), augmenting also the accessibility of the A-
loop to the substrate. In fact, biochemical studies have demonstrated that the SH2-
KD construct presents a higher catalytic activity than KD alone. Additionally, the 
SH2-KD complex favor the opening of the A-loop and the subsequent 
phosphorylation at Y412, which is a required step for a full kinase activation. 
Mutational studies also confirmed the importance of this domain-domain interaction 
in the allosteric modulation of Abl activity. In fact, point mutations in SH2 domain 
that impair the binding (e.g. I164E) are linked with a decreased activity of Abl,76 
whereas mutations that strengthen this interaction (e.g. T231R) lead to an increased 
Abl activity.  
 
 
2.3.3. Inhibition of Abl 
	  
Drugs that inhibit the oncogenic form of Abl kinase (Bcr-Abl) currently in the 
market bind the orthosteric pocket at the ATP binding site. On the basis of their 
molecular mechanism of action, the Bcr-Abl orthosteric inhibitors can be 
distinguished in two classes, the type 1 and the type 2. The type 1 inhibitors interact 
with the active conformation of the kinase, where the catalytically important residues 
are in the optimal position to foster the catalysis. This means that the DFG in the in 
conformation and the A-loop is open. On the contrary the type 2 inhibitors bind the 
inactive conformation of the Bcr-Abl. In this context, the DFG motif in the out, 
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while the A-loop can be found either in the open or in the closed conformation. 
Imatinib is the first Bcr-Abl inhibitor that entered in the market in 2001 and, from 
then on it is still the first line drug to the treatment of CML.77 Imatinib is a type 2 
inhibitor, showing a high selectivity profile and a IC50 of 10.8 nM (Figure 1.7). 
However, the incoming of mutations spanned across the Abl protein, makes Imatinib 
poor or completely inactive against certain mutated form of the enzyme. The most 
common Imatinib-resistant mutations are: G250E, Q252H, Y253H/F, E255K/V, 
T315I, H395P/R, M244V, F317L, M351T, E355G, and F359V. The second 
generation of Bcr-Abl inhibitors is active against all the mutated form of the enzyme 
with the exception of the T315I form. Dasatinib and Nilotibib are examples of this 
class of inhibitors (Figure 1.7). Dasatinib is a type 1 inhibitor, having an IC50 <0.2 
nM, while Nilotinib is a type 2 inhibitor with an IC50 of 38 nM. In 2012, the FDA 
approved the first drug belonging to the third generation of Bcr-Abl inhibitors, which 
are active against the T315I mutation. This drug, Ponatinib (Figure 1.7), has been 
developed by ARIAD pharmaceuticals and has a IC501 nM against the T315I Bcr-
Abl.78 
Together with the ATP orthosteric pocket, structural and biochemical 
investigations have found that also the pocket at the myristate binding site can be 
target to inhibit the Abl function. Compounds as GNF-2 (Figure 1.7) and GNF-5 are, 
in fact, able to inhibit Bcr-Abl-dependent cell growth and different Imatinib resistant 
mutations with exception for T315I. However, the combination of GNF-2 with 
Nilotinib has shown to have a synergistic effect, being able to inhibit also the T315I 
form. Therefore, the combination of orthosteric and allosteric inhibitors represents an 
innovative way to overcome resistance to either agent alone. 
Finally, also the impairment of the SH2/N-lobe interface has been found a viable 
alternative to inhibit allosterically the function of Abl kinase. Recent studies have 
demonstrated that monobodies with highly affinity of the SH2 prevent the formation 
of the SH2-KD complex. This induces the apoptosis in CML cell lines and primary 
human CML cells.66  
 
	   35 
	  
	  
 
Figure 1.7. 2D structures of five Abl inhibitors 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   	  
	   36 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	   37 
Chapter 2  	  
 
 
 
 
Theory 
 
 
 
 
1. Docking 
	  
Molecular docking is a computational technique to predict the binding orientation 
of one ligand into a biomolecular target (i.e. receptor) to form a stable complex 
(Figure 2.1 A). Such information, therefore, might be used to compute the strength of 
association as well as the stability of a given complex. This can be done employing 
scoring function of molecular docking.79  
Docking can be achieved via two steps: i) sampling the conformations of the 
ligand in the active site of the receptor (i.e. posing step); ii) computing the affinities 
between each ligand’s conformation and the receptor (i.e. scoring step). Ideally, 
sampling algorithms should reproduce the experimental binding mode, while scoring 
function should discern between inactive and active molecules, ranking them 
highest.80 
 
	  
Figure 2.1. A) Representation of complex formation starting from unbound receptor 
and ligand. B) Schematic representation of the results obtained after posing step of 
molecular docking simulation. Different ligand-receptor conformations are obtained 
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having a specific value of energy. Only the conformations within the local minima 
(*) are retained for the subsequent scoring phase.      
 
Posing. During a docking calculation, all possible orientations and conformations 
of both protein and ligand should be taken into account in order to exhaustively 
sample the conformational space and retrieve all possible binding modes. In this 
regard, all six degrees of translational and rotational freedom of the ligand would be 
explored along with the internal conformational degrees of freedom of both the 
ligand and protein. However, this is not feasible with the computational resources 
available nowadays. In fact, for a ligand with four rotatable bonds and six rigid-body 
alignment parameters, it has been estimated that approximately 2000000 years of 
computational time (at a rate of 10 configurations per second) are required to make 
an exhaustive conformational search.81 To reduce the overall computational cost, two 
strategies are employed. The first one is to treat only the ligand as flexible and 
consider the receptor as rigid or semi-rigid body (allowing for example the 
movement of selected side chains within the receptor). The second strategy is to 
employ algorithms to reduce computational cost of the conformational sampling 
step.82 In this regard, several algorithms are currently used, where the most common 
are: metropolis Monte Carlo (MC) methods, genetic algorithms (GA) and fragment-
based methods. MC methods apply random Cartesian moves to the system, accepting 
or rejecting the move based on Boltzmann probability. ICM83 and Glide84 are 
examples of software that use MC methods. In the GA algorithm, the evolution of a 
population of possible solutions via genetic operators (mutations crossovers and 
migrations) to a final population is predicted optimizing a predefined fitness 
function. This method is used in GOLD software.85 Lastly, in fragment-based 
methods a molecule is divided in portions, which are docked and subsequently linked 
to reconstruct the entire molecule. FlexX86 and DOCK87 are software that employ 
this method.81 As final result of the conformational search procedure, a set of poses 
that represent the local minima are returned and subsequently submitted to the 
scoring phase (Figure 2.1 B).  
 
Scoring. The aim of the scoring function is to distinguish between the correct and 
incorrect ligand poses, as well as between the active and not active molecules in a 
reasonable computation time. To do so, the scoring functions estimate the binding 
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affinity between the ligand and the receptor (DGbind), adopting various assumptions 
and simplifications. Scoring functions can be divided in force-field-based, empirical 
and knowledge-based.80 
Classical force-field-based scoring functions estimate the binding energy by 
computing the sum of non-bonded interactions (electrostatics and van der Waals).88 
Electrostatic interactions are calculated through Coulombic formalism, while van der 
Waals are described through Lennard-Jones potential function. Extension of force-
field-based scoring functions also take into account of hydrogen bonds, solvations 
and entropy contributions. Software as DOCK, GOLD and AutoDock employ these 
scoring functions.     
The empirical scoring functions compute the binding energy as a sum of different 
terms as hydrogen bond, ionic interaction, hydrophobic effect and binding entropy.89 
The individual terms are rescaled through empirical coefficients obtained by 
regression analysis from dataset of known ligand-receptor complexes. ChemScore, 
PLP and LUDI are examples of empirical scoring functions. 
Lastly, the knowledge-based scoring functions use released crystal structures 
complexes to obtain statistical meaningful information on interatomic contact 
frequencies and/or distances between the ligand and protein.90 In practice, they are 
based on the assumption that the more favorable an interaction is, the greater the 
frequency of occurrence will be. These frequency distributions are further converted 
into pairwise atom-type potentials. PMF, DrugScore and SMoG are an example of 
knowledge-based scoring functions. 
However, typical scoring functions do not treat adequately the solvation effect, 
negatively influencing the affinity prediction. In this case, a rescoring of poses using 
a physics-based scoring as MM-PB/SA and MM-GB/SA (MM stands for molecular 
mechanics, PB and GB for Poisson-Boltzmann and Generalized Born, respectively, 
SA for solvent-accessible surface area), could improve the accuracy of binding 
affinity prediction.91 
 
Molecular docking is an essential tool for the structure-based drug design (SBDD), 
being the fundamental technique employed for Virtual Screening (VS) campaigns. In 
VS, a library of small molecules is docked into the target receptor in order to identify 
hit compounds (i.e. a set of compounds that most likely make favorable interactions 
with the target protein).92 These compounds are subsequently synthetized or 
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purchased and then submitted to biological assay. Compared to the classical high-
throughput screening (HTS), where a set of compounds are directly tested in vitro, 
the VS has a number of advantages because is less time demanding, is low cost and 
allows the evaluation of a broader chemical space.  
 
 
2. Molecular Dynamics simulations 
 
Molecular dynamics (MD) simulations are computational tools employed to study 
the physical basis of the structure and the function of biological systems.29 In other 
words, MD is used to obtain important information on the time evolution of 
conformations of biological macromolecules as well as kinetic and thermodynamic 
insights.93 To do so, MD simulates the atomic motions, exploiting the equation of 
motion defined in classical (i.e. Newtonian) mechanics:   
 
 𝐹"	   = 	  𝑚"𝑎" (1) 
 
Where Fi is the force applied on particle i, mi is the mass of particle i, while ai is 
the acceleration of particle i. Since the force can be also expressed as the gradient of 
the potential energy, the previous formula can be written as: 
 
 −𝑑𝑈𝑑𝑟" = 	  𝑚" 𝑑+𝑟"𝑑𝑡+  (2) 
 
Where U is the potential energy of the system. MD simulations can be seen as an 
iterative process which consists of three stages:  
1) A model of the molecular system is prepared based on X-ray, NMR or 
homology-modeling data. To this, initial random velocities, which depend on the 
temperature of the system, are assigned. 
2) The forces acting on each atom are computed from an equation like:  
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In brief, the total energy is a contribution of bonded and non-bonded interactions. 
For computational feasibility, the potential is taken to be pair-wise additive. 
Chemical bonds and atomic angles are modeled using simple virtual springs, while 
dihedral angles are modeled using a sinusoidal function. Non-bonded forces are 
composed by van der Waals interactions, modeled using the Lennard-Jones 6-12 
potential94 and electrostatic interactions, which are modeled using Coulomb’s low. In 
order to reproduce the real behavior of molecules in motions, the energy terms 
described above are parameterized to fit quantum-mechanical calculations and 
experimental data. Together, these parameters are called ‘force fields’. To date, 
several force fields are routinely used in MD simulations, including AMBER,95 
CHARMM96 and GROMOS.97   
3) The Newton’s equation of motion (1) is solved and the new atomic positions 
and velocities are updated.  
Stages 2) and 3) are iterated several times (i.e. steps or Δt) in order to have the 
molecular trajectory.98 MD is a deterministic method, inasmuch the state of the 
system at any future time can be predicted from its current state.  
From MD simulations, the time average properties A of a system are calculated. In 
accordance with the ergodic hypothesis, which is one of the fundamental axioms of 
statistical mechanics, the ensemble average of a property A is equal to the time 
average (4). 
 
 	  𝐴7P8 = 	   limL→U 1𝑡 𝑑𝑡V𝐴 𝑟; 𝑡′L4  (4) 
 
MD simulations present two main issues: the first one is related to the 
approximations of the current force filed, while the second is the computational cost 
associated to simulate biological relevant time scale. In this respect, many important 
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biological events, as protein folding, drug binding, protein conformational changes, 
take place within timescales much longer than the time length routinely simulated. 
However, the use of novel hardware as well as graphical processing units (GPUs) 
enables to overcome the time-scale limitations giving the possibility of run 
microsecond-long MD simulations. In this regard, the group of DE Shaw is one of 
the pioneers of this approach. In fact, thanks to their supercomputer Anton they are 
able to simulate millisecond of simulations, capturing events as protein 
folding/unfolding99 and drug binding.100  
Besides, enhanced sampling techniques are widely used methods that enable to 
explore the protein conformational landscape using nanosecond or microsecond long 
MD simulations. The main idea behind these methods is the application of an 
external bias to the potential energy of the system, which allows lowering the barrier 
energies between different conformational states and exploring different protein 
configurations in a reasonable time. Examples of these methods are metadynamics 
and accelerated MD simulations, both employed in this thesis.  
 
 
2.1. Metadynamics 
 
In metadynamics simulations an additional bias potential (or force) is added on a 
selected number of degrees of freedom, referred to as collective variables (CVs), in 
order to escape from energetic minima and to facilitate the sampling of the free 
energy landscape. The external potential bias is history dependent and can be written 
as a sum of Gaussians deposited in the CV space to discourage the system from 
revisiting configurations that have already been sampled. The algorithm can be easily 
understood using Laio’s metaphor of the walker, which falls in a swimming pool in 
the night.101 Here, the walker has access to a large amount of sand (i.e. Gaussians) 
that can use to fill the swimming pool. When the swimming pool is full of sand, 
finally the walker is able to climb out of it.  
Let S be a set of d functions of the microscopic coordinates R of the system (5):  
 
 𝑆 𝑅 = (𝑆J 𝑅 ,… , 𝑆2(𝑅)) (5) 
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At time t, the external potential can be written as: 
 
 𝑉_ 𝑆, 𝑡 = 	   𝑑𝑡V𝜔	  𝑒𝑥𝑝 𝑆" 𝑅 − 𝑆" 𝑅 𝑡′ +2	  𝜎"+L4  (6) 
 
Where σi is the width of the Gaussian for the ith CV, while ω is a constant energy 
rate expressed as the ratio between the Gaussian height and the deposition stride τG: 
 
 𝜔 =	  𝑊𝜏_  (7) 
 
The Figure 2.2 shows a schematization of the metadynamic techinique. The walker 
(green dot) explores the unknown free energy landscape and Gaussians are added to 
allow overcaming high energy barriers (a). Once that the free energy surface (FES) is 
completely filled (b), the FES is reconstructed by summing the deposited Gaussians 
(c).  
 
	  
Figure 2.2. Schematic representation of the metadynamics technique. Figure 
adapted from Van Speybroeck et al.102  
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In fact, when the metadynamics reaches the convergence (i.e. the free energy 
landscape is filled), the  VG provides an unbiased estimate of the underlying free 
energy: 
 
 limL	  →	  U 𝑉_ 𝑆, 𝑡 	  ~ − 𝐹 𝑆  (8) 
 
The free energy F(S) is defined as: 
 
 𝐹 𝑆 = 	  − 1𝛽 ln 𝑑𝑅	  𝛿	   𝑆 − 𝑆 𝑅 𝑒klm n  (9) 
 
Where β = (kB T)-1, kB is the Boltzmann constant, T is the temperature of the 
system and U (R) is the potential energy function.  
However, metadynamics simulations have two main drawbacks. The first one is 
related to the correct choice of the CVs. Indeed, to guarantee an effective application 
of metadynamics, the CVs must respect the following guidelines: 
• They should distinguish between the initial and final state and describe all the 
relevant intermediates. 
• They should describe all the slow events that are relevant to the process of 
interest. 
• They should be limited in number, otherwise it will take a very long time to fill 
the FES. 
In this respect, the choice of a wrong CVs or negletting an important CV could 
increase enornously the time required to reach the convergence to the FES and could 
also lead to a typical hysteric behaviour of the recontructed FES.103 Collective 
variables can span from the simplest as distances, angles and radius of gyration to 
most complex as path variables and contact map.  
Another weakness of metadynamics is that it is diffult to decide when to terminate 
a metadynamics run. In fact, in a single run, the VG does not converge to a definite 
value but fluctuates around the correct result, leading to an average error which is 
proportional to the square root of the bias potential  deposition  rate.104, 105 In 
addition, extending too much a metadynamics simulation could irreversibly push the 
system in regions of configurational space which are not physically relevant. 
Interestingly, the well-tempered metadynamics method offers a solution for this 
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issue. In fact, thanks to this approach, it is possible to obtain an estimation of the  
FES  that converges  to  the  exact  result  in  the  long  time  limit.106 In detail, in 
well-tempered metadynamics the bias deposition rate decreases over simulation time 
and the external bias assumes the form:  
 
 𝑉 𝑆, 𝑡 = 	  ∆𝑇	   ln 1 + 𝜔	  𝑁	   𝑆, 𝑡∆𝑇  (10) 
 
where ω has the dimension of an energy rate, ΔT an input parameter with the 
dimension of a temperature and N(S, t) is the histogram of the S variables collected 
during the simulation. In practice, the Gaussian height W is scaled according to: 
 
 𝑊 = 	  𝜔	  𝜏_𝑒krs t,Luv∆w  (11) 
 
Through well-tempered metadynamics, the bias potential does not fully 
compensate the FES, but it converges to:  
 
 𝑉_ 𝑆, 𝑡	   → 	  ∞ = 	  −	   ∆𝑇𝑇 +	  ∆𝑇 	  𝐹 𝑆 + 𝐶 (12) 
 
where C is an immaterial constant. Therefore for ΔT → 0, ordinary MD is 
recovered, whereas the ΔT → ∞ limit corresponds to standard metadynamics. By 
tuning the ΔT in beetween 0 and ∞ one can regulate the extent of FES exploration, 
avoiding the overfilling.  
 
 
2.2. Accelerated MD 
 
In accelerated MD (aMD) simulations a continuous non-negative bias boost 
potential function DV(r) is added to the true potential energy V(r), in order to 
accelerate the dynamics of the system and favor the transition of high energy barriers 
(13). Therefore, the resulting potential energy V*(r) is given by the sum of the true 
potential energy V(r) and the external bias DV(r). The external bias is applied only 
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when V(r) is below a certain threshold E (see Figure 2.3 A), according to the 
following scheme: 
 
 V*(r) =  𝑉 𝑟 ,	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  𝑉(𝑟) ≥ 𝐸𝑉 𝑟 + 	  Δ𝑉 𝑟 ,	  	  	  	  	  	  	  	  	  	  	  	  	  𝑉 𝑟 < 𝐸 (13) 
 
Hence, when the true potential energy V(r) of the system is higher or equal than 
the reference energy E no bias is added and the simulation proceeds as a classical 
MD scheme (13). On the contrary, when the true potential energy is smaller than the 
reference energy, the bias boost is added in order to accelerate the system. The bias 
boost has the following form: 
 
 ∆𝑉 𝑟 = 	   𝐸 − 𝑉 𝑟 +𝛼 + 𝐸 − 𝑉 𝑟  (14) 
 
where the term a is tuning parameter. The presence of the parameter a enables to 
fill the energetic minima, maintaining the underlying shape of the unmodified 
potential energy surface. In detail, when a has a high value, the bias boost smoothly 
merges with the unmodified potential energy surface. Instead, when a is zero the 
modified potential energy V*(r) is equal to E, which corresponds to a solution 
proposed by Rahman and Truly in 2002 (see Figure 2.3 B).107   
 
	  
Figure 2.3. A. Representation of the true potential V(r) (black line), of the 
threshold E (dotted line) and of the bias D V(r) (dashed line). B. Representation of 
potential energy function (black line) and several bias (dotted and dashed lines) 
plotted at different values of a. Figure adapted from Hamelberg D. et al.108  
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In the first application of the aMD simulation, carried out by the McCammon 
group, the external bias potential energy was applied only to the dihedral term of the 
potential energy function, according the rationale that the conformational changes of 
a biomolecular systems are determined chiefly from changes in the torsional.108 
However, this method has a strong limitation when the biomolecule is surrounded by 
solvent. In fact, the large conformational changes of the biomolecule are slowed by 
the diffusion of the solvent around the solute. To overcome this issue, in 2007, the 
same group developed a variant of the method in which the bias was applied to the 
whole potential. Thanks to this modification, the authors were able to sample 
accurately diffusion of the solvent.109 
The choice of both E and a has a great importance, inasmuch they determine the 
acceleration of the simulation. In principle, E has to be higher than minimum 
potential energy (Vmin), otherwise a classical MD simulation is performed. To 
retrieve Vmin, a short classical MD is performed and the resulting average potential 
energy is considered as Vmin.108 Although several trials are required to choose the 
optimal values of both E and a, a general formula has been developed with the aim 
of retrieving values as close as possible to the optimal ones:  
 
 𝐸2"C: = 𝑉2"C:_7P8 + 4	  ×	  𝑁.:3 (15) 
 𝛼2"C: = 4	  	  ×	  𝑁𝑟𝑒𝑠5  (16) 
 𝐸L0L79 = 𝑉L0L79_7P8 + 0.16	  ×	  𝑁7L0M3 (17) 
 𝛼L0L79 = 0.16	  ×	  𝑁7L0M3 (18) 
 
where Nres is the number of residues of the solute, Natoms is the total number of the 
atoms, Vdihe_avg and Vtotal_avg are the average of dihedral and total potential energy. 
Finally, aMD is also able to return the canonical average of an observable A(r). 
Using the modified potential V*(r), the ensemble average of the observable A(r) is: 
 
 𝐴∗ = 	   𝑑𝑟	  𝐴 𝑟 𝑒klr∗(.)𝑑𝑟	  𝑒klr∗(.)  (19) 
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by substituting V*(r) in (19), it becomes: 
 
 𝐴∗ = 	   𝑑𝑟	  𝐴 𝑟 𝑒klr . k	  br(.)𝑑𝑟	  𝑒klr . klr(.)  (20) 
 
To obtain the corrected ensemble average, the phase space of the modified 
potential is reweighted by multiplying each configuration by the strength of the bias 
at each position.   
 
 𝐴 = 	   𝑑𝑟	  𝐴 𝑟 𝑒klr . k	  br(.)𝑒l(.)𝑑𝑟	  𝑒klr . klr(.) 𝑒l(.)  (21) 
 𝐴 = 	   𝑑𝑟	  𝐴 𝑟 𝑒klr(.)𝑑𝑟	  𝑒klr(.) = 	   𝐴  (22) 
 
Although the aMD is an excellent method to enhance the sampling of the phase 
space of a biomolecular system, the reweighting procedure suffers several limitations 
making difficult to recover the original free energy landscape, specially for large 
systems. This is due to the fact that in aMD the bias energy is typically large, 
reaching also hundreds of calories per mole, leading to noise during the reweighting 
procedure. To overcome this issue, in 2015 Miao et al. developed a variant of aMD, 
called Gaussian accelerated MD (GaMD), which enables to reduce the energetic 
noise. In brief, according to this new method the bias boost assumes Gaussian 
distribution that allows a more accurate reweighting respect to the classic aMD.110   
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HRD motif as the central hub of the 
signaling network for activation loop 
autophosphorylation in Abl kinase 
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ABSTRACT 
	  
A number of structural factors modulate the activity of Abelson (Abl) tyrosine 
kinase, whose deregulation is often related to oncogenic processes. First, only the 
open conformation of the Abl kinase domain’s activation loop (A-loop) favors ATP 
binding to the catalytic cleft. In this regard, the trans-autophosphorylation of the 
Y412 residue, which is located along the A-loop, favors the stability of the open 
conformation, in turn enhancing Abl activity. Another key factor for full Abl activity 
is the formation of active conformations of the catalytic DFG motif in the Abl kinase 
domain. Furthermore, binding of the SH2 domain to the N-lobe of the Abl kinase 
domain was recently demonstrated to have a long-range allosteric effect on the 
stabilization of the A-loop open state. Intriguingly, these distinct structural factors 
imply a complex signal transmission network for controlling the A-loop’s flexibility 
and conformational preference for optimal Abl function. However, the exact 
dynamical features of this signal transmission network structure remain unclear. 
Here, we report on microsecond-long molecular dynamics coupled with enhanced 
sampling simulations of multiple Abl model systems, in the presence or absence of 
the SH2 domain, and with the DFG motif flipped in two ways (in or out 
conformation). Through comparative analysis, our simulations augment the 
interpretation of the existing Abl experimental data, revealing a dynamical network 
of interactions that interconnect SH2 domain-binding with A-loop plasticity and 
Y412 autophosphorylation in Abl. This signaling network engages the DFG motif 
and, importantly, other conserved structural elements of the kinase domain, namely 
the EPK-ELK H-bond network and the HRD motif. Our results show that the signal 
propagation for modulating the A-loop spatial localization is highly dependent on the 
HRD motif conformation, which thus acts as the central hub of this (allosteric) 
signaling network controlling Abl activation and function.  
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INTRODUCTION 
	  
The Abelson (Abl) tyrosine kinase is a tightly regulated nonreceptor kinase 
involved in a variety of cellular pathways that control cell growth, survival, and 
morphogenesis.111, 112 The fusion of Abl and the breakpoint cluster region (Bcr) genes 
leads to expression of Bcr-Abl, a hyperactivated protein kinase that lacks certain 
auto-inhibitory mechanisms and is the main driver of chronic myelogenous leukemia 
(CML). For this reason, the main therapeutic avenue for treating CML uses tyrosine 
kinase inhibitors, such as imatinib, to inhibit Bcr-Abl kinase activity.113, 114, 66, 115 
The Abl kinase has a modular structure comprising the two regulatory SH3 and 
SH2 domains and a catalytic kinase domain (KD).69 Like all kinases, KD in Abl is 
formed by the N- and C- lobes, which jointly form a deep cleft where ATP binds. 
Then, the phosphotransfer reaction occurs, with the g-phosphate of the ATP 
transferred onto a tyrosine residue of the substrate proteins, which regulates the Abl 
signaling pathways.67, 68, 116, 117 The activity of Abl is highly controlled by extensive 
allosteric networks118 which, in turn, can be affected by drug binding119, as well as 
point mutations. Importantly, the catalytic process is highly dependent on the 
conformation of the flexible activation loop (A-loop). In Abl, this is a sequence of 29 
residues bounded by the conserved D400-F401-G402 (DFG) and A426-P427-E428 
(APE) motifs. ATP and the peptide substrate can only bind and undergo the 
phosphotransfer reaction when the A-loop is in its fully open conformation. In this 
regard, a key chemical step for Abl activation is the trans-autophosphorylation at the 
Y412 residue located along the A-loop. Several experimental and computational 
studies have in fact demonstrated that phosphorylation at the Y412 stabilizes the A-
loop in a fully open conformation, promoting ATP binding and, thus, full kinase 
activation.120, 121 Indeed, trans-autophosphorylation at the Y412 has been found to 
increase the Abl catalytic activity by ~10-fold.122, 123, 124 Moreover, Abl function also 
depends on the conformation adopted by the DFG motif in KD. Only the DFG-in 
conformation, in which the D400 coordinates the catalytic magnesium ion, allows 
the phosphotransfer reaction.125, 57, 58 In this conformation, the F401 side chain faces 
the ATP binding site, allowing the proper formation of the regulatory spine, i.e. R-
spine (a conserved motif which in Abl is formed by M309, L320, F401, H380 and 
D440) whose proper assembly is known to be important for kinases catalytic 
function.58 Conversely, in the DFG-out conformation, the flipped D400 side chain 
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causes the loss of catalytic kinase function and, also, the reorientation of F401 side 
chain leads to the disengadgment of R-spine (Figure 3.1). 
 Finally, a strained conformation of the well-conserved H380-R381-D382 (HRD) 
motif, located close to the ATP binding site, was recently reported to be crucial for 
full Abl activity. In this conformation, the HRD backbone interacts with the D440 of 
the aF helix via a conserved H-bond network, called EPK-ELK78, 72 (Figure 3.1). The 
presence of this network allows the R381 side chain to interact via a salt bridge with 
the phosphorylated Y412, stabilizing the fully open conformation of the A-loop, 
which in turn favors Abl activity. 126 
In addition to these key structural and catalytic KD elements, the SH2 domain has 
also been found to significantly affect Abl function, thereby acting as a modulatory 
subunit.76, 127 Indeed, structural and biochemical investigations have shown that the 
SH2 binding to the N-lobe of KD in Abl72, 70, 119 (Figure 3.1) favors the A-loop 
phosphorylation, increasing the kinase catalytic activity. The SH2 domain affects the 
A-loop motility stabilizing the fully open conformation, which is thought to be 
optimal for the trans-autophosphorylation reaction.128 This was shown by Dölker et 
al.129 who used MD simulations integrated with mutagenesis experiments to 
demonstrate that SH2 affects the motion of several catalytically important portions of 
KD, which in turn favor catalytically-active conformations of Abl. The b3-aC loop 
was identified as a key structural motif in transmitting the allosteric signal from the 
SH2 domain to the KD. More recently, Tse et al.130 employed molecular simulations 
and the network-based modeling to describe the subtle thermodynamic balance of 
conformational states that shape the allosteric signal within KD, favoring Abl 
activity. While these informative studies describe some of the allosteric effects of 
SH2 domain on Abl activity, how exactly key and distal structural motifs are 
dynamically interconnected so to modulate and favor the A-loop trans-
autophosphorylation in Abl remains poorly defined. What affect A-loop spatial 
conformation and Y412 propensity for phosphorylation? What are the possible 
molecular mechanisms that form and modulate a signal transmission network 
structure for the A-loop spatial orientation and Abl activity?  
To further address these questions, we coupled microsecond-long classical 
molecular dynamics (MD) with free-energy simulations to decipher a structured and 
dynamic allosteric network of interactions, which appears to be critical for 
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modulating A-loop plasticity, in turn regulating the phosphorylation at Y412.131, 132 
This complex network of dynamic interactions was revealed through a comparative 
analysis performed using several different systems of Abl, alone or in complex with 
the modulatory SH2 domain, and with the DFG-in or DFG-out conformations of KD. 
This signaling network engages the DFG motif and, importantly, other conserved 
structural KD elements, such as the EPK-ELK H-bond network and the HRD motif. 
Overall, our simulations suggest that the HRD motif acts as the central hub of the 
allosteric signaling network in Abl, acting cooperatively with the DFG motif and the 
EPK-ELK H-bond network to regulate A-loop accessibility.  
 
 
 
	  
 
Figure 3.1. Left: overview of the Abl kinase domain (KD) (grey) bound to the SH2 
domain (cyan). PDB code: 1OPL chain B. Colors of KD indicate: aC helix (violet), 
DFG motif (blue), catalytic loop (green), A-loop (orange), aF helix (red), R-spine 
(lime). Right: a close view of the network formed by DFG, HRD, and aF helix, both 
in DFG-in (upper box, PDB code: 2F4J) and DFG-out (bottom box, PDB code: 
1OPL chain B) conformations. 
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RESULTS 
	  
Molecular dynamics (MD) simulations. We performed a comparative MD-based 
analysis of three different Abl systems: the SH2/KD complex in the catalytically 
inactive DFG-out conformation (SH2-KDout system), the KD alone in the DFG-out 
(KDout system), and the KD alone in the DFG-in conformation (KDin system, see 
Methods for further details). We wished to clarify how the regulatory subunit SH2’s 
presence or absence and the DFG motif’s initial conformation (in or out) affect A-
loop spatial conformation and Y412 propensity for phosphorylation, which is needed 
for full Abl activation.122, 123, 124 The Y412 conformational states are here considered 
to be prone to the trans-autophosphorylation according to two keys parameters: 1) 
the RMSD of Y412 with respect to the reference X-ray structure 1OPL chain B; 2) 
the distance between the Y412 and D440 along the aF helix (see Methods for further 
details).   
 
SH2-KDout dynamics. Extensive MD simulations of over ~1.8 µs of the SH2-
KDout system highlighted the elevated stability of this complex (see RMSD in Figure 
3.2 and Figure S1). We used a principal component analysis (PCA) to examine the 
dominant motions of the system during the MD simulations. In agreement with 
previous studies, the first eigenvectors describes the so-called “breathing” (or 
“hinge”) and the “lobe-twisting” motions, which are well known to be essential for 
the kinase activity (Figure 3.3). 129, 133, 134, 55, 135, 136, 137, 138 
 
	  
Figure 3.2	  Comparison of RMSD frequency distribution of the three systems (SH2-
KDout, red; KDout, blue; KDin, green) for the KD backbone atoms (left panel), A-loop 
backbone atoms (central panel), and Y412 (right panel). 
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Throughout the simulation, the A-loop remained in its starting fully open 
conformational state (see RMSD in Figure 3.2 and Figure S1). As a consequence, 
Y412 was also stable, as indicated by the single deep basin obtained by plotting the 
d[Y412-D440] values against RMSDY412 (Figure 3.4). In detail, RMSDY412 was 1.89 ± 
0.51 Å (Figure 3.2 and Figure S1), while d[Y412-D440] oscillated around 12.97 ± 0.95 
Å (Figure 3.5), vs. 12.60 Å in the X-ray 1OPL chain B. Hereafter, this conformation 
is referred to as Conf-1. In addition, the H-bond network, formed by the two 
antiparallel b sheets b10 and bA-loop (formed when the A-loop is in the fully open 
conformation), was preserved for throughout the MD trajectory (Figure S2), 
underlining this conformation’s stability. 
Another structural feature that was maintained in its crystallographic position 
throughout the MD simulations was the backbone geometry of the HRD motif (see 
RMSD in Figure S3). This motif is known to be important for proper kinase catalytic 
activity.126 In particular, the backbone torsional angle f of R381 (i.e. R381f) is 
stable, being equal to 59.01° ± 8.02° (vs. 73.8° in the X-ray 1OPL, see Figure 3.5). 
With this HRD conformation, hereafter referred to as native, the R381 side chain 
points toward Y412. This was reflected in the d[Y412-R381] value, i.e. the distance 
between the phenolic oxygen of Y412 and the guanidinium carbon of R381 (Figure 
S4), which was stably maintained at 5.61 ± 1.21 Å (vs. 3.90 Å in the X-ray 1OPL). 
The EPK-ELK H-bond network directly connects the HRD backbone with the aF 
helix (see Methods for details). This network was also preserved during the MD 
simulations. The two H-bonds that form the EPK-ELK network, namely Hb[H380-
D440] and Hb[R381-D440], were steady at 3.46 ± 0.20 Å and 2.98 ± 0.16 Å, helping to 
maintain the overall stability of the native HRD conformation (Figure 3.5). Finally, 
Hb[H380-A399] is an H-bond between the e2 nitrogen of side chain of H380 and the 
carbonyl backbone of the DFG-1 residue A399 (Figure 3.1). Hb[H380-A399] was 
firmly at 3.32 ± 0.64 Å (Figure 3.5) reflecting, in turn, an overall stability of the 
H380 side chain conformation.139  
Overall, these results demonstrate the stability of the SH2-KD complex, with full 
preservation of both the crystallographic open A-loop conformation, in which the 
Y412 is prone to be trans-autophosphorylated, and the native HRD conformation, 
even in the absence of the dasatinib-like inhibitor (see Methods).  
	   57 
 
 
	  
Figure 3.3. A) Projection of MD trajectories of SH2-KDout (red), KDout (blue), and 
KDin (green) along the first two eigenvectors of PCA analysis. B) Projection of the 
same MD trajectories along the first two eigenvectors of KDout. C) The principal 
motion projected along both EV1 and EV2 is superimposed sequentially with 20 
frames of the whole trajectory of SH2-KDout, KDout, and KDin, respectively. The 
dominant movements are the so-called “breathing” and “lobe-twisting” motions. 
The former describes the opposite movements of the two KD lobes, with alternate 
closure and opening of the catalytic cleft, while the latter evidences the N- and the C-
lobe twist against each other. 
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 KDout dynamics. After removing the SH2 regulatory subunit, the A-loop displayed 
an augmented motility (see RMSD Figure 3.2 and Figure S1). The projection of the 
MD trajectory onto the first two eigenvectors shows an extensive sampling of phase 
space, with the system visiting different minima (Figure 3.3). Here, EV1 and EV2 
describe more pronounced breathing and twisting motions compared to that observed 
in SH2-KDout (Figure 3.3) They also suggest that the A-loop visited a larger 
conformational space (Figure 3.3), indicating its overall augmented flexibility 
compared to SH2-KDout system. Indeed, in KDout, the A-loop explored different 
spatial orientations. In fact, in addition to the crystallographic fully open 
conformation, the A-loop also explored a partially closed and a new open 
intermediate conformation. 
In detail, during the first microsecond of simulations, the A-loop is fully open and 
the Y412 is in an optimal conformation in order to be phosphorylated. This is 
indicated by d[Y412-D440], which was maintained at 12.24 ± 1.2 Å (Figure 3.5), and 
by the low RMSDY412 of 1.89 ± 0.55 Å (Conf-1 in Figure 3.4). Importantly, also the 
HRD backbone remained in its native crystallographic geometry, allowing the R381 
side chain to point toward Y412 (Figure S4). Moreover, the EPK-ELK H-bond 
network was assembled well (Figure 3.5), further stabilizing the native HRD 
geometry. 
 However, at about ~0.75 µs, we observed a rotation of the H380c1 angle (Figure 
S5) that caused the definitive rupture of the interaction between the side chain of 
H380, along the HRD, and the backbone of A399 (DFG-1 residue, Figure 3.5). This 
event seems to favor a partial closure of the A-loop in which the Y412 is no longer 
prone to be phosphorylated, because buried in the inner part of KD, pointing toward 
the D440 of the aF helix (see Figure 3.4). In between ~1.00 and ~1.14 µs, the Y412 
assumed the Conf-2 in which d[Y412-D440] was 5.42 ± 0.51 Å (Figure 3.5) and the 
RMSDY412 increased to 3.65 ± 0.57 Å (Figure 3.2 and Figure S1). Then, in between 
~1.14 to ~1.34 µs, the Y412 directly interacted with the D440 assuming the Conf-3, 
in which d[Y412-D440] shortened to 2.90 ± 0.26 Å (Figure 3.5) and the RMSDY412 was 
equal to 4.53 ± 0.25 Å (Figure 3.2 and Figure S1). The formation of the Conf-3 
configuration coincided with the rupture of the EPK-ELK H-bond network, as shown 
by the increased Hb[H380-D440] and Hb[R381-D440], which reached 6.00 ± 0.28 Å and 
5.36 ± 0.37 Å, respectively (Figure 3.5).  
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The loss of the HRD/DFG-1 interaction, together with rupture of the EPK-ELK H-
bond network, generated an overall destabilization of the HRD motif. In fact, the 
backbone of the HRD motif underwent to a peptide flip, as shown by the rotation of 
R381f, which reached a mean value of -87.66° ± 33.23°, then maintained until the 
end of the simulation (Figure 3.5). The torsion of R381f generated a reorientation of 
the R381 side chain, which extended towards the ATP binding site, forming a 
transient H-bond with the side chain of E305 of the aC helix (Figure S6). 
Concomitantly with the observed HRD reorientation, the A-loop spontaneously 
reopened with a major rearrangement that ended in a new intermediate conformation 
maintained until the end of the simulation (~2.6 µs). In this intermediate A-loop 
conformational state, however, Y412 adopted a different orientation with respect to 
the starting one, being rotated upside down with respect to the crystallographic 
orientation and assuming, thus, a non-optimal configuration for the trans-
autophosphorylation reaction. Here, d[Y412-D440] was equal to 14.66 ± 1.80 Å (Figure 
3.5) and the RMSDY412 to 11.20 ± 1.02 Å (Conf-4 in Figure 3.4). Moreover, in this 
state, the bA-loop was flipped by 180° and shifted by two residues along the b10 
sheet, forming a modified H-bond network that stabilized Conf-4 (Figure S2). 
Finally, the EPK-ELK H-bond network was no longer properly assembled, with only 
Hb[H380-D440] being formed (Figure 3.5). In summary, in the KDout simulations, Y412 
was found in a conformation in which is prone to be trans-autophosphorylated for 
only ~40% of the total simulation time.  
To further increase the sampling and validate our findings, we ran two additional 
MD replicas of ~1.1 µs each (Replica 1-KDout and 2-KDout). We began these from a 
snapshot at ~1.2 µs of KDout in which Y412 is in Conf-3. This time, the HRD motif 
did not undergo to a peptide flip, but remained in the native conformation (Figure 
S7C) with the EPK-ELK H-bond network newly restored. Remarkably, the restoring 
of the native HRD conformation allowed the reopening of the A-loop (at ~0.30 for 
Replica 1-KDout and at ~0.55 µs for Replica 2-KDout), which reassumed the fully 
open conformation as in the original X-ray structure (i.e. Conf-1, see Figure S7A and 
B). The A-loop opening restored the crystallographic H-bond networks between the 
b10 and bA-loop sheets, which further stabilized the fully open A-loop conformation 
(Figure S2).  
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To further evaluate the importance of the EPK-ELK H-bond network in stabilizing 
the HRD motif, we ran one additional MD simulation of KD, whereby D440, along 
the aF helix, was mutated into an alanine (herein, D440A-KDout system). This 
mutation prevented the formation of the EPK-ELK H-bond network, inducing an 
overall destabilization of the HRD motif (see RMSD in Figure S3). Notably, this 
time we did not observe any R381f flip, as in the wild-type KDout simulations 
(Figure S9C), suggesting that Hb[H380-D440] formation might be essential for 
stabilizing the rotated HRD backbone geometry. Thus, the lack of EPK-ELK H-bond 
network and the subsequent destabilization of the HRD motif seem the major players 
for triggering a major deformation of the A-loop. Here, indeed, the Y412 adpots a 
new stable conformation in which is buried in the inner part of KD, assuming a non-
optimal configuration for the trans-autophosphorylation (see Figure S8 and S9A for 
further details). 
Finally, we sampled the A-loop conformations through additional MD simulations 
for over ~1.3 µs, starting from a fully inactive and closed A-loop conformation 
(herein, closed-KDout system). In this case, the starting conformation corresponded to 
that crystallized in the presence of imatinib-like inhibitors,114, 72, 140, 141, 142, 143 which 
had not been observed in our aforementioned simulations. In closed-KDout, which is 
based on the apo form of Abl, we noticed that the closed A-loop conformation was 
highly unstable (see RMSD in Figure S8). In particular, after ~350 ns, the A-loop 
spontaneously opened, visiting several transient conformations. However, these did 
not coincide with the fully open state. Along this path, Y412 adopted many different 
configurations due to the significant flexibility of the A-loop, which mostly assumed 
conformations that are not prone to be phosphorylated (Figure S9B, and Figure S10).  
These results indicate that the absence of the regulatory SH2 subunit greatly 
increases the overall A-loop flexibility. With DFG-out, the A-loop adopts an 
ensemble of conformations that, even when partially open, are not optimal for trans-
autophosphorylation. This explains KD’s diminished propensity for 
autophosphorylation. It also confirms that the inactive and fully closed A-loop 
conformation is stabilized by the presence of an ATP inhibitor such as imatinib.144, 145  
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Figure 3.4.	  2D plot of SH2-KDout (red), KDout (blue), and KDin (green) MD trajectory 
data points plotted along d[Y412-D440] –X axes– and the RMSDY412 –Y axes– values. 
The upper and right panels represent the frequency distribution of d[Y412-D440] and 
the RMSDY412, respectively. The left and bottom boxes show representative frames of 
Conf-1, Conf-2, Conf-3, and Conf-4. 
	  
	  
KDin dynamics. The overall system was very stable, as shown by the backbone 
RMSD of KD, with the A-loop in the initial fully open conformation (Figure 3.2 and 
Figure S1). Here too, the first two eigenvectors described the breathing and lobe-
twisting motions (Figure 3.3) similar to those seen for SH2-KDout, which however 
were less pronounced than KDout (Figure 3.3). Like in SH2-KDout, the H-bond 
network between the b10 and bA-loop was preserved during all simulations, further 
suggesting a key contribution in stabilizing the fully open A-loop conformation 
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(Figure S2). As a result, Y412 was stable in Conf-1 in which the residue was prone to 
be phosphorylated (see Figure 3.4).  
Additionally, the HRD motif did not undergo substantial fluctuations, preserving 
its native conformation (see RMSD in Figure S3), with the R381 side chain pointing 
toward Y412. This is indicated by the R381f value of 59.01° ± 8.00° and by d[R381-
Y412], which was maintained at 5.69 ± 1.08 Å (Figure 3.5 and Figure S4). Similarly, 
the EPK-ELK H-bond network was well preserved during all simulations, with 
Hb[H380-D440] and Hb[R381-D440] equal to 3.54 ± 0.19 Å and 2.97 ± 0.15 Å, 
respectively (Figure 3.5). Here, the HRD motif stability is further favored by the 
stable H-bond between the side chain of the HRD motif’s H380 and the carbonyl 
backbone of the DFG motif’s D400, which can be formed only when the DFG is in 
the in conformation. This key interaction, referred to hereafter as Hb[H380-D400], 
remained stable for all MD simulations, with an average length of 2.94 ± 0.24 Å 
(Figure 3.5). As a result, KD was maintained in the catalytically fully active 
conformation for the entire simulation, with Y412 in an optimal state for the trans-
autophosphorylation.  
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Figure 3.5.	  A) Distance along time for d[Y412-D440] (black), Hb[R381-D440] (green), 
Hb[H380-D440] (blue), Hb[H380-A399] (red), Hb[H380-D400] (brown) in the SH2-KDout 
system (upper panel), KDout system (middle panel), and KDin system (lower panel). B) 
Graphic representation of the key distances reported in plot A. PDB code: 1OPL 
chain B. C) Frequency distribution of the R381f dihedral angle in SH2-KDout (red), 
KDout (blue), and KDin (green). 
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Free-Energy Simulations. We used well-tempered metadynamics106, 146 to 
calculate the free-energy surface (FES) related to the A-loop partial closure in the 
different Abl systems. We employed two walkers for each system (i.e. SH2-KDout, 
KDout and KDin) and the confined procedure (see Methods and SI) for a total of six 
independent simulations, starting from either the fully open Conf-1 or the partially 
closed Conf-3 configurations of the A-loop, as observed during our unbiased MD 
simulations. 
In SH2-KDout, four energy minima were detected on the FES. The deepest 
corresponded to the X-ray conformation in which Y412 adopts Conf-1 (d[Y412-D440] 
~13 Å), which confirmed this conformation as the most probable and energetically 
favored one, as observed also in our unbiased MD simulations. Two near minima 
were found at d[Y412-D440] ~5 Å and ~7 Å, which corresponded to Y412 
conformations that are bent toward D440, similarly to Conf-2. The last minimum was 
detected at d[Y412-D440] ~3 Å, in which Y412 directly interacted with D440, i.e. Conf-
3 (Figure 3.6).  
The FES of KDout was characterized by three energetic basins. The global 
minimum here was Conf-3, while Conf-1 represented a relative minimum on the 
energy landscape. This was in line with our unbiased MD simulations, which 
highlighted the stability of Conf-3. Another relative minimum was found at d[Y412-
D440] ~7 Å, which represented an ensemble of conformations in which Y412 adopted 
Conf-2. Compared to SH2-KDout, the Conf-1→Conf-2 transition in KDout was 
energetically more favored, with a slightly lower energy barrier (~3 kcal/mol and ~5 
kcal/mol for KDout and SH2-KDout respectively), which might explain why this 
transition was only observed in our unbiased simulations of KDout, and not in SH2-
KDout (Figure 3.6).  
In the KDin system, the two deepest minima were found when d[Y412-D440] was 
between ~9.5 Å and 12 Å. This interval included an ensemble of conformations in 
which Y412 adopted Conf-1. Two other local minima were found at d[Y412-D440] ~5 
Å and ~3 Å, which corresponded to Conf-2 and Conf-3, respectively. Here, the Conf-
1→Conf-2 transition was energetically more costly than for the SH2-KDout and KDout 
systems, with a barrier energy of ~8 kcal/mol (Figure 3.6). This is in line with the 
high stability of Conf-1 observed during the unbiased MD simulations. 
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Figure 3.6.	   Free-Energy Surface (FES) obtained through multiple walkers well-
tempered metadynamics simulations for the SH2-KDout (red), KDout (blue), and KDin 
(green) systems. The CV represents the distance between the center of mass of D440 
and the oxygen atom of the Y412 side chain, i.e. d[Y412-D440]. 
 
DISCUSSION 
	  
In the present work, we performed a comparative analysis using classical 
molecular dynamics (MD) and free-energy simulations to investigate how the 
regulatory SH2 domain subunit and the DFG motif (in its in or out conformations) 
may affect A-loop spatial arrangements to enable trans-autophosphorylation in Abl, 
which is necessary for full activation.122, 123, 124 We considered the following three 
different Abl systems (see Methods for further details): i) SH2-KDout complex with 
KD in DFG-out conformation; ii) KDout system with KD alone in DFG-out 
conformation; iii) KDin system with KD alone in DFG-in conformation.  
The PCA analysis suggested the presence of two large motions in all systems in 
agreement with previous studies.129, 136, 137 These motions are: i) the opening and 
closing of the two lobes of KD on the active site (i.e. breathing or hinge motion), 
which is known to be essential for efficient catalysis,133, 134, 55 and ii) the twisting of 
the two lobes of KD against each other (i.e. lobe twisting), which is critical for ADP 
release (Figure 3.3).137, 138 The presence of the SH2 domain in SH2-KDout, and the 
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preservation of the active DFG-in conformation in KDin did not alter these key 
motions for catalysis. However, in KDout, these two motions are affected and are 
coupled with the A-loop major conformational flexibility. This likely contributed to 
the diminished catalytic activity, which has been experimentally observed.76, 127 
 In fact, in KDout, the A-loop underwent major conformational rearrangements, 
adopting either fully open (Conf-1), partially closed (Conf-2 and Conf-3), or 
intermediate (Conf-4) conformations (see Figure 3.4). Initially, the starting 
orientation of Y412 in Conf-1 was gradually flipped by ~90° in Conf-2 and Conf-3 
and, later, by 180° in Conf-4, generating a non-optimal conformational state for the 
Y412 trans-autophosphorylation (see Methods for a definition of Y412 states). 
Conversely, in both the SH2-KDout and KDin systems, the A-loop remained stable in 
the fully open Conf-1 throughout our simulations. Additionally, the computed free-
energy landscape indicated that the partial closure of the A-loop (i.e. the Conf-1→ 
Conf-2 transition) was particularly favored in the KDout system. In SH2-KDout and 
KDin, this transition was energetically costly, in agreement with the unbiased 
simulations of those systems, which did not show such a transition. Taken together, 
these results indicate that the fully open A-loop conformation is favored by the 
presence of the SH2 domain or by the preservation of the active DFG-in 
conformation. Notably, this finding reflects the high number of X-ray structures that 
show a fully open A-loop conformation only in the presence of either DFG-in 
conformations or the SH2 domain bound to KD (see Table S1). 
 
The HRD motif as the central hub of the signaling network in Abl. 
Importantly, we observed a relationship between the spatial orientation of the HRD 
motif in Abl and the specific configuration adopted by the A-loop. In the SH2-KDout 
and KDin simulations, the HRD motif conserved the native conformation, in which 
the R381 side chain pointed toward Y412, stabilizing the fully open A-loop 
conformation.133 Conversely, in KDout, the H380 rotated its side chain (Figure S5), 
causing a local shift of the HRD motif and the partial closure of the A-loop, during 
which the Y412 gradually adopted Conf-2 and Conf-3. Consequently, R381f also 
rotated, causing the HRD backbone flip and the Conf-3→Conf-4 transition (Figure 
3.4 and Figure 3.5). In the absence of this R381f rotation, as observed in additional 
KDout MD replicas, the HRD motif returned to the native conformation through a 
spontaneous Conf-3→Conf-1 transition (Figure S7). 
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These results indicate that the spatial orientation of the HRD motif seems therefore 
critical to understanding A-loop plasticity in Abl. The HRD motif directly connects 
with the rigid aF helix via two H-bonds that constitute the well-conserved EPK-ELK 
H-bond network 139, 147, 148 (Figure 3.1). While the centrality of the HRD motif 
suggests its role in preserving the Abl folding,126 our simulations also suggest the 
HRD motif’s crucial role in modulating a complex network of interactions that, when 
broken, lead to major rearrangements of the A-loop. In fact, in both the SH2-KDout 
and KDin systems, the HRD native configuration contributed to the preservation of 
the EPK-ELK H-bond network throughout the trajectories. Conversely, in KDout, the 
HRD peptide flip and the simultaneous rupture of the EPK-ELK H-bond network 
trigger the consequent A-loop rearrangement in Conf-4. 
As expected, in the additional KDout replicas where the HRD motif returned to its 
native conformation, the EPK-ELK H-bond network was also re-formed, as in Conf-
1 state. These results indicate that the native HRD motif conformation helps to 
maintain the proper assembly of the EPK-ELK H-bond network as previously 
suggested by Oruganty et al.126 This in turn seems to affect the A-loop conformation, 
which is critical for Abl function. This was also confirmed by our simulations of the 
point mutation D440A (i.e. the D440A-KDout system), in which the loss of the EPK-
ELK H-bond network and concomitant destabilization of the HRD motif lead to 
consequent significant reorganization of the A-loop conformational state (see Figure 
S8 and Figure S9). Interestingly, this finding is in agreement with experimental 
studies performed on Aurora Kinase, where the point mutation of the well-conserved 
D311 of the aF helix has been observed to prevent the trans-autophosphorylation of 
the A-loop threonine (T288).126  
 In addition to the EPK-ELK H-bond network, we observed one key H-bond 
connecting the DFG and HRD motifs (i.e. Hb[H380-D400], Figure 3.1), which further 
helped stabilize the HRD in the native conformation and, in turn, the fully open 
conformation of the A-loop in Abl.139, 147 In KDin, Hb[H380-D400] was formed and 
preserved well, locking the H380 side chain in its crystallographic orientation. In 
contrast, in KDout, the Hb[H380-D400] was not formed because of the DFG-out initial 
conformation, but the H380 side chain interacted with the DFG-1 residue A399. This 
H-bond (i.e. Hb[H380-A399]), however, did not preserve the native HRD conformation. 
In fact, Hb[H380-A399] increased from ~3 Å to ~7 Å during MD simulations, causing 
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the rotation of the H380 side chain and the consequent destabilization of the HRD 
motif, which explains the partial closure of the A-loop. Remarkably, the presence of 
the SH2 domain in SH2-KDout prevented this destabilization, despite the absence of 
Hb[H380-D400]. In SH2-KDout, in fact, Hb[H380-A399] remained stable, with the HRD 
motif steady in its native conformation. 
Taken together, these findings suggest that the HRD motif stabilization is highly 
interconnected with the preservation of both its H-bond with the DFG motif and the 
EPK-ELK H-bond network. In turn, this structured H-bond network is critical in 
modulating the A-loop spatial conformations, and favor its fully open state. The 
active DFG-in conformation of Abl promotes the correct assembly of this H-bond 
network, whereas the inactive DFG-out conformation impairs the proper DFG/HRD 
interaction, resulting in an overall A-loop destabilization. Finally, the SH2 domain 
offsets the destabilizing effects provoked by the DFG-out motif, stabilizing the fully 
open conformation of the A-loop in which the Y412 is prone to be phosphorylatatd 
(i.e. Conf-1, see Figure 3.7). 
Finally, it is worth noting that the orientation of the HRD motif affects also the R-
spine assembly, which is known to be important for the regulation of kinase 
activity.57, 58 For example, in KDout, the H380 side chain rotation and the HRD 
peptide flip disrupt the starting configuration of the R-spine, resulting in the A-loop 
conformational rearrangement. Conversely, in SH2-KDout and in KDin systems, 
where the HRD motif did not undergo conformational rearrangements, the 
crystallographic alignment of the R-spine was preserved, with the A-loop that stably 
maintained in the fully open conformation. Taken together, these results suggest that 
the R-spine might be involved in regulating the A-loop orientation, being integral 
part of the signal that goes from the SH2 domain to the A-loop, passing from the β3-
αC loop, a KD portion found to be important to connect the SH2 and KD.129 Clearly, 
this point merits further investigations in order to clarify better the possible 
connection between the R-spine and signal propagation for modulating the A-loop 
spatial localization. 
 
Extension to other protein kinases. Structural data of Aurora, Src, and Hck 
kinases also support the HRD motif as being a key player in modulating the A-loop 
folding state. As with Abl, the trans-autophosphorylation of T288 in Aurora and 
Y416 in Src and Hck is necessary to stabilize the A-loop in the fully open 
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conformation, generating optimal catalytic activity.149, 150, 151, 152 In this 
conformational state, the A-loop is properly stabilized by the electrostatic interaction 
between the phosphorylated residue and the arginine of the HRD motif, which adopts 
the same native conformation observed in Abl. In detail, the HRD arginine points 
toward the phosphorylatable residue (T288/Y416) and the EPK-ELK H-bond 
network and the DFG/HRD interaction are properly formed (see PDBid 1OL5, 
3HA6, 3E5A, 3DQW, and 2HK5).153, 154, 155, 156 However, different X-ray structures 
of inactive states of Aurora, Src, and Hck captured different A-loop intermediates, 
with disordered conformations where the phosphorylatable T288/Y416 was far from 
the arginine of the HRD motif (PDBid 3DJ5, 3DJ6, 2J50, 1FMK, 2HCK and 
1AD5).157, 158, 159 Remarkably, in all these structures, the HRD motif was flipped, 
indicating that preserving the native HRD conformation might also be crucial to 
maintaining the fully open A-loop state in other protein kinases.  
 
Overall, these data indicate that, in Abl, the highly structured H-bond network 
centered on the HRD motif likely represents an allosteric switch for modulating A-
loop spatial orientation. In fact, in our simulations, the rupture of this well-arranged 
H-bond network is clearly coupled with the destabilization of the fully open A-loop 
conformation. This induces major A-loop rearrangements, with formation of an 
ensemble of A-loop conformations that are poorly prone to undergoing 
phosphorylation. Structural data analysis of other tyrosine and serine/threonine 
kinases further supports the idea that proper HRD motif orientation and preservation 
of the structured H-bond network centered on it are critical to maintaining the A-loop 
in the fully open conformation. Thus, these results suggest that specific key structural 
components of KD in Abl (namely the DFG motif, the HRD motif, and the EPK-
ELK H-bond network) act cooperatively to regulate the A-loop dynamics and spatial 
arrangement. In our simulations, the central hub of this extended signal network was 
the HRD motif, which may thus be the core of the signal transduction mechanism for 
(allosteric) modulation in Abl. Based on the structural similarity of Abl with several 
other kinases, it seems reasonable to extend this hypothesis to other protein kinases 
such as Aurora, Src, and Hck kinases, where the conserved HRD motif could act 
similarly to modulate the signal transduction pathways within the KD domain.57, 148  
The SH2 domain is an allosteric control mechanism for this complex signaling 
network of A-loop spatial orientation and Abl activity.  
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Thus, these results augment the interpretation of the existing Abl experimental 
data and may help the rational design of new Abl binders that interfere directly or 
allosterically with this signaling network. 160, 161, 162 
 
 
	  
 
Figure 3.7. Schematic representation of the Y412 conformations observed during 
our MD simulations of the SH2-KDout (left), KDin (middle), and KDout (right) systems. 
All simulations started in Conf-1 state, where the A-loop was in the fully open 
conformation and prone to be phosphorylated. In both SH2-KDout and KDin, the A-
loop remained in the initial phosphorylatable Conf-1 state. Conversely, in KDout, the 
A-loop conformation was partially closed during the MD, visiting Conf-2 and Conf-
3. Multiple MD replicas from these metastable conformational states showed that the 
A-loop can re-open either toward a nonphosphorylatable intermediate Conf-4 state 
or toward the starting phosphorylatable, fully open Conf-1 state. 
 
 
METHODS  
	  
Structural model and classical MD simulations. We used 5 model systems, 
namely: 1) the Abl kinase domain (KD) in the DFG-out conformation and in 
complex with the SH2 modulatory subunit (SH2-KDout); 2) the DFG-out KD, without 
the SH2 domain (KDout); 3) the DFG-in KD (KDin); 4) the DFG-out KD with the 
D440A mutation (D440A-KDout); and 5) the DFG-out KD with the A-loop in the 
closed conformation (closed-KDout). 
The SH2-KDout system was constructed using the X-ray structure of Abl in the 
DFG-out conformation bound to the SH2 modulatory domain in the ‘top-hat’ 
conformation (PDBid 1OPL chain B).72  Both the SH2-KD linker and the terminal 
portion of the αI helix, which are missing in the X-ray, were modeled using Prime 
software of Maestro suite (Figure S11). The resulting model is consistent with the 
Abl sequence length used in the experiments of Lamontanara et al. (see SI for 
details).128 The KDout system was built using the same structure used for the SH2-
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KDout model, after removing the SH2 modulatory domain. The KDin system was 
constructed using the X-ray structure of Abl in the DFG-in conformation (PDBid 
2F4J).163 The D440A-KDout system was constructed using the KDout model, 
introducing the D440 mutation. The closed-KDout system was constructed using the 
X-ray structure of Abl kinase bound to imatinib and myristic acid (PDBid 1OPJ 
chain B). To ensure that the removal of myristic acid does not significantly perturb 
the structure of the myristate pocket, we monitored the behavior of this hydrophobic 
cavity along the MD simulations (see SI for further details). For all systems, the co-
crystallized ligands were removed. Each system was solvated with TIP3P water 
molecules164 and neutralized with Na+ ions. The total number of atoms was ~76000 
(SH2-KDout), ~45-50000 for each of the other systems (see SI for more details). The 
proteins were parameterized using the Amber99SB force field165 (see SI for details 
on the MD set up). Overall, we collected MD simulations of ~1.8 µs for SH2-KDout, 
~2.6 µs for KDout, 1.1 µs for both Replica 1-KDout and 2-KDout, and ~1.3 µs for KDin, 
D440A-KDout and closed-KDout, for a total of over ~10.5 µs of MD.  
 
Analysis of structural data from MD simulations. The root-mean-square 
deviation (RMSD) of the protein backbone after the equilibration time (~100 ns) 
with respect to the crystal structures was used to evaluate the stability of the systems 
during the MD simulations and perform comparative analyses. The principal 
component analysis (PCA) was performed to reduce the dimensional space of the 
data sets from MD trajectories, highlighting the principal motions of the systems.166  
Experimental evidence suggests that Y412, situated along the A-loop, is efficiently 
trans-autophosphorylated when the A-loop assumes the fully open conformation (as 
in the X-ray structure PDBid 1OPL chain B), whereas it is less prone to be 
phosphorylated in closed conformations (as in the PDBid 1OPJ). In our MD 
simulations, we adopted two parameters to define the conformational rearrangement 
and spatial delocalization of Y412 along the A-loop: 1) the RMSD of Y412 with 
respect to the reference X-ray structure 1OPL chain B (hereafter RMSDY412); 2) the 
distance between the phenolic oxygen of Y412 and the center of mass of the 
carboxylic oxygens of D440 located in the rigid aF helix (d[Y412-D440], see Figure 
3.4).  
Based on this metric, we obtained four clusters that correspond to a given Y412 
conformation (Figure 3.4): i) Cluster 1 corresponds to the ensemble of Y412 
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conformations where the A-loop is in the fully open conformation, as in the 1OPL X-
ray structure, and the Y412 is prone to be trans-autophosphorylated (Conf-1). The 
minimum point of this cluster is located at RMSDY412 = ~1.5 Å and d[Y412-D440] = 
~13 Å. ii) Cluster 2 corresponds to those conformations in with the A-loop is 
partially closed and, consequently, the Y412 is not prone to be trans-
autophosphorylated (Conf-2). This cluster is centered at RMSDY412 = ~3.5 Å and 
d[Y412-D440] = ~5.5 Å. iii) Cluster 3, as in Conf-2, represents the conformations in 
which the A-loop is partially closed, but this time the Y412 directly interacts with the 
D440 via an H-bond (Conf-3). Here too, the Y412 assumes a non-optimal position 
for trans-autophosphorylation. The minimum point of this cluster is located at 
RMSDY412 = ~4.5 Å and d[Y412-D440] = ~3 Å. iiii) Cluster 4 corresponds to those 
conformations in which the A-loop is open and the Y412 is flipped with respect to 
the conformation seen in Conf-1. Thus, Y412 assumes a non-optimal conformation 
for trans-autophosphorylation (Conf-4). This cluster is centered at RMSDY412 = ~11 
Å and d[Y412-D440] = ~15.5 Å. These cutoffs were chosen to optimally separate the 
frequency distributions of the two variables (see SI).  
 A recent study has demonstrated that the EPK-ELK H-bond network formation 
could be related to a proper catalytic activity of kinases.126, 167 In Abl, the EPK-ELK 
H-bond network comprises two H-bonds between the oxygen atoms of the D440 
carboxylate group in the aF helix and the backbone amide of both the H380 and 
R381 residues of the HRD motif (hereafter referred to as Hb[H380-D440] and Hb[R381-
D440], respectively). In Abl, the proper assembly of the EPK-ELK H-bond network 
depends on the backbone torsional angle f of R381 (R381f), which favors the 
interaction between the R381 side chain and the phosphorylated Y412, further 
locking the open A-loop conformation.121 Thus, we consider Abl to be fully active 
only when the A-loop is fully open (i.e. prone to be trans-autophosphorylatated), the 
DFG motif assumes the in conformation, and the EPK-ELK H-bond network is 
formed. 
 
Multiple walkers metadynamics. Here, we are interested in computing the free 
energy surface (FES) of the A-loop conformational transition from the fully open 
conformations, in which the Y412 is prone to be trans-autophosphorylated as in the 
crystal 1OPL chain B, to the partially closed conformations, in which the Y412 is 
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two states are described by the distance d[Y412-D440], i.e. the employed collective 
variable (CV). However, MD simulations show that the A-loop undergoes partial 
unfolding at large CV values, adopting unstructured states as those observed in KDout 
and in 1OPJ simulations (see KDout paragraph and Figure S12). In our study, these 
unstructured states of the A-loop are of no interest and, thus, should be avoided in 
sampling the conformational space.  
To do so, we considered our system having a bistable energy profile as that 
reported in Figure 3.8, where the basin A gathers the structured A-loop 
conformations (both prone and non-prone to be trans-autophosphorylated), while the 
basin B includes the unstructured A-loop conformations, i.e., structures of no 
interest. Our goal is therefore to sample as much as possible the A-loop 
conformational states in basin A, possibly avoiding the sampling of basin B. To this 
aim, one may simply add a restraining potential at the CV value that separates A 
from B. However, this simple approach is often related to issues that can be far from 
trivial. For example, a soft restraining potential would not prevent the exploration of 
basin B. On the other hand, increasing the restraining potential may induce 
significant structural distortions, especially in systems characterized by a large 
flexibility, as in our case. Moreover, the use of walls may originate problems of 
hysteresis.  
To overcome these potential issues, here we developed and applied a simple new 
approach that slightly differs from the use of potential walls. Our approach is based 
on the confinement of the multiple walkers metadynamics runs. That is, when a 
metadynamic run (a “walker”) hits a specified CV boundary value (indicating that 
the system is entering in the basin B), the simulation is restarted from conformations 
stored in a pool P of frames saved during the previous metadynamics simulations in 
basin A. In this way, metadynamics continue the exploration of the relevant basin by 
improving the sampling of transversal and often rather slow degrees of freedom. In 
our simple bistable system A and B, this approach proceeds as follows: 1) the 
simulation is monitored every t ps and the state of the system (in either A or B) is 
determined; 2) if the system is in A, the simulation continues and the current 
conformation is stored in the pool P of restart structures; 3) if the system happens to 
be close to fall into B, it is placed back into the basin A, by randomly choosing a 
restart conformation from P. The whole procedure represents a specific realization of 
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the technique of multiple walkers introduced by Raiteri et al.168 The walkers are 
asyncronous, as a new walker only starts when the preceding crossed the boundary 
value. The use of multiple walkers can be very powerful to improve the convergence 
of the free energy in CV subspaces of complex biomolecular systems, as also 
proposed recently for protein-ligand complexes.  
 
	  
Figure 3.8.	   A) 1D bistable potential with form 𝑈 𝑥 = 𝑎 1 2 𝑥 − 4 + −1 4 𝑥 − 4   with a=100 kJ/mol. The basin A is defined by 𝐶𝑉 < 4Å while basin 
B is defined as 𝐶𝑉 ⩾ 4Å. The free energy obtained with well-tempered (WT) 
metadynamics is reported together with that obtained by means of the confinement 
procedure. B) Behavior of the CV in the confined simulation. Green dots indicate the 
position of the CV at the first step of the restarted system.  
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Importantly, we validated our confined multiple walkers metadynamics on a 
simple 1D bistable spring with potential energy U(x) as shown in Figure 3.8. We 
performed well-tempered metadynamics on this system by biasing the spring length, 
using a hill height of 0.2 kJ/mol, a hill width of 0.2 Å, a fictitious CV temperature of 
1500 K, a system temperature of 300 K, a deposition rate of 1 ps-1 and the total 
simulation length 2 million steps. This allows reproducing the free energy profile in 
both basins, A and B. The restarting procedure is applied to restrict the sampling 
within basin A. The boundary CV value is set to 4 Å. As it can be noticed in Figure 
3.8, the free energy profile obtained for basin A converges to the profile of the 
standard well-tempered simulation after few restarts, and a total simulation length of 
500,000 steps. Notably, restart conformations can be extracted with equal 
probabilities, as long as the walker spends enough time in the basin of interest, 
loosing memory of its initial position (for a discussion on the related timescales see 
ref. 168).  
In the case of Abl kinase, we adopted well-tempered metadynamics (WT-
MetaD)106, 146 and two walkers for each system (i.e. KDout, KDout, and KDin) that 
started from two different A-loop conformations: i) the fully open Conf-1 (d[Y412-
D440] ~12 Å); ii) the partially closed Conf-3 (d[Y412-D440] ~3 Å) – see SI for details. 
The confined simulations are monitored every 1 ns. The FES is determined as a 
function of d[Y412-D440], which is the CV that identifies the partial closure of the A-
loop. Finally, it is worth to mention that we employed a CV value of 17 Å for our 
confined multiple walkers metadynamics (see Figure S12). This allowed us to avoid 
the well-known problem related to possible distortion of the free energy profile 
around the boundary, in a CV interval of approximately the same size of the gaussian 
width used.169, 170, 171, 172 
 
 
 
Supporting Information 
Details on systems preparation, protocols employed for MD simulations, details of 
analysis of data, and tables ad figures referenced in the text are available at Appendix 
A. 
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Automated analysis of binding pocket 
dynamics and allosteric networks in 
proteins 
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ABSTRACT 
	  
Detection and characterization of binding pockets in proteins is crucial to study 
biological regulation, and perform drug design. This is because endogenous ligands 
and drugs modulate the target's function through their binding to specific functional 
pockets, sometimes also connected through allosteric networks. In these regards, 
ever-increasing molecular dynamics (MD) simulations are nowadays used routinely 
to investigate the spatiotemporal evolution of biomolecules, and characterize their 
innate dynamics and plastic behavior within the cell. Yet, there is no computational 
tool for the automatic analysis of binding pocket dynamics and allosteric signaling 
networks in proteins, as represented by an MD-generated equilibrium ensemble of 
structures. Here, we address this need presenting a fully automated method that 
implements an original algorithm to analyze extended MD trajectories, without any a 
priori information on the existence of pockets and allosteric networks. We exemplify 
the method’s capability to efficiently analyze microsecond-long MD simulations, and 
match experimental data, of a few selected pharmaceutically relevant proteins (PNP, 
A2A and Abl kinase). These analyses exemplify the potential of this method, 
including its prospective use for binding pocket characterization in structure-based 
drug design.   
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INTRODUCTION 
	  
Binding pockets are often crucial for modulating the function of biomolecules, 
such as those in protein enzymes and ion channels. For this reason, small molecule 
drugs exert their action through their binding to a functional pocket of the protein 
target(s). Binding to functional pockets is, thus, at the very basis of the beneficial 
pharmacological effect of drugs. Detection and characterization of these functional 
binding pockets is therefore of paramount importance for biochemistry and drug 
discovery. 
In this respect, molecular dynamics (MD) is nowadays routinely used to 
characterize the spatiotemporal evolution of biomolecules. These MD simulations 
now span from hundreds of nanoseconds to even few milliseconds, therefore 
allowing to explore exhaustively the dynamics and plasticity of large protein 
systems.29 This means, importantly, that MD can also capture the appearance, 
evolution and structural modifications of binding pockets. Notably, these include 
also those superficial and shallow transient cavities that are often involved in protein 
function through their interaction with a small substrate or another partner protein. 
However, in MD, these events are described by large structural ensembles forming 
increasingly extended trajectories, which nowadays can reach hundreds of Gigabytes 
and, soon, tens of Terabytes and more. Therefore, a major need today is to develop 
algorithms capable to extract automatically the embedded information from these big 
MD-generated data sets and generate intelligible reports on the spatiotemporal 
evolution of the targeted protein, including its potentially druggable binding pockets.  
Already, there are a number of different algorithms for the detection of protein 
binding pockets in static structures. Some of these rely on the Voronoi diagrams 
(MolAxis,173 MOLE174), grids (POCKET,175 PocketFinder176), or the molecular 
surfaces and probes (HOLE,177 SURFNET178). Later, other advanced algorithms were 
derived from these, including NanoShaper,179 which is our algorithm based on the 
rigorous Alpha Shapes theory.180, 6, 48, 4  All these algorithms are instrumental to the 
analysis of an MD-generated conformational ensemble of structures and their 
binding pockets, usually performed via structural alignment, such as in MDpocket,49 
PocketAnalizerPCA,181 Epock,182 Trj_cavity183 and TRAPP.184 However, the resulting 
information may be affected by the specific reference structure used for the 
alignment. In alternative, atom-based algorithms like PROVAR185 and EPOSBP,186 
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avoid the alignment step. Nevertheless, most of these methods limit their analysis to 
the a priori-defined pocket of interest. while none of them is able to recognize 
possible signal transmission networks formed by distal allosteric pockets. Automatic 
detection of allosteric signals in proteins remains challenging, with methods based on 
normal mode,187 community network analysis,46, 130 coevolution analysis23 and 
machine learning techniques.188 These methods, however, do not allow an automatic 
analysis of the spatiotemporal evolution of pockets, and their communication 
network, as investigated by extended MD simulations.  
In this context, here we present an original algorithm to analyze extended MD 
trajectories, which automatically execute a) an alignment-independent identification 
of all the pockets on the protein surface, b) a quantification and visualization of the 
volume and surface area of all the pockets found in the protein, for each structural 
frame forming the MD trajectory, c) a history graph of interactions between pockets, 
described as merging and splitting events, d) a detection of allosteric signal 
transmission networks along the protein surface, defined as interconnected pocket 
motions (see theory section).  
We demonstrate the power of this new algorithm through the unprecedented 
analysis of the structure-dynamic-function relationship automatically extracted from 
extended MD simulations of a few selected test cases of pharmaceutical relevance, 
namely: i) the purine nucleoside phosphorylase (PNP) enzyme, ii) the adenosinic 
teceptor (A2A) simulated in POPC membrane and ii) the Abelson (Abl) kinase. Taken 
together, these examples illustrate the potential large implications of such powerful 
analysis, including its use for structure-based drug design.  
 
 
RESULTS  
	  
Protein binding pocket detection and dynamics. First, we tested the ability of our 
new algorithm implemented in Pocketron to identify and monitor protein pocket 
dynamics. Toward this end, we first used a ~700 nanosecond long MD simulations 
of the purine nucleoside phosphorylase (PNP), a homotrimeric enzyme that is 
involved in the purine metabolism and T-cell function.189, 190 PNP inhibition is a 
strategy to treat T-cell mediated diseases such as leukemia and lymphoma.191  
Pocketron identified a total of 22 pockets that exist for more than 30% of the 
overall simulations describing the dynamic docking of DADMe-ImmH into PNP. 
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Among the most persistent ones, Pocketron identified three large pockets, namely 
pocketID (pID) 4, pID 9 and pID 12 (Figure SI 1). These have a persistency of ~79% 
for pID 4 and ~96% for both pID 9 and pID 12. These three pockets are at the edge 
between the adjacent PNP monomers (see Figure 4.1). Each of them corresponds to 
the known orthosteric binding site that is targeted by PNP inhibitors, such as 
Immucillin-H and DADMe-ImmH.192, 193 These pockets have an average volume of 
367.0, 893.9 and 976.6 1 Å3, respectively. These volumes are larger than in the holo 
PNP crystal, where these pockets are 332.1, 326.7 and 408.6 Å3, respectively. This 
indicates that the orthosteric pockets, possess an elevated plasticity. Notably, the 
reduced volume of pID 4 is explained by the existence of a nearby stable pocket, pID 
13, which has a persistency of 94% and an average volume of 313.5 Å3. These two 
pockets merge for ~26% of the simulations time, resulting in a single larger 
orthosteric binding pocket having an average volume of 676.9 Å3, which is 
comparable with the other two orthosteric pockets pID 9 and pID 12. Furthermore, 
our algorithm detected two smaller pockets, pID 3 and pID 14, located in proximity 
of the orthosteric binding pockets pID 4 and pID 12 (Figure 4.1 and Figure SI 1). 
These pockets are present for the 71% and 73% of the simulation time and have an 
average value of 132.7 A3 and 144.4 A3, respectively, in agreement with their value 
in the PNP X-ray structure (202.9 and 232.3 Å3, respectively). Interestingly, these 
pockets have been shown to be a pre-binding site in which the inhibitor DADMe-
ImmH transiently binds before accessing on of the orthosteric sites. Notably, this 
pre-binding site was not found in proximity of the orthosteric pocket pID 9.194 
Likely, this is because during our simulations, pID 9 already contains the pre-binding 
site, as suggested by its larger volume compared to pID 4 and pID 12.  
Another pocket, namely pID 22, is detected at the center of the trimerization 
interface (Figure SI 1), with an average volume of 397.9 A3 (248.1 A3 in the X-ray 
structure) and a time persistency of 88%. Intriguingly, this pocket shows a marked 
communication pattern with the orthosteric binding site of each monomer during the 
MD simulations (Figure SI 2). This suggests a signaling transmission network among 
the different monomers mediated by this common interface pocket, possibly 
explaining the “one-third-the-site” observation of Schramm and coworkers195 (see 
Discussion). 
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Figure 4.1.	   A) Localization of the main pockets computed for the PNP X-ray 
structure 3K8O. On the right, the orthosteric ligand DADMe-ImmH is positioned in 
the orthosteric pocket (orange molecule) as in the X-ray structure and in the pre-
binding pocket (yellow molecule) as in our MD simulations. B) Volume along time of 
the three orthosteric pockets pID 4, pID 9 and pID 12. 
 
 
 
Identification of interaction patterns among pockets in proteins. Our algorithm 
detects pocket interactions as pocket splitting and merging along an MD simulation 
(see Theory). Here, we demonstrate such feature on 1) the Adenosinic Receptor A2A, 
a G-protein coupled receptor (GPCR) that regulate myocardial blood flow, the 
release of glutamate and dopamine, and that is a promising target for pain, 
depression and neurological diseases as Parkinson; 2) the Abelson (Abl) tyrosine 
kinase, a protein involved in cell growth and survival. Abl kinase is a validated target 
for the treatment of several types of cancer.66 Importantly, both proteins present 
multiple binding pockets that are largely characterized by biochemical and structural 
investigations. 
 
	  Adenosinic Receptor A2A. The analysis performed on 100-nanosecond long A2A 
trajectory revealed the presence of 13 pockets, which are present for more than 30% 
of the simulations. Among them, pID 15 and pID 22 coincide with the already 
known and structurally characterized orthosteric and allosteric binding sites, 
respectively. In particular, pID 15 is located in the extracellular side of the receptor 
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and is targeted by both agonist and antagonist drugs, as adenosine196 and 
ZM241385.197 Instead, pID 22 is located in the core of the transmembrane (TM) 
bundle and is normally occupied by a sodium ion that can be displaced by allosteric 
drugs as amiloride and HMA (see Figure 4.2).198, 26 Our analysis revealed that pID 15 
and pID 22 communicate during the MD simulations through merging and splitting 
events. This means that these pockets share a set of residues at the interface between 
them. These residues are Val 84, Ala 88, Phe 242 and Trp 246 (see Figure 4.2 A), 
which allow a cross-talk between these pockets. Interestingly, MD simulations and 
experimental studies have demonstrated ligand-dependent A2A signaling involving an 
allosteric effect through these two pockets.199, 198, 200  
 Although the two pockets are physically well separated during most of the 
simulations, Pocketron identified and visualized when the two pockets underwent 
either merge or split events. For example, we show frame 844 – out of a thousand 
frames analyzed – where the larger orthosteric pocket pID 15 incorporates the 
allosteric pID 22 (see Figure 4.2 B). Remarkably, when the two pockets are merged 
together, they allow the formation of a small channel that can permit the passage of 
the sodium from the extracellular side to the allosteric pocket, as suggested by 
thermal stability studies198 and MD simulations.201 In this context, the shared residues 
at the edge between the two pocket (again, Val 84, Ala 88, Phe 242 and Trp 246) 
might act as a gate of the channel, mediating its opening, closure, and thus 
modulating sodium entrance. In fact, it has been well established that the 
conformation flexibility of Trp 246, known also as “toggle switch” residue, is 
associated with the activation mechanism of GPCRs.202, 203, 204, 205 In summary, these 
results show that Pocketron describes interaction patterns between orthosteric and 
allosteric pockets, in agreement with experimental data. 
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Figure 4.2.	  A) Time persistency of residues that define the orthosteric pocket (blue 
stem, pID 15) and the allosteric pocket (red stem, pID 22). B)  Volume plot of pID 15 
and pID 22 in selected frames and representation of merging and splitting events. 
 
Abelson (Abl) tyrosine kinase. Here, we analyzed the MD simulations of the 
kinase domain (KD) of Abl, both in the catalytically active DFG-in (KDin) and 
inactive DFG-out (KDout) conformations (see Methods for details). Among the most 
persistent pockets in KDin, Pocketron successfully identified the large ATP pocket 
(pID 5). Besides pID 5, Pocketron also found another nearby pocket in between the 
DFG motif and the aC helix (pID 3), which is known to be an allosteric site in KD. 
In fact, the two pockets, pID 5 and pID 3, do actually communicate in our MD 
simulations, having a large set of shared residues listed in Table SI 1. For ~63% of 
the simulations, they remain two separated pockets with volume 438.7 A3 and 166.7 
A3. However, for the ~35% of the simulations, the two pockets merge into a single 
large pocket having an average volume of 497.4 A3 (see Figure 4.3).  
Also in KDout, Pocketron identified the ATP pocket pID 5 and the nearby 
allosteric pocket pID 3 having an average volume of 338.6 A3 and 221.8 A3, 
respectively. However, this time an additional pocket was identified, pID 28, which 
is located in between the P-loop and the b3-aC-helix loop, and which has a smaller 
volume of 150.5 A3. Notably, the region containing this new pocket has been 
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targeted by a new class of diphenylamine-derived allosteric inhibitors in MEK 1 and 
MEK 2 kinases.206 Also here, the three pockets pID 3, pID 5 and pID 28 share a set 
of residues (listed in table SI 1), which indicates a communication network among 
them. Interestingly, in this case they exist separately only for ~11% of the overall 
simulated time, due to more frequent merge events with respect to the catalytically 
active KDin system (see Figure 4.3). 
According to our analysis, in the catalytically active KDin system, the DFG-in 
conformation limits the cross-talk between the ATP pocket and the nearby pocket 
pID 3. In contrast, in KDout, the DFG-out conformation favors the communication 
with the surrounding pockets pID 3 and pID 28. Indeed, the DFG-out conformation 
has been demonstrated to augment the flexibility of the ATP binding site, which is 
translated into the loss of KD activity.207, 129 Thus, our analysis suggests that the 
specific DFG conformation, in or out, affect the formation of transient pockets and 
their communication network, which in turn modulates the overall shape of the ATP 
binding site and the resulting KD activity. 
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Figure 4.3. Representation of the dynamical behavior of the ATP pockets during the 
MD simulations of KDin system (a and b) and KDout systems (c-f). In the KDin, in 
(a) the ATP pocket pID 5 coexists with the near pID 3 for the 63% of the simulation, 
while in (b) pID 5 is the only pocket for the 35.0%. In KDout, in (c) the ATP pocket 
coexists with pID 3 and pID 28 for the 10.8% of the MD simulation; In (d) the ATP 
pocket is the only binding site for the 38.5% of the simulations, while in (e) it 
coexists with pID 3 for the 20.2% and in (f) it coexists with pID 28 for the 23.5% of 
the simulations. 
 
Allosteric signal transmission networks inferred from pocket dynamics. Here, 
we tested the capability of our new algorithm to retrieve allosteric signal propagation 
pathways in proteins as represented by an MD-generated equilibrium ensemble of 
structures. As a paradigmatic example, we investigated the Abl kinase, which is one 
of the most characterized systems in terms of molecular determinants for protein 
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allostery.129, 207 We performed a comparative analysis of four different Abl systems: 
1) the wild type KDin form, 2) KD bound to myristate (Myr/KDin), 3) the KD apo 
form of the T315I mutation (T315I-KDin), 4) system T315I-KDin bound to myristate 
(Myr/T315I-KDin). 
In all systems, our analysis detected both the orthosteric ATP pocket and the 
allosteric myristate pocket, which is located in the C-lobe of the KD.114 Also, the 
analysis of the MD frames returned an intensive interconnection of atoms across 
pockets distributed on the protein surface. These interconnections were detected as 
off-diagonal elements of the square matrix N (see Theory). Notably, such a cross-talk 
establishes a long-range communication network between the distal orthosteric ATP 
and the allosteric myristate pockets (see Figure 4.4), which is well-known to be 
central for the allosteric signal propagation in Abl. In particular, in both KDin and 
Myr/KDin, the ATP and the myristate pockets are linked through a long-range 
communication network that passes through a number (~3 to 5) of small transient 
pockets (average volume ~90 Å, and persistency between 20 and 70%) mainly 
located in the C-lobe and involving mostly the aG and aI-helix (Figure 4.4). 
Notably, the location of pockets coincides with that of the new allosteric pockets 
reported by Shan et al. in their study on binding pathways in Src kinase. Notably, in 
the MD simulations of Abl with the drug resistant T315I point mutation (i.e. T315I-
KDin system), the ATP ↔ myristate long-range communication network is actually 
disrupted (Figure 4.4). The perturbation of such communication pathway detected in 
T315I-KDin system might explain dysregulation of the T315I kinase form.208 
Remarkably, however, in our simulations where the myristate bind to the T315I Abl 
mutated form (i.e. Myr/T315I-KDin system), the ATP ↔ myristate pockets long-
range communication network is completely restored, as in the wild-type system. 
This result is in line with experimental studies that show that myristate mimetics 
elicit a structural rearrangement on the ATP pocket, influencing the binding affinity 
of orthosteric inhibitors.114, 209 This MD-based allosteric communication network210 
could also explain HX MS experiments that further detailed the presence of an 
allosteric signal propagation pathway from myristate to the ATP pockets, passing 
through KD structural elements as the aI-helix.209  
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Figure 4.4. Networks of the most persistent pockets found in KDin, T315I-KDin, 
Myr/KDin and Myr/T315I-KDin trajectories. Each pocket (i.e. node of the network) 
is represented as a green sphere and the different colors indicate the pocket 
persistency. The pockets are connected through black lines (i.e. edges of the 
network). The width of each edge is proportional to the communication frequency. 
The networks connect the ATP binding site and the myristate binding site in all 
systems except for T315I-KDin. 
 
DISCUSSION 
 
In this work, we present a novel algorithm, implemented in a new software named 
Pocketron, for the detection of all pockets on a given biomolecular system. This 
algorithm allows examining extended MD trajectories, monitoring the 
spatiotemporal evolution of all the cavities, including those transient pockets that 
form allosteric communication networks to modulate protein function. Notably, this 
analysis was performed without any a priori information on the existence of pockets 
and communication network. Here, we validate this algorithm using three different 
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biomolecular systems, namely the Purine Nucleoside Phosphorylase (PNP) enzyme, 
the Adenosinic Receptor (A2A) and the Abelson (Abl) kinase. 
Firstly, Pocketron identified all the experimentally known orthosteric binding sites 
in the PNP homotrimeric enzyme, namely pID 4, pID 9 and pID 12. Interestingly, 
these pockets are also among the most persistent and larger ones, indicating that 
these two parameters might be important to evaluate promising targetable sites and 
hot spot. In addition, our analysis also identified smaller pockets in proximity of the 
aforementioned larger binding sites. Notably, these auxiliary pockets were involved 
in a pre-binding state of DADMe-ImmH, a PNP inhibitor, which was found to 
transiently interact with this small pocket, before entering into the main orthosteric 
site.194 The analysis of the volume variation along time evidenced an elevated 
plasticity of the orthosteric binding pockets. In fact, the average volume of the three 
pockets is higher respect to crystallographic value, indicating that during the 
simulations the pockets undergo to a structural rearrangement which facilitate the 
binding of DADMe-ImmH inhibitors observed during the simulations. Also, our 
analysis revealed a marked communication pattern between the orthosteric pocket 
and nearby pre-binding site pocket which is due to an elevated frequency of merge 
and split events. Taken together, our findings detailed an elevated plasticity of PNP 
orthosteric binding sites. Remarkably, this is in line with structural studies that 
showed a major conformational alteration of two structural motifs of the binding site 
(i.e. His 257-helix and His 64-loop) upon inhibitor’s binding, which affect the size 
and the shape of binding pocket.211 Notably, the elevated flexibility of this structural 
region in PNP has been used recently to demonstrate that MD can be effectively 
employed to improve virtual screening results. Pocketron also identified a long-range 
communication pathway among the orthosteric pockets and another pocket detected 
at the center of the trimerization interface (pID 22). This pathway might indicate the 
presence of an allosteric signal that connects the far orthosteric pockets, passing via 
the trimerization interface. This can support the “one-third-the-site” theory of 
Shramm and collaborators, although further computational and experimental studies 
are still needed to clarify the allosteric behavior of PNP enzyme. Overall, these 
results confirm the ability of this new algorithm to detect all pockets on the protein 
surface, and monitor their conformational flexibility, irrespective of their size, 
location and extension.  
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Subsequently, Pocketron was used to monitor local communication network 
among near binding sites described as pocket merge and split events (see Theory). 
To do so, we first analyzed the MD trajectory of A2A simulated in POPC membrane. 
Also here, Pocketron was able to identify the experimentally known pockets, which 
are the orthosteric binding site, located in proximity of the extracellular side, and the 
underlying sodium allosteric site. In addition, our analysis showed that the two 
pockets communicate during simulation, sharing a set of residues located in the 
interface of the two sites (i.e. Val 84, Ala 88, Phe 242 and Trp 246). Notably, this 
result is in line with experimental and computational studies that propose an 
allosteric cross-talk between the two cavities, which is crucial for the modulation of 
A2A function. In this regard, the plasticity of this region might have a functional role 
in mediating the allosteric signal transmission between the two pockets. In fact, 
experimental studies have demonstrated that the conformational flexibility of Trp 
246, also known as “toggle switch”, is key in guiding the activation/deactivation of 
the receptor. Pocketron also identified selected frames of the MD trajectory in which 
the two pockets are merged into a single entity. This led to the formation of a small 
channel through which the Na+ ion could access the cytosol from the extracellular 
space, as experimentally reported.  
Merging and splitting events have been also shown in our MD simulations of the 
Abl kinase. Here, we focused chiefly on the orthosteric ATP pocket, comparing the 
results obtained through the analysis of the catalytically active DFG-in and 
catalytically inactive DFG-out kinase domain (KDin and KDout, respectively). 
Together with the ATP pocket, Pocketron also revealed the presence of two 
subpockets. One is an allosteric pocket often exploited by type II kinase inhibitors, 
while the other is in between the P-loop and the b3-aC-helix loop -present only in 
KDout (see Figure 4.3). Notably, this region has been targeted by a new class of 
MEK1 and 2 kinase inhibitors and also accommodated the piperazine-phenyl-
pyrimidine moiety of SCH772984 in both ERK1 and ERK2 kinases. This suggests 
that this pocket can be exploited for designing new compounds that target selectively 
the inactive (i.e. DFG-out) Abl form. Moreover, our analysis evidenced that split and 
merge events among ATP and the aforementioned subpockets are more frequent in 
the inactive KDout than in the active KDin form. This intensive cross-talk reflects an 
elevated plasticity of the ATP binding site in the case of KDout, as also confirmed 
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previous computational studied.207, 129 As a consequence, the augmented 
conformational flexibility of the ATP binding site mirrored a diminished catalytic 
activity. Therefore, through the merge/split analysis, we demonstrated that our tool 
can capture even subtle protein conformational changes, providing useful insights 
into the comprehension of protein function. 
Lastly, we tested the ability of Pocketron to identify communication networks of 
pockets spanned across the overall KD of Abl. Interestingly, we found a long-range 
cross talk between the two distant orthosteric ATP and the allosteric myristate 
pockets. This cross talk has been largely reported in the literature and represents one 
among the several allosteric mechanisms that modulate the kinase function. 
According to the resulting pocket communication network, the allosteric signal 
passes through a set of pockets located in proximity of aG and aI-helix of the C-
lobe, which is a region that can be target by allosteric kinase inhibitors, as suggested 
by a recent computational study (Figure 4.4). This region, therefore, can be 
considered crucial to mediate the allosteric signal transmission between the allosteric 
pocket and the ATP binding site. Indeed, both HX MS experiments and MD 
simulations indicated that both aG and aI-helix are involved in the allosteric signal 
propagation. According to our results, the integrity of the network is essential for a 
proper kinase functionality. In fact, Pocketron detected a perturbation of the pocket 
communication network only in the dysregulated T315I Abl form, that occur at the 
level of aG and aI-helix of the C-lobe (Figure 4.4). Therefore, the T315I point 
mutation induces a structural rearrangement of the pocket communication network, 
which might explain the deregulation of the T315I Abl form.   
Hence, these findings suggest that the interaction network among superficial 
pockets can be seen as an external reflection of conformational rearrangements 
occurring also inside the protein212 and Pocketron can be considered a new 
computational method for an effective analysis of allosteric signal propagation.   
 
 
CONCLUSIONS 
	  
In this paper, we present a novel algorithm, implemented in the new software 
Pocketron, which permits an automated detection and detailed analyses of protein 
pockets and their spatiotemporal behavior along extended MD simulations. Notably, 
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this algorithm is able to characterize the history of each pocket, reporting topological 
events as merge and split, as well as temporal information on their formation and 
disappearance. Moreover, for each detected pocket, Pocketron returns its persistence 
and volume along time, listing all atoms and residues that define each pocket. 
Another key feature of Pocketron is its capability to identify communication 
networks among near and far pockets and to retrieve allosteric signal propagation 
pathways.  
All these features have been validated here by analyzing extended MD trajectories 
of selected pharmaceutical relevant biomolecular systems. The results also exemplify 
how this new algorithm could be successfully employed in the field of drug 
discovery to identify and characterize new hot spot, transient pockets, and 
communication network for signaling propagation, without any a priori information 
on their existence.  
 
 
THEORY 
	  
Outline of the method. In Pocketron, we identify surface pockets and track their 
evolution along a molecular dynamics (MD) trajectory. A first algorithm is devoted 
to the detection of pockets on the protein surface, with particular attention to those 
that could be binding or druggable sites. It has been implemented in the 0.7 version 
of NanoShaper (freely available at www.electrostaticszone.eu). This algorithm 
performs such task for every given frame of an MD trajectory. The execution time 
for the detection of binding pockets in a single frame of a protein of ~2000 atoms is 
in the range of 2-6 seconds. A second algorithm is dedicated to the characterization 
of pocket dynamics along an MD trajectory. This new algorithm implements a 
unique and dynamics-consistent identifier of each atom of every pocket. In this way, 
the spatiotemporal evolution of each pocket is monitored over the entire MD 
trajectory. Both algorithms are described in the following sections, while Pocketron 
is implemented in the BiKiLifeSciences software. 
Static pocket detection. The pocket detection algorithm in Pocketron is based on 
the Solvent Excluded Surface (SES), or Connolly-Richards surface, which is defined 
as that obtained by rolling a spherical probe over the Van der Waals surface of the 
molecular system, described as the union of atomic spheres. We computed the SES 
analytically via the Alpha Shapes theory.179 Then, Pocketron identifies surface 
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pockets by making the volumetric difference of the regions enclosed by the SESs 
obtained with two different probe radii. The smaller rolling spherical probe has a 
radius of 1.4 Å, which corresponds to the spherical approximation of a water 
molecule (Figure 4.5). Conversely, the larger rolling spherical probe has a default 
radius of 3Å (Figure 4.5). We found that these specific size values, which can 
however be modified at will, together with a subsequent filter selecting only pockets 
with a volume of at least 11.5 Å3 (~3 water molecules), provide a reasonable 
identification of pockets and potential binding sites. Thus, Pocketron analyzes the 
entire protein surface, enumerating the identified pockets and storing their calculated 
volume and list of contributing atoms-per-pocket. Moreover, Pocketron also provides 
a grid-based representation of each identified pocket.  
 
	  
Figure 4.5. Solvent Excluded Surface based pocket definition. The pocket definition 
here follows the Richards-Lee definition of the solvent excluded surface, that is the 
surface obtained by rolling a probe over the atomic system as shown in the left 
panel. In our case, the pockets are identified by performing the volumetric difference 
between the regions enclosed by the SESs obtained with a larger probe, (right panel, 
in orange), and a smaller one. In our case the radii values are 3Å and 1.4 Å, 
respectively. The resulting regions are then duly polished, in order to eliminate 
spurious ones. 
 
Dynamical pocket tracking algorithm. The atoms forming each pocket are the 
fundamental elements of our new algorithm for monitoring pocket dynamics in that 
they represent the actual tracked elements. In fact, the algorithm tracks all the atom-
based events occurring along an MD trajectory, without the need of any structural 
alignment or prior knowledge concerning the region where to search for pockets. In 
this way, exchange of atoms among adjacent pockets is tracked, indicating cross-talk 
events between them. By ‘atom exchange’ is meant the fact that the same atom is 
found to belong to different pockets in different times of the simulation. This 
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analysis considers as significant so-called “merging” and “splitting” events, which 
are calculated via simple operations on the sets of atoms that form each pocket. More 
specifically, a “merge” event occurs when atoms that belonged, in a previous frame, 
to separated pockets, in the current frame belong to a sole pocket. Symmetrically, a 
“split” event is when atoms of a previously single pocket get separated and form two 
or more distinct new pockets. To carefully guarantee consistency in pocket tracking, 
Pocketron initially stores the list of pockets found in the first frame, as defined by 
their constituent atoms, and assigns a unique ID to each stored pocket. Then, for 
every additional frame, the current set of pockets is computed and compared with the 
stored ones. Only in case of mismatch with respect to all of the stored pockets, the 
current pocket is stored as a new entry in the stored pocket’s list and assigned a new 
ID. To measure the degree of similarity between two pockets, Pocketron uses the 
Jaccard index. For example, let A and B be the sets of atoms belonging to two 
pockets. Then, the Jaccard index between them is defined as: 
 
 𝐽 𝐴, 𝐵 = |𝐴 ∩ 𝐵||𝐴 ∪ 𝐵| (1) 
 
where the modulus symbol indicates the cardinality of the atom sets. If A and B are 
identical, i.e. have the same constituent atoms, the index reaches its maximum value 
of 1. In case only a fraction of atoms is shared between A and B, the index provides 
the number of matching atoms (numerator) divided by cardinality of the union of the 
atom sets. In case there is no matching, the index is null.  
Pocket identification is therefore performed through the similarity matrix M. Each 
entry M(i,k) is the Jaccard index between atom constituting the i-th stored pocket 
and those of the k-th pocket detected in the current frame. At every frame, each 
pocket is compared to all of the already stored ones. If M(i,k) = 0 "i, then the k-th 
pocket is considered as a new one and is stored. Otherwise, the k-th pocket will be 
connected to the one, among the stored ones, which maximizes the Jaccard index. In 
mathematical terms said 𝑝" the i-th stored pocket and 𝑝u(𝑡) the k-th detected pocket 
on the frame at time t the M matrix is therefore the following: 
 
 
(2) M≜ 𝐽(𝑝J, 𝑝J(𝑡)) ⋯ 𝐽(𝑝J, 𝑝(𝑡))⋮ ⋱ ⋮𝐽(𝑝, 𝑝J(𝑡)) ⋯ 𝐽(𝑝, 𝑝(𝑡)) 
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where K is the total number of detected pockets in the current frame and N is the 
total number of stored pockets so far. As already mentioned, the pocket ID 
assignment is done via finding the maximum entry for every column of M: 
 
(3) 
 
where the index wk is the index corresponding to the stored pocket to which k is 
assigned to. If M(wk,k) = 0, a new entry, with its own new ID, is created and stored 
in the pocket list.  
Similarly, to detect merging and splitting events, Pocketron builds the matrix F, so as 
that F(k,j) is the Jaccard index of the k-th pocket at instant t and the j-th pocket found 
in the previous frame at instant t-1. Then the F matrix is: 
 
(4) 
 
 
where now J is the total number of pockets at the t-1 instant, (i.e. the previous 
frame). Traversing this matrix allows to easily detect merge and split events. Indeed, 
termed “nz” the operator that returns all the non-zero entries of a row/column vector 
and termed “(i,:) ” and “(:,i)” the operators which return all the elements of the i-th 
row/column, respectively, we have that: 
 
(5) 
 
where Merge(𝑝u(𝑡)) is the set containing all the indexes of the pockets detected at 
the (t-1)-th frame that shared some atoms with pocket k. If this set is empty, then no 
merge event involved 𝑝u(𝑡). Symmetrically, Split(𝑝(𝑡 − 1)), is the set containing 
all the indexes of the pockets detected at the t–th frame that shared some atoms with 
pocket labeled as j at the frame (t-1)-th. If this set is empty, then no split event 
involved 𝑝(𝑡 − 1).  
 As a technical note, we observe that the entries of the F matrix directly concern only 
the pockets detected at the t and t-1 instants. However, once the merging and 
F≜ 𝐽(𝑝J(𝑡), 𝑝J(𝑡 − 1)) ⋯ 𝐽(𝑝J(𝑡), 𝑝 (𝑡 − 1))⋮ ⋱ ⋮𝐽(𝑝(𝑡), 𝑝J(𝑡 − 1)) ⋯ 𝐽(𝑝(𝑡), 𝑝 (𝑡 − 1)) 
Merge(𝑝u(𝑡))      =  arg	  nz£𝐅(𝑘, : )¦ 
Split(𝑝 (𝑡 − 1))  =  arg	  nz£𝐅(: , 𝑗)¦ 
𝑤u = argmaxi=1..N 	  𝐌(𝑖, 𝑘);	  ∀k = 1. . K 
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splitting events are detected, to connect these pockets to the stored ones and to make 
the tracking consistent, once again the M matrix is used as previously described. 
Detection of a signal transmission network. Given the mentioned tracking 
capability along time, the volume and surface area of all pockets are stored, at every 
frame. Thus, at the end of the analysis, Pocketron has a set of atoms characterizing 
each pocket and the full history of the volume, area, splitting and merging events, for 
all the unique pockets detected along the MD run. During the tracking, atoms are 
used to identify the best matching ID, nevertheless the instantaneous information of 
the residues that at instant t characterize a given pocket is stored too. This allows to 
compute the probability – expressed as a relative frequency – of each residue to be 
part of a given pocket. In addition, for each pocket, all of the merging and splitting 
events with other pockets are stored. Indeed, one of the final result of the tracking 
process is a square matrix NM, the (i,j)-th entry of which represents the merging 
probability between two pockets expressed as the number of times they merge over 
the total number of frames. Similarly, the square matrix NS expresses the 
corresponding statistics for the splitting events. Empirically, we found that NS and 
NM corresponding entries very often coincide in magnitude, indicating that splitting 
and merge events often occur at the same time. For this reason, we keep as aggregate 
statistics the matrix N that for each entry collects the max value of the corresponding 
entries in NM and NS. The non-trivial nature of the information stored in N calls for 
effective graphical methods to represent binding pocket dynamics, also considering 
that N is highly sparse.  Pocketron translates the merging and splitting frequency 
matrix N into a 3-dimensional network graph, where the nodes of the graph are 
pockets, while the edges indicate the communication between two pockets. In detail, 
the position of each node (i.e., a pocket) is the center of mass of the atoms that form 
that pocket. The color of the pocket indicates its persistency over the simulated time. 
The more persistent is the pocket, the lighter is its color. The thickness of the edge is 
directly proportional to the frequency of merging and splitting events between the 
two connected pockets. That is, the higher is the communication between the two 
pockets, the thicker is the edge in between the two pockets.  
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METHODS 
 
Structural models. In the present work, we employed Pocketron for analyzing the 
MD simulations of three different systems, namely Purine Nucleoside Phosphorylase 
(PNP), Adenosinic Receptor (A2A) and Abelson (Abl) kinase. The homotrimeric 
construct of PNP was modelled using 3K8O X-ray structures and was simulated in 
presence of nine DADME-ImmH ligands and phosphate ions, retrieved from 1RSZ 
and 1RR6 PDB structures, respectively. A2A receptor was built using chiefly 3UZC 
X-ray structures, while 4EIY X-ray structure was used as template for the missing 
ECL2 in 3UZC. The apo protein was embedded in POPC membrane. For Abl we 
built 5 different model systems. Two of them include the apo wild-type KD alone 
both in the DFG-in (KDin) and in DFG-out conformation (KDout). Two consist of the 
KD mutated at the gatekeeper residue T315 – located at the ATP binding site – with 
an isoleucine residue. These mutated forms are either in the apo (T315I-KDin) or in 
complex with myristate (Myr/T315I-KDin). The last system is the wild type KD in 
complex with myristate (Myr/KDin). The KDout system was built starting from 1OPL 
chain B X-ray structure after the removal of the SH2 domain. The remaining systems 
were modelled staring from the 2F4J X-ray structure. For further details see 
Supporting Information.  
 
MD simulations. PNP was parameterized using Amber ff99SB-ildn force field, 
while General Amber Force Field (GAFF) was employed to parameterize the ligands 
and the ions. Ligand partial charges were fitted using the RESP procedure via 
Antechamber. The system was immersed in TIP3P water box and consisted of 
~100,000 atoms. After 350 ns of equilibration which led the system to a temperature 
of 300 K and to a pressure of 1 bar, we run the production in NVT ensemble. We 
collected ~710 ns of simulation stored in ~1800 frames for Pocketron analysis.  
A2A was parameterized using the Amber ff99SB-ildn force field. The protein and 
the POPC membrane were immersed in TIP3P water box reaching a total of 65802 
atoms. Also, here the system was first equilibrated to reach a temperature of 300 K 
and a pressure of 1 bar, while the production was run for 100 ns in NPT ensemble. 
We extracted from the trajectory ~1000 frames for Pocketron analysis.  
The five Abl kinase systems ware parameterized using the Amber ff99SB force field. 
For Myr/T315I-KDin and Myr/KDin models the myristate was parameterized using 
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General Amber Force Field (GAFF) after computing the point charges at HF/6-31G* 
level theory. The systems were solvated in TIP3P water and consisted of ~45000 
atoms. After 5 ns of equilibration the systems reached a temperature of 300 K and a 
pressure of 1 bar, we run the production in NPT ensemble for a simulation time that 
spans from ~0.8 µs to ~2.5 µs. Here, Pocketron was used to analyze from ~16,000 to 
~50,000 frames. See SI for more details.  
 
Pocketron parameters. For each Pocketron analysis, we set the small and the 
large probe radii respectively to 1.4 and 3 Å. To avoid unnecessary noise due to the 
detection of very small pockets, we set the minimal volume of a detectable pocket to 
the equivalent of 5 water molecules for PNP and A2A and 4 water molecules for Abl. 
Finally, we want to stress that for tracking purposes, we removed from each system 
trajectory all the ligands, the ions, the membrane, water molecules, taking into 
account only the protein. 
 
 
Supporting Information 
Details on systems preparation, figures and tables reported in the main body are 
available at Appendix B. 
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Structural characterization of BTK 
kinase via integrative modeling 
techniques  
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INTRODUCTION 
Bruton’s tyrosin kinase (Btk) is a non-receptor kinase that belongs to Tec family, 
chiefly expressed in hematopoietic cells, as B cells, platelets,213 neutrophils214 and 
macrophages.215 Btk has a prominent role in B-cell antigen receptor (BCR) signaling, 
fostering the development of B-cells.216 Mutations in Btk gene often results in the 
lack of Btk protein or in its impaired function, which is the main cause of the 
overcoming of primary immunodeficiency X-linked agammaglobulinemia (XLA).217 
Such a disease is characterized by the block of B cell development, leading to the 
lack of antibodies and causing, in turn, an increased susceptibility to infections. 
Therefore, given its important role in B-cell development and function, Btk is 
nowadays an attractive drug target for the treatment of B-cell malignancies and 
autoimmune disease.218, 219  
Btk has a modular structure similar to that of Src family kinases, containing the 
SH3, the SH2 and the catalytic Kinase Domain (KD). In addition, Btk is also 
endowed of the Pleckstrin Homology (PH) domain, which allows the binding with 
the phosphatidylinositol (3,4,5)-trisphosphate (PIP3) in membrane, and the Tec 
Homology (TH) domain, which contains a zinc finger motif, which is important for 
protein stability and function.220, 221 Recent biophysical and structural studies 
revealed that, when in the inactive (or auto-inhibited) form, Btk assumes a closed 
and compact conformation.222 Here, the SH2 and the SH3 domains are bound the 
lateral part of KD as also reported for Src family kinases and Abl kinase. The PH and 
TH domains, instead, are located on the back of the SH3-SH2-KD complex. When 
active, Btk seems to adopt an elongated conformation, as reported by previous small-
angle X-ray scattering (SAXS) measurements of full-length Btk.223 The activation of 
Btk is initiated by its interaction with PIP3 at the membrane. The membrane 
recruitment triggers the trans-auto phosphorylation both at Tyr551, which is the 
canonical phosphorylation site at the activation loop (A-loop) and at Tyr233 in the 
SH3 domain.224, 225 Phosphorylation, in turn, releases the chemical constraints that 
lock Btk in the closed conformation, allowing the formation of the elongated 
configuration of Btk, as also observed in several other kinases.223 Recently, the 
elongated active conformation has been also reported in Abl kinase through X-ray 
crystallography.70 These X-ray structures show that the SH2 domain binds the N-lobe 
of KD. Interestingly, biochemical and computational studies have found that the 
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binding of the SH2 allosterically increases both the catalytic activity and the 
phosphorylation of the Tyr412 at the A-loop, a required step for full kinase 
activity.207, 129, 128 These findings demonstrated that the SH2 domain in Abl not only 
has a role in mediating the protein-protein interaction, but also modulates of kinase 
activity. In fact, the disruption of the SH2-KD interaction is considered a viable 
strategy to inhibit the Abl function.76 
As mentioned before, likewise to Abl, Btk also contains the SH2 domain and 
adopts an elongated conformation when active. Therefore, it is reasonable to 
hypothesize that also in Btk, the SH2 might both modulate allosterically the kinase 
activity and favor the phosphorylation of the A-loop at Tyr551. However, unlike 
Abl, detailed structural insights on the SH2-KD interaction of Btk are missing. 
Notably, this information is essential to unveil the molecular mechanisms 
responsible for the allosteric signal propagation across the SH2-KD complex. In the 
present work, we integrated molecular modeling and biophysical techniques to 
provide structural insights on the SH2-KD interaction in Btk. To do so, we firstly 
performed enhanced sampling molecular dynamics (MD) simulations to retrieve an 
ensemble of SH2-KD conformations that were subsequently compared with SAXS 
data. As preliminary result, this procedure enabled us to select SH2-KD complexes 
that better fit the experimental data.  
 
	  
RESULTS AND DISCUSSION  
 
 In the present work, we coupled computational studies, based on enhanced 
sampling MD simulations, with structural and biochemical studies to provide 
structural insights on the formation of the activated SH2-KD complex in Btk kinase. 
In particular, through MD simulations, we performed a dynamic domain-domain 
docking in order to probe the interactions that favor the SH2-KD binding. Then, we 
retrieved an ensemble of relevant SH2-KD complexes from MD trajectories that 
were integrated to SAXS data in order to propose a model of the active SH2-KD 
complex.  
  Prediction of SH2 anchor point residues. Firstly, we focused our attention on 
the identification of key residues of the SH2 that might have a role in mediating the 
interaction with KD. Toward this aim, we performed a bioinformatics-based 
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analysis, by means of the whiscy web server. This allowed predicting surface 
residues of SH2 domain that are more likely to be involved in the binding with KD. 
As a result, whiscy predicted 12 residues as putative interaction points of the SH2 
domain (red residues in Figure 5.1) and 25 residues as putative surrounding residues 
(green residues in Figure 5.1). These residues are clustered in two distinct sites of the 
SH2 domain, which are referred to as S1 and S2.  S1 corresponds to surface binding 
site nearby the phospho-peptide binding pocket, while S2 is in between the aB helix 
and the SH2-KD linker (Figure 5.1). Since S1 is already involved in the binding with 
the peptide substrate,226 it is unlikely that it interacts also with KD. Therefore, we 
discarded S1 from subsequent analysis, focusing our attention only on S2.  
	  
	  
	  
	  
Figure 5.1. SH2 domain of Btk kinase (pdb code: 2GE9). The portions in red 
represent the residues that whiscy predicted as putative anchor points for the PPI, 
while the residues in green are the predicted surrounding spots. As illustrative scope 
the peptide is depicted in pink. It has been retrieved by Itk NMR structure with the 
code 2ETZ.  
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To further corroborate our hypothesis, according to which S2 is involved in the 
interaction with KD, our performed mutational studies on SH2 domain. In order to 
select a set of SH2 residues to mutate, we crossed the information obtained by 
whiscy prediction and known point mutations that are found in XLA-patients.227 As a 
result, we selected the following Btk mutations: His364Asp, Ser371Pro, Arg372Gly, 
Lys374Asn. To assess whether a point mutation in SH2 domain either favors or 
hampers the binding with KD we set up a biochemical assay as suggested in Grebien 
et al. 76 and Lamontanara et al.128 Briefly, in this assay we measured the 
phosphorylation of the A-loop at the Tyr551, which is known to be increased upon 
binding of SH2 domain with KD. Therefore, mutations that prevent the SH2-KD 
binding should return a decreased A-loop phosphorylation compared to the wild 
type. As a result, in all the Btk mutants the phosphorylation at Tyr551 is diminished 
respect the wild-type construct, which conserved its basal phosphorylation rate 
(Figure 5.2). Hence, these results indicated that His364, Ser371, Arg372 and Lys374 
might be important for SH2 binding, having a role in mediating the interaction with 
KD.  
	  
Figure 5.2. The indicated SH3-SH2-KD constructs both in wild-type and mutated 
form were analyzed by immunoblotting with an anti-pY551 antibody. 
	  
	  
	  
Role of the linker in SH2-KD complex formation. At this point, we focused our 
attention on the SH2-KD linker with the aim of understanding its role in the 
formation of SH2-KD complex in Btk kinase. To do so, we performed a ~200 ns 
long aMD simulation of SH2-KD system in absence of the linker (see Methods). We 
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monitored the binding events of the two domains during the simulations, computing 
the distance between the center of mass (COM) of the SH2 domain and the COM of 
the N-lobe of KD (i.e. d1). In the first ~80 ns of simulations, d1 oscillates between 
~40 and ~90 Å, indicating that the two domains approached each other even though 
binding events have not been detected (Figure 5.3). From ~80 ns until the end of the 
trajectory, the distance between SH2 and KD increases reaching a value of ~150 Å, 
indicating that the SH2 moved away from the KD (Figure 5.3). These results indicate 
that in absence of the SH2-KD linker the two domains do not bind in our 
simulations. 
To confirm our findings, our collaborators performed size exclusion 
chromatography and isothermal titration calorimetry (ITC) experiments in order to 
evaluate the interaction between the SH2 domain and KD (see Methods). Notably, 
both experiments revealed that the two domains do not interact to each other, further 
corroborating the results obtained through aMD simulations. Therefore, the 
interaction between the SH2 and KD is impaired without the SH2-KD linker, which, 
in turn, might be a key structural element that ensure a proficient domain-domain 
interaction. 
	  
	  
	  
Figure 5.3. Time evolution distance between the COM of SH2 and KD in SH2-KD 
system. 
	  
	  
Investigating the binding events through aMD simulations. Here, we 
performed aMD simulations of Btk SH2-KD model in presence of SH2-KD linker 
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(i.e. SH2-KD-Linker, see Methods) in order to study domain-domain binding 
dynamics and to retrieve potential structures of the SH2-KD complex. To increase 
the sampling of the phase space, we run 11 independent replicates that last ~200 ns 
each, for a total of ~2.2 µs of aMD simulations. After visiting several transient and 
unbounded states, a binding event occurred in all replicates.  
Firstly, we focused our attention on the role that His364, Ser371, Arg372 and 
Lys374 have in mediating the binding between the SH2 domain and KD. To do so, 
we computed the number of contacts between the aforementioned residues and both 
the SH2-KD linker and N-lobe of KD during the simulations (see Methods). As a 
result, His364, Ser371 and Arg372 often interact with the SH2-KD linker, having a 
frequency of contacts from 12 to 20% (see orange and red spots in Figure 5.4). This 
suggests that during our simulations, the linker adopts a secondary structure that 
facilitate the interaction with the SH2 domain, confirming our previous hypothesis 
according to which the linker plays a structural role in favoring the SH2-KD binding. 
Besides, His364, Ser371, Arg372 and Lys374 also interact with the N-lobe. In 
particular, His364 preferably interact with a region in proximity of the b3-aC loop 
(see Figure 5.4). Instead, Ser371, Arg372 and Lys374 rather bind the back of KD in 
between the b2-b3 loop and the aC helix. (see Figure 5.4). These results indicate that 
His364, Ser371, Arg372 and Lys374 favor the formation of SH2-KD complex, 
because they interact directly with precise portions of both the linker and N-lobe of 
KD. Notably, these findings are in line with previous bioinformatics and biochemical 
studies, further confirming the role of His364, Ser371, Arg372 and Lys374 in 
stabilizing the bound form of SH2-KD. 
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Figure 5.4. Representation of contact frequency of His364, Ser371, Arg372 and 
Lys374 mapped onto SH2-KD complex (starting frame of all MD trajectories). The 
color code represents the frequency of contacts along the simulations.     
	  
Comparison of aMD simulations with SAXS data. At this point, we performed a 
cluster analysis to retrieve the most populated configurations of the SH2-KD 
complex sampled during the MD simulations and compare them with the SAXS data 
generated by our collaborators. The final goal is to retrieve SH2-KD configurations 
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having a theoretical SAXS scattering curve similar to the experimental one and fit 
the complexes in the SAXS envelop. Overall this procedure allows us to determine 
the most probable SH2-KD complexes that better fit the experimental data.  
The cluster analysis returned nine main clusters which are populated from ~1 to 
~30% of the simulations time (see Figure 5.5). From each cluster, we extracted the 
centroid structure, which are depicted together in Figure 5.5. From here, it can be 
noted that the SH2 domain assumed three main spatial orientations respect to KD. In 
particular, it can be found on the “central-right side” of KD, as cluster 1 (C1) and C2, 
on the “back side” of KD, as C3, C7 and C9 and finally on the “top side” of KD as 
C4, C5, C6 and C8. Interestingly, the top side orientation of the SH2 domain is the 
most populated one (47.2% against 17.6% and 35.2% of the central-right side and 
back side, respectively), suggesting that the elongated complex is the most probable 
for Btk kinase. It is worth pointing out that some clusters have been submitted to a 
re-cluster analysis in order to remove the noise and define sub-configurations of the 
main cluster. For example, C3 has been divided in six sub-clusters (i.e. C3-1 to C3-
6). Through this procedure we obtained a total of 28 clusters.  
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Figure 5.5. Representation of the centroids of the nine clusters obtained from aMD 
ensemble. On the top the nine centroids are superimposed in order to distinguish the 
different SH2 spatial orientation. Also, the population of each cluster, in terms of 
percentage over the entire simulation, is reported. On the bottom, the nine centroids 
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are depicted separately. The SH2 is colored in cyan, the KD in grey, while the SH2-
KD linker in violet. The residues His364, Ser371, Arg372 and Lys374, discussed in 
the main body, are represented in orange.  
	  
	  
At this point, we employed the software Crysol to evaluate the theoretical 
scattering curves from the 28 cluster centroids and fit them to the experimental 
SAXS scattering curves. The quality of the fit is a function of the computed c2 value. 
The lower the value the better is the fitting with the experimental curve. From this 
procedure, four clusters, namely C4-1, C4-2, C5-2 and C6, resulted to better fit the 
experimental scattering curve, having a c2 value of 2.14, 1.65, 1.94 and 2.50, 
respectively (see Figure 5.6 A and Table 5.1). Remarkably, all these clusters have an 
elongated conformation where the SH2 domain is on the top side of KD. These data 
are in agreement with the results obtained from cluster analysis, indicating that the 
most populated configurations of our aMD simulations are also those that better fit 
the experimental data. In addition, also the computed radii of gyration R(g) of C4-1, 
C4-2, C5-2 and C6 are in agreement with the experimental one (30.7, 31.7, 30.9 and 
31.2 Å of C4-1, C4-2, C5-2, C6, respectively, against 34.3 Å of experimental one). 
Subsequently, by means of Situs package, we performed an automated fitting 
procedure of C4-1, C4-2, C5-2 and C6 3D structures with the SAXS envelop. The 
docked structures are depicted in Figure 5.6 B. 
	  
	  
Table 5.1. List of theoretical chi-square values (c2) and radii of gyration (R(g)) of 28 
cluster centroids computed by means of Crysol.  
 c2 R(g)  c2 R(g) 
C1 25.79 24.30 C5-2 1.94 30.98 
C2 12.89 26.40 C5-3 5.96 28.79 
C3-1 8.14 27.45 C5-4 5.15 28.88 
C3-2 11.65 26.57 C5-5 4.42 29.54 
C3-3 7.94 27.52 C6 2.50 31.23 
C3-4 10.64 27.11 C7 9.52 27.17 
C3-5 7.96 27.76 C8-1 9.90 27.22 
C3-6 9.32 27.19 C8-2 9.28 27.67 
C4-1 2.14 30.71 C9-1 4.81 29.21 
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C4-2 1.65 31.79 C9-2 5.62 28.82 
C4-3 5.49 28.68 C9-3 11.87 26.73 
C4-4 5.13 28.93 C9-4 7.35 28.69 
C4-5 5.77 28.43 C9-5 7.21 28.02 
C5-1 8.36 27.67 C9-6 7.18 28.22 
	  
	  
	  
	  
	  
	  
 
Figure 5.6. A) Fitting of theoretical curves of C4-1, C4-2, C5-2 and C6 with the 
experimental scattering SAXS curve. B) Each 3D structure of the four centroids are 
docked into the SAXS envelop (cyan spheres). Only the best scored structures are 
reported.   
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Ongoing simulations and experiments.  
Preliminary results showed that selected structures retrieved from aMD-generated 
conformational ensemble have a spatial orientation of both KD and SH2 domain that 
is in agreement with SAXS experimental data. In particular, theoretical scattering 
curves of C4-1, C4-2, C5-2 and C6 structures present a low c2 value (2.14, 1.65, 1.94 
and 2.50, respectively). However, a further refinement of the models is needed to 
decrease the c2 of the four structures. Toward this aim, additional classical MD 
simulations of C4-1, C4-2, C5-2 and C6 structures are running in order to relax the 
structures. Selected frames from these 4 MD trajectories will be newly compared 
with the experimental SAXS scattering curve and only the best complexes will be 
fitted to the SAXS envelop.  
Besides, a new Btk SH2-KD construct has been prepared and will be submitted to 
new SAXS experiments by our collaborators. Unlike the construct used in the 
reported SAXS experiments, this new construct is not endowed of an N-terminal tag, 
which has been found to cause noise during the modeling of the SAXS envelop. In 
fact, as can be seen in Figure 5.6 B, the resulting map of the tagged-Btk is 
remarkably larger compared to the space occupied by the SH2-KD complex. This, in 
turn, negatively affects the docking of our atomistic models with the SAXS envelop.    
 
 
METHODS 
	  
Experimental section 
Size Exclusion and ITC. Btk kinase domain (residues 391-659) was expressed and 
purified. Btk SH2 domain (residues 270-390) was cloned into a pETM30 vector and 
expressed in E. coli during 4 hours at 28˚C. Cells were lysed in lysis buffer and 
purified using Ni-NTA beads (Qiagen). Protein was eluted in buffer containing 
50mM Tris pH7.5, 500nM NaCl, 1mM DTT, 300mM imidazole and 5% glycerol and 
the 6xHis-tag cleaved by TEV protease during overnight dialysis at 4˚C in buffer 
50mM Tris pH7.5, 150nM NaCl, 1mM DTT and 5% glycerol. After a reverse Ni-
NTA purification, the flow-through containing the SH2 domain was further purified 
by size exclusion chromatography in the same buffer, concentrated and frozen. 
Intermolecular interactions between the Btk kinase and SH2 domains were first 
tested by size exclusion chromatography. First, purified proteins were run separately 
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in a Superdex75 10-300 column (GE Healthcare) to verify their elution pattern. 
Then, a sample containing Btk kinase domain and SH2 at equimolar ratio was 
incubated at 4˚C during 4 hours and run on the S75 10-300 column to detect any 
peak shifts in case of interaction. The isothermal titration calorimetry (ITC) assay 
was performed using the MicroCal™iTC200 (GE Healthcare). Purified Btk kinase 
domain and SH2 were dialysed overnight against buffer containing 25mM Tris 
pH7.5, 40mM NaCl and 1mM TCEP at 4˚C. Thermodynamic measurement was done 
by placing 300 uL of 45uM KD in the sample cell and adding 100ul of hBtk-Sh2 
450uM (ratio 1:10) stepwise by 16 microinjections at 25˚C. Data was analyzed using 
the software provided by the fabricant. 
 
Small-angle X-ray scattering (SAXS). A kinase dead (D521N) version of Btk 
containing the kinase and SH2 domains (residues 270-659) was cloned into a 
pFAST-BAC-Htb vector and expressed in Sf9 insect cells for 72 hours at 28˚C (Bac-
To-Bac expression). Cells were lysed in buffer containing 50mM Tris pH7.5, 500nM 
NaCl, 1mM DTT, 10mM imidazole, 5% glycerol and 10U/ml benzonase. Lysate was 
centrifuged 35 minutes at 75,000xg and purified using Ni-NTA beads (Qiagen). 
Protein was eluted in buffer containing 50mM Tris pH7.5, 500nM NaCl, 1mM DTT, 
300mM imidazole and 5% glycerol and purified by size exclusion on a Superdex75 
16-60 column (GE Healthcare) in buffer containing 50mM Tris pH7.5, 150nM NaCl, 
1mM DTT and 5% glycerol. Purified protein was frozen and aliquoted with 
concentration ranges varying from 0.5 to 2.8mg/ml. Sample purity and molecular 
mass were verified by mass spectrometry, gel filtration and coomassie staining. 
Small-angle X-ray scattering (SAXS) measurements were performed at EMBL P12 
beamline (DESY, Hamburg). In brief, Btk SH2-Kinase protein samples were 
measured using an automatic robot228 at the beam line and data recorded at 10˚C 
using a PILATUS 1M pixel detector (DECTRIS), and data processing performed by 
automated pipeline. Further analysis of scattering I(0) and the radius of gyration (Rg) 
were performed in PRIMUS, pair-distance distribution function P(r) evaluated in 
GNOM, and porod volume and molecular mass estimated. Preliminary ab initio 
models were computed using DAMMIF229 and GASBOR230 for bead and dummy 
residue models respectively, using data from the range 0.02<s<0.15 Å.  
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Computational section 
System preparation. In this work, we simulated the binding of the SH2 domain on 
KD of Btk in presence and in absence of the linker sequence. These two systems are 
referred to as SH2-KD-Linker and SH2-KD, respectively. Both systems were 
modelled starting from the X-ray structure of KD and the NMR structure of the SH2 
domain with the PDB codes 1K2P and 2GE9, respectively. In detail, KD consists of 
residues from 397 to 654, while SH2 from 270 to 387. The SH2 domain was 
positioned on the top of KD at a distance of ~ 60 Å from it. The distance is measured 
considering center of mass of SH2 and N-lobe of KD. In SH2-KD-Linker system, the 
linker sequence (residues from 388 to 396) was manually according to the FASTA 
sequence. The models ware built by means of Maestro of Schrödinger suite. 
Hydrogens atom were using tleap of AmberTools14. All the MD simulations were 
performed in implicit solvent. The protein was parameterized using the ff14Bonlysc, 
which is ff99SB in combination with the side chain parameters form ff14SB. The 
GB-Neck2 implicit solvent model was employed in combination of mbondi3 radii 
(Nguyen, Simmerling 2013, 9, 2020-2034). We chose such set up because was 
successfully employed in a similar work carried out by Nguyen et al.231  
  
aMD simulations. Firstly, the system was minimized using steepest descent 
algorithm for 250 cycles and with conjugate gradient for the remaining 250 cycles. 
The system was heated until 300 K in 500 ps in Langevin dynamics using a collision 
frequency γ of 1 ps-1. SHAKE algorithm was employed and only bonds involving 
hydrogens were constrained. All the protein atoms were restrained applying a weight 
of 10 kcal/mol·Å2. In order to better equilibrate the linker, three additional steps MD 
simulation of 500 ps each were carried out, restraining only the SH2 and KD parts 
using a weight of 10, 1 and 0.1 kcal/mol·Å2. Finally, all the restraints were removed 
for the production phase which consisted of 5 ns of classical MD simulation. 
Accelerated MD (aMD) simulations were performed applying a boost potential to 
all dihedral angles of the system with the input parameters Edihe and αdihe, where: 
 
Edihe = Vdihe_avg + 4 · solute residues 
αdihe = 1/5 · 4 · solute residues 
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Vdihe_avg is the average dihedral energy obtained in the classical MD simulation.108 
Samples were collected every 0.2 ps. The simulations were run using PMEMD 
module of Amber14 wit GPU acceleration. 
 
Data analysis 
Prediction of anchor/interaction points of SH2 domain. Whiscy (What Information 
does Surface Conservation Yields) web server was adopted to predict the residues of 
the SH2 that might be the anchor points for the interaction with KD. In brief, whiscy 
is based on the assumption that conserved surface residues across homologues 
proteins have a high propensity to interact with other proteins.232 As input file of 
whiscy run, we gave a multiple sequence alignment (MSA), computed via M-coffee 
web server, of 32 tyrosine kinases and the Btk FASTA, as reference structure. 
Contacts analysis. Here, we identified the contacts between a set of residues in the 
SH2, which have been found to be important to mediate the SH2-KD interaction and 
the KD. The residues are His364, Ser371, Arg372 an Lys374. To do so, we 
employed an in-house tcl-based script that, for each frame of the trajectory, recorded 
the residues of KD around 5 Å of the aforementioned residues. The results were 
subsequently plotted directly of the KD structure using an in-house python-based 
script. The analysis was performed after merging all the 11 replicates for a total of 
~2.2 µs of aMD simulations.  
Clustering analysis. All the trajectories were submitted to a clustering procedure 
using an in-house software. First, the trajectories were submitted to a PCA analysis 
in order to dimensionally reduce the data. Only the a carbons were considered for 
the analysis. The eigenvectors that described the 80 % of the overall variance were 
retained for the analysis. Subsequently, the trajectory plotted on the relevant 
eigenvectors was submitted to the clustering procedure by applying a hierarchical 
scheme. Also here, the analysis was performed after merging all the 11 replicates.   
Scattering data analysis. Crysol233 was employed to fit the theoretical scattering of 
the atomic models with the experimental one. Atomic models with the lowest c2 
value were subsequently docked into the SAXS low-resolution map by means of 
Situs package.234  
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Chapter 6  	  
 
 
 
 
Drug discovery projects 
 
 
 
 
 
1. RhoJ 
	  
1.1. Introduction 
	  
Rho GTPases are proteins belonging to the Ras superfamily that play important 
role in several cell processes such as cell morphology, motility, proliferation, 
differentiation and apoptosis.235 Rho GTPases can be found in active GTP-bound and 
in the inactive GDP-bound conformation. Importantly, their activity is positively 
controlled by guanine nucleotide exchange factors and negatively controlled by 
GTPase-activating proteins. Once loaded with the GTP, the GTPase proteins bind to 
several substrates, activating a set of downstream effectors.236 The Rho GTPase 
family contains 21 members,237 among which is RhoJ (or TCL) a protein 
characterized only in 2000.236 RhoJ shares the 85% and the 78% amino acid 
similarity with TC10 and Cdc42, respectively. Like TC10 and Cdc42, RhoJ binds the 
Cdc42/Rac interacting binding domain (CRIB) of PAK and WASP.     
A study performed by Ho et al. demonstrated that RhoJ is a regulator protein that 
plays a fundamental role the resistance to chemotherapy in melanoma cells.238 In 
particular, RhoJ binds and activates PAK1 kinase in response to DNA damage, 
which in turn activate several downstream effectors leading to a decreased DNA 
damage–induced apoptosis. In addition, the same group found that RhoJ is also 
implicated in melanoma cell migration and invasion in vitro, by modulating actin 
cytoskeletal dynamics in a PAK1-dependent manner.239 Taken together this results 
indicated that RhoJ is a viable pharmaceutical target for the treatment of melanoma. 
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In particular, molecules that disable the RhoJ/PAK1 pathway might both increase the 
sensitivity of melanoma tumors to DNA damage and inhibit melanoma invasion and 
metastasis. In this context, we performed a structure-based virtual screening 
campaign in order to identify compounds able to target RhoJ/PAK1 interaction. As a 
result, we found six hit compounds active at low micromolar range, which currently 
are in the lead optimization phase in our labs.    
 
 
1.2. Computational methods 
	  
Protein preparation. Since the lack of X-ray structure of RhoJ protein, we built a 
homology model to use as receptor for the virtual screening campaign. As template 
structure, we decided to employ the Cdc42 protein in complex with the CRIB 
domain of Pak6 (PDB code 2ODB, resolution of 2.4 Å, Figure 6.1). Despite TC10 
has a higher sequence similarity with RhoJ than Cdc42 (85% and 78%, respectively), 
we decided to employ Cdc42 because 2ODB is the only structure complexed with a 
CRIB domain of PAK kinase. This choice allows building a more reliable model of 
RhoJ for the study of RhoJ/PAK1 interaction. By means of Prime software 
implemented in Maestro, we modeled the FASTA sequence of RhoJ on the Cdc42 
template. At this point, we prepared the protein by using the Protein Preparation 
Wizard workflow implemented in Maestro as well. According to this procedure 
hydrogen atoms were added and charges and protonation states were assigned 
titrating the protein at pH 7. Steric clashes were relieved by performing a small 
number of minimization steps, not intended to minimize the system completely. In 
our study, the minimization (OPLS force field) was stopped when the RMSD of the 
non-hydrogen atoms reached 0.30 Å. 
 
Ligands preparation. We employed a proprietary chemical collection available in 
the D3 Department at IIT for the virtual screening. This collection contains a diverse 
and nonredundant set of ~15,000 molecules, which are readily available for 
experimental testing. We prepared the molecules using LigPrep software 
implemented in Maestro. Firstly, we added hydrogens and generated ionization states 
at pH 7.4 ± 0.5. Then we generated various tautomers and all stereochemical isomers 
when not specified in the input structures. For each structure containing a ring 
moiety, the low-energy conformation was computed and retained. Lastly, a short 
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minimization step was carried out in order to relax the 3D structure of each 
molecule.  
At this point we filtered the resulting database in order to discard molecules that 
are not endowed of drug-like properties. For example, molecules poorly soluble or 
too large in size where excluded from the final database. To do so, we firstly 
computed the ADME descriptors for each molecule using QikProp software 
implemented in Maestro. As filter, we discarded all the molecules that do not respect 
the Lipinsky’s rule of five. In particular, this rule states that molecules having no 
more than 5 H-bond donors, no more than 10 H-bond acceptors, a MW less than 500 
Da and a partition coefficient (logP) not greater than 5 have properties that make 
them likely to be a candidate drug.             
  
Virtual screening. The first step of the virtual screening consisted on the 
identification of the pocket on the RhoJ surface to center the grid. To do so, we 
firstly analyzed the crystallographic complex of Cdc42 and the CRIB domain of 
PAK6 (PDB code 2ODB). In fact, due to high sequence similarity of both Cdc42-
RhoJ and the CRIB domain of PAK6-PAK1, it is reasonable to think that the 
interactions between Cdc42 and PAK6 are also conserved in RhoJ and PAK1. In 
Cdc42-PAK6 complex we identified a pocket on the Cdc42 surface in proximity of 
Ser71, Arg68, Tyr64 (see Figure 6.1). Interestingly, the Trp40 of PAK6 binds this 
pocket interacting via an H-bond with Ser71, suggesting that this interaction might 
be one of the anchor points that mediate the protein-protein interaction. Since this 
surface cavity is conserved also in RhoJ, displaying the same residues than in Cdc42 
and also the tryptophan is conserved in PAK1, we used this pocket to center the grid. 
The cubic grid box was centered on Ser89 of RhoJ having a side of the box of 26Å. 
We used Glide to perform the virtual screening, using Single Precision and retaining 
one pose for each ligand.    
 
1.3. Preliminary results 
 
After a visual inspection of the binding mode of the best scored molecules, we 
selected 50 compounds to be sent for biological evaluation. Among these, 8 
molecules resulted active with an IC50 of low-mid micromolar range. Interestingly, 
the binding mode of these molecules shows a common feature that is the interaction 
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via an H-bond with the Ser89. Also, these molecules bear a planar ring, single or 
condensed that overlap nicely with the Trp40 of PAK6 in 2ODB (Figure 6.1). Taken 
together these results confirm that the interaction with Ser89 is an important anchor 
point to allow the binding of protein-protein inhibitors.  
Currently in our labs, we are optimizing our compounds by small chemical 
modifications in order to increase the affinity with the receptor and to reach an 
optimal pharmacokinetic profile to study them in vivo.     
 
    
	  
 
Figure 6.1. A) Cdc42 protein (grey) in complex with the CRIB domain of PAK6 (red) 
and a GTP-like molecule (green) bound the GTP binding site. PDB code 2ODB. B) 
Close up view of the surface binding pocket of Cdc42. The Trp40, belonging to PAK6 
interacts via an H-bond with the Ser71 of Cdc42. C) Homology model of RhoJ. D) 
Binding mode of our hit compound (yellow). The scaffold of our compound overlaps 
well with the Trp40 of PAK6.    
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2. Acid Ceramidase 
	  
2.1. Introduction 
	  
Acid ceramidase (AC) is a cysteine amidase that hydrolyses the proapoptotic lipid-
derived messenger ceramide, a central molecule in sphingolipid metabolism and 
signaling. The expression of AC is abnormally high in several tumors, suggesting 
that dysregulation of ceramide metabolism could be linked to cancer development 
and progression.240, 241 Indeed, AC overexpression has been detected in various types 
of human cancer (e.g., melanoma, head and neck, prostate and colon cancer). 
Moreover, autoantibodies against AC have been found in serum of melanoma 
patients, suggesting that AC might also be utilized as biomarker for disease 
prognosis.242 There is also evidence that overexpression of AC may be related with 
higher resistance to pharmacological induction of apoptosis,243, 244 while AC 
inhibition sensitizes cancer cells to the action of anti-cancer therapeutics.243 Taken 
together, there is a growing body of evidence that indicates AC inhibition as an 
effective and innovative therapeutic approach to treat melanoma, as well as other 
cancers.245, 246  
Recently, potent inhibitors of AC have been identified,247, 248 such as the 
benzoxazolone carboxamide compounds. These inhibitors are quite potent, being 
active in the nanomolar range. Notably, this class of inhibitors block AC through the 
formation of a covalent adduct with the catalytic Cys-143. This covalent ligand-
target interaction is due to the presence of an urea group in the benzoxazolone 
carboxamide derivatives. The urea is cleaved to generate the covalent AC-inhibitor 
complex.249 Although promising, these benzoxazolone carboxamides derivatives 
however suffer from limited stability, which may hinder their future development 
towards clinically viable therapeutic agents. In order to understand what chemical 
features are necessary for potent AC inhibition, while improving chemical stability, 
we developed a set of different scaffolds. In analogy to their template benzoxazolone 
carboxamide derivatives, such compounds covalently inhibit AC. The general 
pharmacophore of this compounds combines 6+5 fused rings heterocycle with 
different aliphatic chains, linked via an urea functional group. In this context, I 
applied molecular modeling techniques focusing on the urea moiety, aiming at 
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understanding whether a particular urea spatial orientation is preferred for AC 
inhibition. 
 
 
2.2. Computational methods 
	  
We analyzed six compounds having a phenylbutyl moiety and benzimidazole 
derivative linked via an urea functional group (compound 8, 10, 19, 20, 21 and 22). 
We performed a force field-based coordinate scan of dihedral angle y formed by C2-
N3-C3’-O3’ atoms. To do this we employed the coordinate scan tool implemented in 
Maestro software, version 10.4. First the scaffold of the six compounds were 
manually designed replacing the phenylbutyl moiety with a methyl group. Then the 
360° coordinate scan was performed using the OPLS 2005 force field in water and 
incrementing the dihedral angle of 10°. 
 
 
2.3. Results 
	  
On the most potent and promising AC inhibitors (compounds 8, 10, 19, 20, 21 and 
22), we performed a coordinate scan analysis as a function of the dihedral angle y 
centered along the N3-C3’ axis of the C2-N3-C3’-O3’ atoms of the urea moiety. In 
this way, we could identify the most favorable conformations assumed by the urea, 
which undergoes nucleophilic attack by the Cys-143 residue in AC, generating the 
covalent enzyme-ligand adduct. In all compounds, we detected two energetic minima 
for y. One located at y = 180°, where the oxygen atom of the urea group at position 
1 is oriented toward the ‘outer’ side of the molecule (this conformation is named as 
eso, Figure 6.2) One located at y = 360°, where the oxygen atom points toward the 
‘inner’ side of the molecule (this conformation is named as endo, Figure 6.2). 
Interestingly, the most active compounds 8, 10 and 22 (IC50 of 0.9 ± 0.2, 2.5 ± 0.1 
and 1.0 ± 0.4 nM, respectively) prefer the eso conformation, while the others prefer 
endo conformations. Compound 8 is highly stabilized in eso thanks to the formation 
of an intramolecular H-bond between the amino group in position 2 and the oxygen 
atom of the urea. However, eso conformations are also preferred in 10 and 22, in the 
absence of this H-bond, indicating that such conformation is stabilized by the nature 
of the central core. In fact, the less active compounds 19, 20 and 21, (IC50 of >10000, 
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21.0 ± 6.9 and 13.9 ± 3.9 nM, respectively) prefer the endo conformation in which 
all of them form an intramolecular H-bond (Figure 6.2). These results thus suggest 
that the nucleophilic attack performed by Cys-143 is favored when the urea assumes 
the eso conformations, which therefore return more potent compounds, while amide 
bond distortion might be relevant for amide bond hydrolysis. The minimal energy 
conformation assumed by y and, in particular, the stabilization of the eso 
conformation seems to be an important prerequisite for the rational design of a potent 
compound against AC.  
 
	  
 
Figure 6.2. Coordinate scan plot for compounds 8, 10, 19, 20, 21 and 22. The pink 
dot in the plot locates the absolute minimum conformation of y. It can be in eso 
when y is 180° or in endo when y is 0° or 360°.  The 2D structure depicted in each 
graph represents the minimum conformation.   
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HRD motif as the central hub of the 
signaling network for activation loop 
autophosphorylation in Abl kinase 
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Supplementary text 
 
 
Structural model 
	  
As reported in the paper, we employed 1OPL chain B X-ray structure (resolution 
3.4 Å) to model the SH2-KDout and KDout systems. This structure has been also 
employed in recent computational studies that demonstrated the importance of the 
SH2 domain in favoring the catalytic activity of Abl kinase,129, 130 Notably, the KD of 
1OPL chain B matches well the 2HZI structure (another crystal of Abl, with better 
resolution), returning an RMSD of 0.4 Å. The backbone and the side chains of 
residues located in the most important structural motifs of KD overlap very well 
(namely, the A-loop, the DFG motif, the HRD motif and the αF helix), 
demonstrating only subtle differences in the exposed side chains (Fig. S13). Notably, 
we added the missing residues from the X-ray 1OPL chain B, namely the SH2-KD 
linker (residues 238-251 Abl isoform 1b numbering) and the terminal part of the αI 
helix (residues 519-531) to simulate the entire structure of the SH2-KD complex 
employed in the experimental studies performed by Lamontanara et al.128 
The SH2-KD linker is an important component of kinases. When Abl is in an auto-
inhibited form (as in the PDBid 1OPK), the SH2-KD linker interacts with domain 
residues stabilizing the closed form of the protein. Conversely, in the top-hat 
conformation, the SH2-KD linker is highly flexible and exposed to the solvent, as 
evidenced by SAXS data. Despite the linker does not directly interact with the 
kinase, the presence of the linker within the SH2-KDout system is essential to 
simulate a realistic model of the SH2-KD complex. Indeed, the linker could act as a 
leash, modulating the degree of freedom of both the SH2 domain and the KD, thus 
acting on the motions of the complex. The absence of this important structural 
feature could have led to unnatural or unrealistic motions that we wanted to avoid. 
The missing residues of the linker were added manually using as reference the 
FASTA sequence. Then, such portion was submitted to conformational search using 
the refinement tool of Prime where only the lowest energy conformer was retained 
(Fig. S11). The terminal portion of the αI helix was built by homology modeling, 
using the PDB code 2F4J as a template. Also, the Prime software was employed for 
this task. To reproduce the wild-type structure of SH2-KDout and KDout, the N382 
was replaced with an aspartate, while for the KDin system the P415 was replaced 
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with one histidine. The final structure of the SH2-KDout system includes residues 
from 138 to 531, while for the other systems (i.e. KDout, KDin, D440A-KDout, 
Closed-KDout) the final structures include residues from 248 to 531.  
Hydrogen atoms were added to each system. Subsequently, each system was 
immersed in a water box where the distance between the solute and the edge of the 
box was set to 10 Å. To neutralize the overall charge of the systems, a number of 
water molecules equal to the protein net charge were replaced by Na+ counter-ions. 
For all these three procedures, we used the tLEAP program of the AMBER 10 
package.	  
	  
	  
Classical molecular dynamics simulations 
 
To run classical MD simulations, we adopted a two-step protocol that includes: i) 
equilibration phase; ii) production phase. For the equilibration phase, each system 
was minimized using a steepest-descent minimization algorithm. Then, each system 
was heated from 0 to 300 K in 100 ps in NVT ensemble, keeping the Cα atoms fixed 
in their original positions, using an harmonic force constant of 1000 kJ mol-1 nm-2. 
Subsequently, 5 ns NPT simulation was carried out for each heated system at 300 K 
and 1 bar, maintaining Cα constrained. At this point, all the constraints were 
removed and the production phase of MD was carried out in the NPT ensemble. 
However, we considered the first 100 ns of the production phase as part of the initial 
equilibration and for this reason it was discarded from subsequent analyses. Bonds 
involving hydrogen atoms were restrained to their equilibrium length with the P-
LINCS algorithm. 
All simulations were performed using a short-range neighbor list cutoff of 9 Å, 
whereas long-range electrostatics were treated with the Particle Mesh Ewald method 
using a Fourier grid spacing of 1.6 Å and a cubic spline interpolation. This set up 
was employed also in a number of published works presenting microsecond-long 
MD simulations. Periodic boundary conditions in the three directions of Cartesian 
space were applied and a time step of 2 fs was set for integrating the equations of 
motion. All simulations were performed with Gromacs 4.6 software. A Parrinello-
Rahman barostat and a velocity-rescaling thermostat were employed with a 
relaxation time t of 2 ps and 0.1 ps, respectively. 
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All analyses were performed on snapshots saved every 50 ps from the original 
trajectory for a total of ~36000 (SH2-KDout), ~52000 (KDout), ~22000 (Replica1-
KDout), ~22000 (Replica2-KDout), ~26000 (KDin), ~26000 (D440A-KDout), ~26000 
(closed-KDout) frames.  
 
 
Analysis of structural data from MD 
 
To evaluate the stability of the systems during our MD simulations, we computed 
the RMSD of the protein backbone employing g_rms tool of Gromacs 4.6 package. 
In addition, for the closed-KDout system we performed a deeper analysis on the 
myristate binding pocket to ensure that the structure of the cavity did not undergo 
major perturbations after the removal of the co-crystallized myristic acid. The RMSD 
of the Cα atoms of the pocket, which is formed by the residues around 8 Å from the 
myristic acid, returned a value of 1.19 ± 0.33 Å, indicating an overall stability of this 
cavity. Also, we computed the contact map of the Cα atoms of the pocket using 
g_mdmat tool of Gromacs 4.6 package (Fig. S14). This analysis further confirms the 
overall stability of this cavity with a preservation of the overall structure of the 
pocket in our simulations, even in the absence of the co-crystallized binder.  
The principal component analysis (PCA) is a method employed to describe long 
trajectories in terms of a small number of variables, called principal components or 
essential degrees of freedom.166 Initially, we removed translation and rotation of the 
whole protein by superimposing each snapshot of the MD simulations onto the 
starting frame (i.e. X-ray structure). Then, we computed the 3N dimensional 
covariance matrix, C, of the atomic fluctuations. The elements of C are defined as: 
 𝑐"G = (𝑥" − 𝑥" )(𝑥G − 𝑥G ) 	  
	  
where 𝑥" and 𝑥G are the atomic coordinates and the brackets 	    indicate the average 
over time. Finally, a set of eigenvectors and eigenvalues were obtained through the 
diagonalization of the symmetric matrix C. The eigenvectors represent the directions 
in a multidimensional space, describing independent modes in atomic motions, while 
the eigenvalues represent their corresponding amplitudes. As a result, the first few 
PC modes characterize the dominant motions of the protein in each trajectory. The 
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most flexible parts of KD (i.e. the first 13 and the last 15 residues of the N- and C-
terminal tail, respectively) were discarded from the analysis in order to avoid the 
associated noise. The PCA was performed by using g_covar and g_anaeig tools of 
Gromacs 4.6 package. 
 
 
Classical metadynamics simulations 
	  
In the present work, the well-tempererd metadynamic simulations was coupled 
with multiple walkers technique in order to evaluate the energetic cost due to the A-
loop partial closure observed during the unbiased MD simulation.168 
In detail, we run two well-tempererd metadynamic simulations (i.e. two walkers) 
for each system, employing two different A-loop staring configurations: 1) the 
phosphorylatable fully-open conformation, in which CV (i.e. the distance between 
the phenolic oxygen of Y412 and the COM of carboxylate atoms of D440) is ~12 Å; 
2) the non-phosphorylatable partially closed conformation, in which CV is ~3 Å. For 
the first walker we extracted a frame from the respective equilibrated unbiased MD 
simulations. For the second walker, instead, we employed two different procedures 
for extracting the starting frame. For KDout system we extracted a frame from the 
unbiased MD simulations. Instead, for SH2-KDout and KDin systems we first 
performed a classical metadynamics simulation to enable the closure of the A-loop 
and to obtain a conformation in which CV is ~3 Å. In the classical metadynamics 
simulation the bias added to a defined collective variable S (i.e. CV) can be written 
as 
 
𝑉_	   𝑆, 𝑡 = 	   𝑑𝑡VL4 𝜔	  exp − 	   𝑆" 𝑅 − 𝑆" 𝑅 𝑡V
+2𝜎"+2"±J 	  	  	  	   	  
	  
	  
where σi is the width of the Gaussian, while ω is the ratio between the Gaussian 
height (W) and the deposition stride (tG). In our simulations we set σi = 0.3 Å, W = 2 
kJ/mol and tG = 500. 
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Cut-off definition for Y412 conformations 
	  
In the present work, we adopted a specific metric for discriminating the different 
Y412 conformations observed during the MD simulations. Such metric consists of 
two parameters: i) the RMSD of Y412 in respect to the 1OPL chain B X-ray position 
(RMSDY412); ii) the distance between Y412 and the reference residue D440 along the 
aF helix, chosen for its high stability along the MD simulations (d[Y412-D440]). The 
measurement of the RMSD among several conformations retrieved from the MD 
trajectories quantifies their similarity in respect to a reference one. In this case a low 
RMSDY412 value stands for Y412 conformations that are similar to the 
phosphorylatable state adopted in the X-ray 1OPL chain B. However, the drawback 
in using only the RMSDY412 value is that we could not distinguish if an increase of 
the RMSD is due to a subtle change in the orientation of Y412 side chain or to a 
displacement of the entire Y412 residue. For this reason we adopted an additional 
parameter (d[Y412-D440]) that gives us a clear view on the Y412 localization in 
respect to the native position. By plotting together the d[Y412-D440] and RMSDY412 
values we obtained a distribution of points that were subsequently submitted to a 2D 
histogram analysis to get the weighted population distribution. As a result we 
obtained four main states for KDout and one for SH2-KDout and KDin (see Fig. 3.4 in 
the main text). To separate the phosphorylatable from the non-phosphorylatable 
states we employed a cut-off on both RMSDY412 and d[Y412-D440]. For choosing the 
cut-off value we applied the following procedure:  first, the RMSDY412 and d[Y412-
D440] values of the three systems (i.e. SH2-KDout, KDout and KDin) were distributed 
separately into histograms using a bin width of 0.2 Å. Then, each histogram was 
fitted through a Gaussian function, (red, blue and green curves for SH2-KDout, KDout 
and KDin respectively in Fig. 3.4 of the main body of the paper). Here, we identified 
the cluster that contains the Y412 conformations that resemble the crystallographic 
one (i.e. cluster 1/ Conf-1 in Fig. 3.4). Finally, to quantitatively separate such cluster 
from the other ones, we used as RMSDY412 cut-off the middle value between the tails 
of first two blue gaussians, (starting from the bottom of Figure 3.4) that is 3.5 Å. 
Likewise, the d[Y412-D440] cut-off is the middle value between the tails of second and 
the third blue gaussians (starting from the left of Fig. 3.4) that is 8 Å. 
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Supplementary figures 
	  
	  
	  
	  
	  
Figure S1. Time evolution of the RMSD for the backbone atoms of KD (violet), A-
loop (orange), and Y412 (turquoise) of SH2-KDout (upper panel), KDout (central 
panel), and KDin (lower panel). The average RMSD values for the KD are 2.26 ± 
0.20 Å (SH2-KDout), 2.58 ± 0.33 Å (KDout) and 2.07 ± 0.36 Å (KDin), for the A-loop 
are 2.77 ± 0.35 Å (SH2-KDout), 3.71 ± 0.79 Å (KDout) and 1.37 ± 0.31 Å (KDin), while 
for the Y412 are 1.89 ± 0.51 Å (SH2-KDout), 6.11 ± 4.37 Å (KDout) and 1.31 ± 0.52 Å 
(KDin).  	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Figure S2. A) Representation of time evolution distances of d[Y412(NH)-F435(O)] (red), 
d[Y412(O)-F435(NH)] (orange), d[A414(NH)- N433(O)] (brown), d[A414(NH)-F435(O)] (green), 
d[A414(O)-F435(NH)] (blue), d[Y412(O)-I437(NH)] (violet) of the 7 simulated systems. The 
crystallographic H-bond network between b10 and bA-loop is formed by d[Y412(NH)-
F435(O)], d[Y412(O)-F435(NH)] and d[A414(NH)- N 433(O)]. The flip of bA-loop observed only 
in KDout trajectory leads to the formation of a new H-bond network between b10 and 
bA-loop formed this time by d[A414(NH)-F435(O)], d[A414(O)-F435(NH)] and d[Y412(O)-
I437(NH)]. In both D440A-KDout and closed-KDout the H-bond network between b10 
and bA-loop is not formed. B) Schematic representation of flip observed during the 
KDout trajectory. The phosphorylatable Y412 is represented in surface.	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Figure S3. A) Time evolution of RMSD backbone atoms of the HRD motif for SH2-
KDout (red), KDout (blue), KDin (green), D440A-KDout (purple) and closed-KDout 
(orange) trajectories. The average RMSD values for the HRD motif are 1.08 ± 0.29 
Å (SH2-KDout), 1.80 ± 0.54 Å (KDout), 0.70 ± 0.10 Å (KDin), 1.90 ± 0.26 Å (D440A-
KDout) and 1.46 ± 0.36 Å (Closed-KDout). B) Normalized frequency distributions of 
the RMSD values.	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Figure S4. Time evolution of d[R381-Y412] respectively for SH2-KDout (upper panel), 
KDout (middle panel) and KDin (lower panel). The dashed orange line represents the 
crystallographic value of 1OPL chain B structure (3.90 Å). The average value of 
d[R381-Y412] are 5.61 ± 1.21 Å (SH2-KDout), 12.37 ± 8.02 Å (KDout) and 5.69 ± 1.08 Å 
(KDin). 
	  
	  
	  
	  
	  
	  
Figure S5. Values along time of c1 dihedral angle of H380 of SH2-KDout (upper 
panel), KDout (middle panel) and KDin (lower panel).	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Figure S6. Representation of the frequency of the H-bond between the E305 along 
the aC helix and the R381 located at the HRD motif in the KDout trajectory. The 
black dots, evidenced by the orange square, indicate the presence of an H-bond 
between such residue pair that becomes more frequent in the last part of the KDout 
trajectory (i.e. when the Y412 is in Conf-4).     	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Figure S7. A) Time evolution of d[Y412-D440] in Replica1-KDout (upper panel) and 
Replica2-KDout (lower panel). Both trajectories start in Conf-3, where the d[Y412-
D440] is ~3Å, but at ~0.3 and 0.55 µs the distance elongates reaching ~12Å for 
Replica1-KDout and Replica2-KDout , respectively. B) 2D plot of Replica1-KDout (left 
panel) and Replica2-KDout (right panel) trajectories data points projected along 
d[Y412-D440] –X axes- and the RMSDY412 –Y axes-. In both systems, the Y412 visited 2 
states: the staring Conf-3 and the phosphorylatable Conf-1. C) Normalized 
frequency distribution of R381f dihedral angle in Replica1-KDout (grey dashed line), 
Replica2-KDout (black line) trajectories. 
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Figure S8. Time evolution of the RMSD of the backbone atoms of KD (violet), A-
loop (orange) and Y412 (turquoise) of D440A-KDout (upper panel) and Closed-KDout 
(lower panel) simulations. The average RMSD values for the KD are 2.82 ± 0.26 Å 
(D440A-KDout), 3.25 ± 0.62 Å (Closed-KDout), for the A-loop are 4.60 ± 0.77 Å 
(D440A-KDout), 7.04 ± 1.82 Å (Closed-KDout), while for the Y412 are 7.81 ± 0.88 Å 
(D440A-KDout), 11.57 ± 5.27 Å (Closed-KDout).    
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Figure S9. A) 2D plot of D440A-KDout MD trajectory projected along d[Y412-A440] –
X axes- and RMSDY412 values –Y axes- values. The figure under the plot represents 
the most populated conformation. B) 2D plot of Closed-KDout MD trajectory 
projected along d[Y412-D440] –X axes- and RMSDY412 values –Y axes- values. The 
figures under the plot represent the most populated conformations. C) Frequency 
distribution of R381f dihedral angle in D440A-KDout (violet) and Closed-KDout 
(orange). 
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Figure S10. RMSD projection along time of the backbone A-loop respect to the 
closed conformation, assumed in 1OPJ X-ray (orange) and respect to fully open 
conformation as in 1OPL X-ray (violet) in Closed-KDout simulations.	  
	  
	  
	  
	  
	  
	  
 
Figure S11. Representation of the modeled SH2-KD linker (orange) of the SH2-
KDout system.  
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Figure S12. 2D plot of d[Y412-D440] values plotted against d[Y412(NH)-F435(O)] (which 
is a key H-bond for the formation of the two antiparallel b sheets b10-bA-loop H-
bond network) in the KDout trajectory. The A basin corresponds to those 
conformations in which the A-loop is fully open. The B and C basins correspond to 
those conformations in which the A-loop in partially closed. The conformations in A, 
B and C are defined as “structured” (see multiple walkers metadynamics paragraph 
in methods section) inasmuch the A-loop conserves the overall native assembly. This 
is evidenced by the proper formation of the b10-bA-loop H-bond network (light blue 
background). The increase of d[Y412-D440] values is related to the destabilization of 
the A-loop which assumes “unstructured” conformations (basin D) causing the 
rupture of the b10-bA-loop H-bond network (white background). Since in this work 
we focused only in computing the free energy profile of the A-loop fully open -> 
partial closed transitions among different Abl systems, we applied a cut-off on 
d[Y412-D440] (dotted black line) to discard the non-interesting “unstructured” A-loop 
conformations.         	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Figure S13. Overlap between 1OPL chain B X-ray structure (resolution 3.4 Å) and 
2HZI X-ray structure (resolution 1.7 Å). On the left side the two kinase domains are 
overlapped. On the right side, the superposition of key portions of KD (i.e. DFG 
motif, HRD motif, A-loop and αF-helix) is shown.      
	  
	  
	  
	  
	  
	  
	  
Figure S14. Contact map of residues of the myristate binding site in 1OPJ X-ray 
structure (upper triangular matrix) and in the closed-KDout MD simulations (lower 
triangular matrix). The contact map is calculated for the Cα atom around 8 Å from 
the myristic acid.	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PDB ID Chain ID Ligand ID Resolution Mutation Species DFG A-loop HRD-R(ϕ) αC-Helix Domain
1FPU A PRC 2.40 M.M. OUT CLOSED (+)77,96 ° IN KD
1FPU B PRC 2.40 M.M. OUT CLOSED (+)76,84° IN KD
1IEP A STI 2.10 M.M. OUT CLOSED (+)87,76° IN KD
1IEP B STI 2.10 M.M. OUT CLOSED (+)87,89° IN KD
1M52 A P17 2.60 M.M. OUT OPEN (-)84.41° IN KD
1M52 B P17 2.60 M.M. OUT OPEN (-)78.82° IN KD
1OPJ A STI +MYR 1.75 M.M. OUT CLOSED (+)85.47° IN KD
1OPJ B STI +MYR 1.75 M.M. OUT CLOSED (+)87.48° IN KD
1OPK A P16+MYR 1.80 D382N M.M. OUT OPEN (+)73.87° IN SH2-SH3-KD
1OPL A P16+MYR 3.42 D382N, K29R, E29D H.S. OUT OPEN (+)73.72° IN SH2-SH3-KD
1OPL B P16 3.42 D382N, K29R, E29D H.S. OUT OPEN (+)73.81° IN SH2-KD
2E2B A 406 2.20 H.S. OUT CLOSED (+)81.83° IN KD
2E2B B 406 2.20 H.S. OUT CLOSED (+)77.65° IN KD
2F4J A VX6 1.91 H396P H.S. IN OPEN (+)72.68° IN KD
2FO0 A P16+MYR 2.27 D382N H.S. OUT OPEN (+)80.44° IN SH2-SH3-KD
2G1T A 112 1.80 H.S. IN Src/like (+)74.07° OUT KD
2G1T B 112 1.80 H.S. IN Src/like (+)81.24° OUT KD
2G1T C 112 1.80 H.S. IN Src/like (+)80.53° OUT KD
2G1T D 112 1.80 H.S. IN Src/like (+)85.75 OUT KD
2G2F A 112 2.70 H396P H.S. Intermediate OPEN (-)60.45 OUT KD
2G2F B AGS 2.70 H396P H.S. OUT OPEN (-)73.34° IN KD
2G2H A P16 2.00 H396P H.S. Intermediate OPEN (-)68.95° OUT KD
2G2H B P16 2.00 H396P H.S. OUT OPEN (-)89.37° IN KD
2G2I A ADP 3.12 H396P H.S. IN OPEN (-)55.25° IN KD
2G2I B ADP 3.12 H396P H.S. IN OPEN (-)66.16° IN KD
2GQG A 1N1 2.40 H.S. IN OPEN (+)69.10° IN KD
2GQG B 1N1 2.40 H.S. IN OPEN (+)65.85° IN KD
2HIW A 7MP 2.20 H.S. OUT CLOSED (+)84.67° IN KD
2HIW B 7MP 2.20 H.S. OUT CLOSED (+)79.19° IN KD
2HYY A STI 2.40 H.S. OUT CLOSED (+)91.16° IN KD
2HYY B STI 2.40 H.S. OUT CLOSED (+)81.02° IN KD
2HYY C STI 2.40 H.S. OUT CLOSED (+)83.65° IN KD
2HYY D STI 2.40 H.S. OUT CLOSED (+)86.15° IN KD
2HZ0 A GIN 2.10 H.S. OUT OPEN/disordered (+)79.36° IN KD
2HZ0 B GIN 2.10 H.S. OUT N.A. (+)87.26° IN KD
2HZ4 A 4ST 2.80 H.S. IN OPEN (+)66.10° IN KD
2HZ4 B 4ST 2.80 H.S. IN OPEN (+)66.31° IN KD
2HZ4 C 4ST 2.80 H.S. IN OPEN (+)68.76° IN KD
2HZI A JIN 1.70 H.S. OUT OPEN (+)74.37° IN KD
2HZI B JIN 1.70 H.S. OUT OPEN (+)76.53° IN KD
2HZN A KIN 2.70 M.M. OUT CLOSED (+)87.41° IN KD
2QOH A P3Y 1.95 M.M. IN OPEN (+)78.16° IN KD
2QOH B P3Y 1.95 M.M. IN OPEN (+)74.38° IN KD
2V7A A 627 2.50 T315I H.S. IN OPEN (+)83.27° IN KD
2V7A B 627 2.50 T315I H.S. IN OPEN (+)77.78° IN KD
2Z60 A P3Y 1.95 T315I M.M. IN OPEN (+)73.73° IN KD
3CS9 A NIL 2.21 H.S. OUT CLOSED (+)85.05° IN KD
3CS9 B NIL 2.21 H.S. OUT N.A. (+)81.36° IN KD
3CS9 C NIL 2.21 H.S. OUT N.A. (+)81.89° IN KD
3CS9 D NIL 2.21 H.S. OUT CLOSED (+)79.28° IN KD
3DK3 A SX7 2.02 Y393F, L445P M.M. Intermediate OPEN (+)76.79° IN KD
3DK3 B SX7 2.02 Y393F, L445P M.M. Intermediate OPEN (+)76.90° IN KD
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Table S1. Properties of available X-ray structures of Abl kinase (ABL1 gene). From 
left to right: PDB code, chain, ID of ligand co-crystalized, resolution, mutation (if 
empty is the wild type structure), species (H.M. is Homo Sapiens, while M.M. is 
Mus Musculus), conformation of DFG motif, conformation of A-loop, dihedral angle 
value of R381 , orientation of the  C helix, domains crystalized.   
 
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
	  
3DK6 A SX7 2.02 Y253F, L445P M.M. OUT OPEN (+)73.35° IN KD
3DK6 B SX7 2.02 Y253F, L445P M.M. OUT OPEN (+)76.04° IN KD
3DK7 A SX7 2.01 T315I, L445P M.M. Intermediate OPEN (+)79.79° IN KD
3DK7 B SX7 2.01 T315I, L445P M.M. OUT OPEN (+)75.78° IN KD
3IK3 A 0LI 1.90 T315I M.M. OUT CLOSED (+)85.69° IN KD
3IK3 B 0LI 1.90 T315I M.M. OUT CLOSED (+)90.87° IN KD
3K5V A STI+STJ 1.74 M.M. OUT CLOSED (+)87.70° IN KD
3K5V B STI+STJ 1.74 M.M. OUT CLOSED (+)86.12° IN KD
3KF4 A B90 1.90 M.M. IN OPEN (+)80.64° IN KD
3KF4 B B90 1.90 M.M. IN OPEN (+)78.87° IN KD
3KFA A B91 1.22 M.M. OUT CLOSED (+)82.13° IN KD
3KFA B B91 1.22 M.M. OUT CLOSED (+)81.87° IN KD
3MS9 A STI+MS9 1.80 M.M. OUT CLOSED (not 
complete)
(+)83.07° IN KD
3MS9 B STI+MS9 1.80 M.M. OUT CLOSED (+)86.58° IN KD
3MSS A STI+MS7 1.95 M.M. OUT CLOSED (not 
complete)
(+)83.94° IN KD
3MSS B STI+MS7 1.95 M.M. OUT CLOSED (not 
complete)
(+)85.34° IN KD
3MSS C STI+MS7 1.95 M.M. OUT CLOSED (not 
complete)
(+)86.43° IN KD
3MSS D STI+MS7 1.95 M.M. OUT CLOSED (not 
complete)
(+)89.03° IN KD
3OXZ A 0LI 2.20 M.M. OUT CLOSED (not 
complete)
(+)81.82° IN KD
3OY3 A XY3 1.95 T315I M.M. OUT CLOSED (+)78.88° IN KD
3OY3 B XY3 1.95 T315I M.M. OUT CLOSED (+)81.96° IN KD
3PYY A STI+3YY 1.85 H.S. OUT CLOSED (+)91.69° IN KD
3PYY B STI+3YY 1.85 H.S. OUT N.A. (+)86.30° IN KD
3QRI A 919 2.10 H.S. OUT CLOSED (+)84.86° IN KD
3QRI B 919 2.10 H.S. OUT CLOSED (+)85.01° IN KD
3QRJ A 919 1.82 T315I H.S. OUT CLOSED (+)80.26° IN KD
3QRJ B 919 1.82 T315I H.S. OUT CLOSED (+)86.92° IN KD
3QRK A 9DP 2.30 H.S. OUT CLOSED (+)87.80° IN KD
3UE4 A DB8 2.42 H.S. OUT OPEN (-)83.80° IN KD
3UE4 B DB8 2.42 H.S. OUT OPEN (+)76.68° IN KD
4TWP A AXI 2.40 T315I H.S. IN OPEN (+)83.70° IN KD
4TWP B AXI 2.40 T315I H.S. IN OPEN (+)78.18° IN KD
4WA9 A AXI 2.20 H.S. OUT OPEN (-)84.31° N.A. KD
4WA9 B AXI 2.20 H.S. OUT OPEN (-)81.76° IN KD
4XEY A 1N1 2.89 H.S. Intermediate OPEN (-)78.66° OUT KD
4XEY B 1N1 2.89 H.S. Intermediate OPEN (-)79.90° OUT SH2-KD
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Supplementary text 
 
 
System Preparation 
All the systems simulated in the present work were prepared by means of 
AmberTools, version 10 and Gaussian for the ligand partial charge computation.  
 
PNP 
The PNP system consists of PNP homotrimeric unit with 9 DADME-ImmH ligand 
and phosphate ions. The PNP trimer was modeled starting from the PDB code 3K8O 
using the chains E, Q and Y. The missing fist residue (glutammate) in chains E and 
Q was added manually after superimposing the two chains with chain Y. The 
tautomerization of H257 was imposed epsilon according to 214. DADME-ImmH 
ligand was retrieved from PDB code 1RSZ and placed around PNP trimer, while 
phosphate ions were placed in the same positions found in PDB code 1RR6 X-ray 
structure. Partial charges of DADME-ImmH and phosphate ions were computed 
using HF/6-31G* theory level, imposing a net charge of +1 for DADME-ImmH. 
General Amber Force Field (GAFF) was employed to parameterize the ligands and 
the ions, while partial charges were fitted using the RESP procedure (via 
Antechamber). O2-P-OH and HO-OH-P angles were modified in order to avoid 
failures of the SHAKE algorithm.194 Finally, protein was parameterized with 
AmberFF99SB-ILDN force field and immersed in TIP3P water box of ~11,000,000 
Å3, containing nearly 100,000 atoms in total. 
 
Adenosinic Receptor (A2A) 
The A2A system was built using the PDB code 3UZC X-ray structure. The 
missing loop (residues 150-157) was modeled using PDB code 4EIY as template. 
Alanine was mutated to serine to reproduce the wild type system. The protein was 
embedded in a POPC membrane bilayer of 75 x 75 Å2 size with a water layer of 30Å 
for each side. The membrane was assembled with CharmmGUI server while the 
posing and the physical plugging of the protein within the bilayer was done with 
Membrane Tool present in BiKi LifeSciences. 
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Abl kinase 
For Abl kinase we defined 8 model systems, namely a) SH2-KDwt, b) SH2-
KDT231R, c) SH2-KDI164E, d) KDout, e) KDin, f) T315I-KDin, g) Myr/KDin and h) 
Myr/T315I-KDin. Systems a, b and c were built starting from the PDB code 1OPL 
chain B X-ray structure which is the KD of Abl in complex with the SH2 domain. 
For a comprehensive description of the modeling procedures see ref.207 In addition, 
for the modeling of b and c, we replaced threonine 231 with arginine and isoleucine 
164 with glutamate, respectively. Also the systems d and e, which are KD alone in 
DFG-out and DFG-in conformations, respectively, were prepared using PDB code 
1OPL chain B and 2F4J structures as reported in ref.207 System f was prepared by 
replacing threonine 315 with isoleucine from system e. System g was build starting 
from system e, manually adding the myristate molecule at the myristate pocket. To 
better fit the myristate we employed as reference the PDB code 1OPL chain A. 
Finally, system h was build starting from system g and mutating T315 with 
isoleucine. Point charges of myristate were computed at HF/6-31G* level theory, 
while the General Amber Force Field (GAFF) was used to parameterize the 
myristate. All the systems were parameterized with Amber99SB force field. 
  
Molecular dynamics (MD) simulations 
Pnp 
The system was first equilibrated for 350 ps in NVT ensemble in 5 steps: 150 ps 
constraining all protein heavy atoms using a harmonic constant 40 kcal mol-1 Å-2; 50 
ps constraining the protein backbone using a harmonic constant 20 kcal mol-1 Å-2; 50 
ps where the protein backbone is constrained at 10 kcal mol-1 Å-2 and 50 ps with a 
constraint of 1 kcal mol-1 Å-2 for the protein backbone. Then the system underwent to 
other 350 ps MD simulations in NPT ensemble at 1 bar. For the production phase we 
run about 1000 ns of simulations in NVT ensemble using ACEMD engine. The 
equation of motion was integrated every 2 fs. Bond involving hydrogen atoms were 
restrained to their equilibrium length with the SHAKE algorithm. A short-range 
nonbonded cutoff of 9 Å was applied, whereas long-range electrostatics was treated 
with the Particle Mesh Ewald method. Temperature was maintained at 300 K using 
Langevin thermostat and damping of 0.1 ps.   
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Adenosinic Receptor (A2A) 
The system was equilibrated for 300 ps in NVT ensemble employing 3 steps of 
100 ps each at 100, 200 and 300 K. In the first two steps a harmonic constraint of 
1000 kJ/mol/Å2 was applied at the protein backbone. Then, 1 ns at NPT ensemble 
was run to reach pressure equilibrium. The production was run for 100 ns in NPT 
ensemble. A short-range nonbonded cutoff of 11 Å was applied, whereas long-range 
electrostatics was treated with the PME method. Bussi-Parrinello thermostat was 
employed and to constraint all bonds LINCS algorithm was employed. Pressure was 
kept anisotropic (X,Y plane). MD simulations were performed with Gromacs 4.6.1 
engine.  
 
Abl kinase 
First the systems underwent to a heating phase, in which the systems reached 300 
K in 100 ps in NVT ensemble, keeping the Cα atoms fixed in their original positions, 
using an harmonic force constant of 1000 kJ/mol/Å2. Then the pressure was 
equilibrated running 5 ns of NPT simulation reaching 1 bar and maintaining Cα 
restrained. Production phase was performed in NPT ensemble. Bond involving 
hydrogen atoms were restrained with the LINCS algorithm. A short-range 
nonbonded cutoff of 9 Å was applied, whereas long-range electrostatics was treated 
with the PME method. The equations of motion was integrated every 2 fs. The 
Parrinello-Rahaman barostat and the velocity-rescaling thermostat were employed 
with a relaxation time t of 2 ps and 0.1 ps, respectively. Coordinates of the systems 
were collected every 50 ps for each run. All the simulations were performed with 
Gromacs 4.6 engine. Overall, we collected ~1.8 µs for SH2-KDwt, ~1.5 µs for SH2-
KDT231R, ~1.3 µs for SH2-KDI164E, ~1.3 µs for KDin, ~1.3 µs for KDout , ~1.0 µs for 
T315I-KDin, ~0.8 µs for Myr/T315I-KDin and ~1.0 µs for Myr/KDin.  
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Supplementary figures 
 
 
 
 
Figure S1. Representation of atoms that underlie the three orthosteric pockets in 
PNP. The first and the second orthosteric pockets are represented by pID 9 (blue 
spheres) and pID 12 (green spheres). The union of pID4 and pID 13 (red and yellow, 
respectively) represent the third orthosteric pocket.   
	  
	  
	  
	  
	  
Figure S2. Pocket network on PNP system. Each pocket (i.e. node of the network) is 
represented as a green sphere, while the black line (i.e. edge of the network) 
represent the communication between pockets. Only pockets with a persistency over 
the simulation time higher that 30% are represented.    
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Supplementary tables 
	  
	  
Table S1. Time persistency of residues that define the ATP pocket in KDout and KDin.  
 
 
  KDout            KDin 
Residue pID 5 pID 28 pID 3 pID 5 pID 3 
L267 83,4 0 0 90,5 0 
G268 0 0 0 61 0 
G269 0 0 0 65,4 0 
G270 0 0 0 60,9 0 
Q271 0 0 0 72,8 0 
Y272 49,4 0 0 54,1 0 
G273 25,8 0 0 0 0 
E274 21,8 0 0 0 0 
V275 90,7 0 0 97,2 0 
A288 90,5 0 0 97,8 0 
V289 20,3 0 0 49,7 0 
K290 87,9 33,8 0 97,8 0 
T291 0 27 0 0 0 
L292 0 29,2 0 0 0 
K293 0 31,6 0 0 0 
E301 0 20,4 0 0 43,4 
F302 25,4 34,1 0 0 21,1 
K304 0 0 0 0 34,3 
E305 35,3 31,5 33,4 83 56,6 
A306 26,4 0 0 0 0 
V307 0 0 32,6 0 50,8 
M308 42,9 0 22,6 81,4 0 
V317 85,9 0 0 91,6 0 
L319 26 0 0 0 0 
I332 50,8 20,7 0 74,4 0 
T334 89,3 0 0 97,8 0 
E335 74,8 0 0 69,2 0 
F336 85 0 0 77 0 
N341 49,1 0 0 80,2 0 
P378 0 0 21,6 0 21,3 
R381 0 0 0 0 28,6 
D382 0 0 0 56,2 0 
R386 49,2 0 0 82 0 
N387 37,4 0 0 83,8 0 
C388 0 0 0 22,4 0 
L389 89,3 0 0 93,3 0 
A399 88,7 0 0 97,8 0 
D400 88,1 0 0 97,9 0 
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F401 90,5 0 0 64,3 48,7 
G402 0 0 0 32 58,8 
L403 29,7 0 26 33,7 52,1 
S404 0 0 29,3 0 55,6 
R405 0 0 24,5 0 61,4 
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